Keratitis-Ichthyosis-Deafness Syndrome

Mendelian MONDO:0007850 Pathograph 32 Show in embeddings browser Ectodermal Dysplasia Genodermatosis Syndromic Hearing Loss

Keratitis-ichthyosis-deafness (KID) syndrome is a rare autosomal dominant ectodermal dysplasia defined by the triad of vascularizing keratitis, erythrokeratodermic/ichthyosiform skin lesions, and congenital sensorineural hearing loss. It is caused by heterozygous missense variants in GJB2, encoding the gap-junction protein connexin 26 (Cx26); a small number of cases are caused by GJB6 (connexin 30). The single most common allele, p.D50N, accounts for the large majority of cases. The mechanism is the mirror image of the recessive GJB2 deafness at the same locus. DFNB1 is a loss-of-function, dosage disease: two null alleles leave too little Cx26 and cause nonsyndromic deafness with no skin phenotype. KID is a gain of function. A single missense allele - clustered in the cytoplasmic N-terminus and first extracellular loop, the domains that gate the channel - produces connexin hemichannels (undocked hexamers in non-junctional membrane) that open when they should be shut. The aberrant hemichannels lose their normal restraint by extracellular calcium and, for some alleles, become directly permeable to calcium, so keratinocytes are loaded with calcium and leak ATP. That is why a loss-of-function null causes only deafness while a single gain-of-function missense causes disease across every Cx26-expressing epithelium - epidermis, cornea, and the non-sensory cells of the cochlea. A complication of the simple "hyperactive homomeric hemichannel" account is that some severe KID alleles (S17F) form non-functional homomeric hemichannels in isolation, yet still cause florid disease. In skin, Cx26 is co-expressed with Cx43 and Cx30; the syndromic N-terminal mutations acquire the ability to oligomerise with the normally incompatible Cx43, producing hyperactive heteromeric hemichannels but non-functional heteromeric gap-junction channels. So the pathogenic hemichannel can be heteromeric rather than homomeric, and the disease combines a gain of hemichannel leak with a dominant loss of intercellular coupling. This entry is the autosomal dominant, connexin-related disease. Two separate autosomal recessive entities that carry "KID" in their names are deliberately out of scope (see notes): AP1B1-related KIDAR (a vesicular-trafficking disorder, MONDO:0859278) and VPS33B-related ARKID.

Ask OpenScientist

Ask a research question about Keratitis-Ichthyosis-Deafness Syndrome. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

1
Inheritance
11
Pathophys.
16
Phenotypes
2
Hypotheses
2
Gaps
32
Pathograph
2
Genes
6
Medical Actions
2
Subtypes
2
Differentials
3
Models
37
References
1
Deep Research
👪

Inheritance

1
Autosomal dominant HP:0000006
A single heterozygous GJB2 (or, rarely, GJB6) missense variant is sufficient. Most cases are sporadic de novo events - more than 90% of published cases - but vertical transmission through affected pedigrees is documented, and the recurrence of an identical allele in siblings of unaffected parents has been traced to germline (gonadal) mosaicism, which is important for genetic counselling of the lethal neonatal form.
Autosomal dominant inheritance Penetrance: INCOMPLETE Expressivity: VARIABLE
Show evidence (3 references)
PMID:11912510 SUPPORT Human Clinical
"One of these mutations was detected in six unrelated sporadic case subjects and also segregated in one family with vertical transmission of KID. These results indicate the presence of a common, recurrent mutation and establish its autosomal dominant nature."
Establishes the autosomal dominant nature of KID and that both sporadic and familial transmission occur at the same recurrent allele.
PMID:29159249 SUPPORT Human Clinical
"more than 90% of cases are caused by sporadic mutations predominantly in gap junction protein β2 (GJB2) on chromosome 13q11-q12"
Quantifies the predominance of sporadic (de novo) mutations over familial transmission.
PMID:20412116 SUPPORT Human Clinical
"These results establish the role of germline mosaicism in KID syndrome and warrant careful genetic counseling."
Documents germline (gonadal) mosaicism as the explanation for sibling recurrence from clinically unaffected parents.
◆

Subtypes

2
Lethal neonatal (fatal) form of KID
A severe form presenting in the first year of life with overwhelming skin infection and septicaemia, caused by specific GJB2 alleles - p.G45E (the prototype) and p.A88V. These alleles form the most hyperactive hemichannels. Recurrence in siblings of unaffected parents has been traced to germline mosaicism, enabling prenatal diagnosis.
Show evidence (2 references)
PMID:15633193 SUPPORT Human Clinical
"We identified a de novo GJB2 mutation G45E in a patient displaying the fatal form of the disease."
Ties the fatal neonatal form to the de novo G45E allele.
PMID:18024254 SUPPORT Human Clinical
"A rare form of the KID syndrome is a fatal course in the first year of life due to severe skin lesion infections and septicaemia."
Describes the lethal neonatal course and its infectious cause.
Hystrix-like ichthyosis-deafness (HID)
Historically separated from KID by spiny (hystrix-like) verrucous hyperkeratosis and electron-microscopic differences, HID was shown to carry the same connexin 26 mutation as KID and is now regarded as the same disease. Curated as a subtype label rather than a separate entry.
Show evidence (1 reference)
PMID:12072059 SUPPORT Human Clinical
"We show that KID and HID syndromes are identical at the molecular level and confirm the clinical impression that these syndromes are one and the same."
Establishes HID and KID as molecularly identical, justifying a subtype label rather than a separate entry.
◈

Mechanistic Hypotheses

2
Homomeric hyperactive-hemichannel gain of function
hyperactive_hemichannel CANONICAL
The leading and most-tested account: syndromic Cx26 mutants form homomeric hemichannels that open aberrantly, losing extracellular-calcium restraint (D50N, A40V, D50A, A88V, G12R) or becoming directly calcium-permeable (G45E), loading cells with calcium, leaking ATP, and driving cell death - a "leaky membrane" common to most KID alleles.
Pathograph links
Hyperactive Connexin 26 Hemichannels -> Keratinocyte Calcium Overload and ATP Release DIRECT
Heteromeric Cx26/Cx43(Cx30) hyperactive hemichannel
heteromeric_connexin_interaction EMERGING
The refinement needed to explain alleles (S17F) whose homomeric hemichannels are silent yet whose disease is severe: the mutant acquires the ability to oligomerise with the normally incompatible Cx43 (and with Cx30), forming hyperactive heteromeric hemichannels but non-functional heteromeric gap-junction channels. This unifies the gain-of-leak and loss-of-coupling arms and may be the general mechanism for N-terminal syndromic mutations.
Pathograph links
Hyperactive Connexin 26 Hemichannels -> Aberrant Heteromeric Interaction with Cx43 and Cx30 DIRECT
Aberrant Heteromeric Interaction with Cx43 and Cx30 -> Keratinocyte Calcium Overload and ATP Release DIRECT
?

Discussions and Knowledge Gaps

2
Does supporting-cell hemichannel hyperactivity actually cause the human sensorineural deafness of KID, given that the direct demonstration is in a mouse cochlea and Cx26 is absent from hair cells?
HUMAN MODEL MISMATCH kid_cochlear_hemichannel_to_deafness
Attached to
pathophysiology#Cochlear Supporting Cell Hemichannel Hyperactivity pathophysiology#Sensorineural Hair Cell Dysfunction
The cochlear mechanism rests on a Cx26-S17F knock-in mouse showing hyperactive supporting-cell hemichannels and stereocilia loss, plus a single human temporal bone (G45E) showing neuroepithelial dysplasia. No coupling or hemichannel measurement exists in a human KID cochlea, and the causal step from a supporting-cell leak to hair cell death is inferred rather than measured in human tissue. It is a mismatch, not an absence of evidence: the mouse result is clean but is one allele in one species.
Proposed experiments
Supporting-cell hemichannel activity and hair cell survival across KID alleles
kid_cochlear_supporting_cell_readout
Measure supporting-cell hemichannel current and hair cell survival in cochlear explants carrying the common human KID alleles (D50N, S17F) at native connexin stoichiometry, and test whether a hemichannel blocker preserves hair cells.
Would support
pathophysiology#Cochlear Supporting Cell Hemichannel Hyperactivity
Would refute
pathophysiology#Cochlear Supporting Cell Hemichannel Hyperactivity
Supporting outcome
  • Hyperactive supporting-cell hemichannels and hair cell loss are reproduced by the common human alleles and are prevented by hemichannel blockade.
Refuting outcome
  • Supporting-cell hemichannel activity is normal for the common alleles, so the deafness requires a mechanism other than the supporting-cell leak.
Show evidence (1 reference)
PMID:16885744 SUPPORT INDIRECT Human Clinical
"GJB2 mutations can cause deafness in KID syndrome, and possibly in other GJB2 mutant phenotypes, by disrupting cochlear differentiation."
The only human cochlear observation available, and it is a single temporal bone framed as a hypothesis about cochlear differentiation - which is the scope of the human evidence this mismatch is about. INDIRECT because it supports the size of the gap rather than the mouse mechanism itself.
Is the pathogenic hemichannel in KID homomeric Cx26, or does it require heteromeric assembly with Cx43/Cx30?
CONTROVERSY kid_homomeric_vs_heteromeric_mechanism
Attached to
pathophysiology#Hyperactive Connexin 26 Hemichannels pathophysiology#Aberrant Heteromeric Interaction with Cx43 and Cx30
Most alleles form hyperactive homomeric hemichannels, which is the canonical account, but S17F forms non-functional homomeric hemichannels yet causes severe disease, and only becomes hyperactive when co-expressed with Cx43 or Cx30. Whether the heteromeric route is a special case for a few alleles or the general mechanism for all N-terminal syndromic mutations is unresolved, and it matters for therapy: an allele-agnostic hemichannel blocker versus an allele-specific silencing approach make different bets on this question.
Show evidence (2 references)
PMID:25625422 SUPPORT In Vitro
"some syndromic mutations, like Cx26S17F, lead to non-functional HCs, but they still developed a severe KID syndrome phenotype"
States the observation that the homomeric hyperactive-hemichannel account cannot explain, which is what makes this an open controversy rather than a settled mechanism.
PMID:23447037 SUPPORT In Vitro
"These results show that these two mutations exhibit a shared gain of functional activity and support the hypothesis that increased hemichannel activity is a common feature of human Cx26 mutations responsible for KID syndrome."
The other side of the controversy: the homomeric account, argued from alleles that do form hyperactive homomeric hemichannels.
⚙

Pathophysiology

11
Heterozygous Gain-of-Function GJB2 Missense Variant
Mechanism confidence: Established
The initiating lesion. A single GJB2 allele carries a missense change that substitutes a conserved residue in the cytoplasmic N-terminus or first extracellular loop of connexin 26 - the domains controlling channel gating and permeability. Unlike the recessive loss-of-function alleles at this locus, which give nonsyndromic deafness only, these alleles produce a channel that is still made and delivered but behaves aberrantly. p.D50N is by far the most common; p.S17F and p.G12R are recurrent; p.G45E and p.A88V cause a lethal neonatal form.
GJB2 hgnc:4284 HUGO Gene Nomenclature Committee (hgnc) Relation: this pathophysiological event involves this gene This pathophysiological event involves GJB2 (hgnc:4284). hgnc:4284 is a gene from the HUGO Gene Nomenclature Committee.
Genetic context GJB2 hgnc:4284 HUGO Gene Nomenclature Committee (hgnc) Relation: this genetic context concerns this gene This genetic context concerns GJB2 (hgnc:4284). hgnc:4284 is a gene from the HUGO Gene Nomenclature Committee. variant_origin: DE_NOVO zygosity: HETEROZYGOUS functional_impact_category: GAIN_OF_FUNCTION
Recorded as GAIN_OF_FUNCTION at the variant level: the mutant subunit adds a pathological activity (aberrant hemichannel opening) rather than merely failing, which is what distinguishes syndromic KID alleles from the recessive nonsyndromic null alleles at the same locus. Several alleles additionally exert a dominant-negative effect on co-expressed connexins (see downstream nodes), so a single category cannot capture every allele's full behaviour.
Downstream
Hyperactive Connexin 26 Hemichannels The mutant subunit assembles into hemichannels whose gating is deranged.
Show evidence (2 references)
PMID:11912510 SUPPORT Human Clinical
"In each of 10 patients with KID, we identified a point mutation leading to substitution of conserved residues in the cytoplasmic amino terminus or first extracellular domain of Cx26."
Localises the causal missense variants to the N-terminal and E1 gating domains of connexin 26.
PMID:19939300 SUPPORT INDIRECT Other
"Since nonsyndromic deafness is predominantly a loss-of-function disorder, it follows that the syndromic mutants must show an alteration, or gain, of function to cause skin disease."
States the loss-of-function-versus-gain-of-function logic that classifies KID alleles as gain-of-function. INDIRECT because it is a review's inference from the genotype-phenotype pattern rather than a direct assay of one allele.
Hyperactive Connexin 26 Hemichannels
Mechanism confidence: Established
Connexins oligomerise into hexameric hemichannels (connexons); in non-junctional membrane an undocked hemichannel connects the cytoplasm to the extracellular space. Syndromic Cx26 mutants form hemichannels that open when they should be closed. The two best-characterised aberrations are loss of the normal restraint by extracellular calcium (the channels stay open at physiological Ca2+, as for A40V and D50N) and, for some alleles, a channel that is itself directly permeable to calcium (G45E). The result is an inappropriate conductance across the plasma membrane that has been measured as increased whole-cell hemichannel current for D50N, D50A, A88V, G12R, G45E and A40V, and which accelerates cell death in low extracellular calcium.
Heteromeric Cx26/Cx43(Cx30) hyperactive hemichannel Homomeric hyperactive-hemichannel gain of function
calcium ion transmembrane transport GO:0070588 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased calcium ion transmembrane transport (GO:0070588). GO:0070588 is a biological process from the Gene Ontology. ↑ INCREASED
gap junction hemichannel activity GO:0055077 Gene Ontology (GO) Relation: this pathophysiological event involves this molecular function This pathophysiological event involves gap junction hemichannel activity, annotated with gap junction hemi-channel activity (GO:0055077), qualified as gain of function. GO:0055077 is a molecular function from the Gene Ontology. ⇑ GAIN OF FUNCTION
Experimental models
D50N patient-derived immortalized keratinocytes (KID-KC) CELL LINE Patient cells at the native heterozygous genotype reproduce the hyperactive hemichannel and impaired coupling, unlike prior models that expressed the mutant allele alone.
Downstream
Keratinocyte Calcium Overload and ATP Release Homomeric hyperactive-hemichannel gain of function
Aberrant Heteromeric Interaction with Cx43 and Cx30 Heteromeric Cx26/Cx43(Cx30) hyperactive hemichannel
Corneal Epithelial Gap Junction Dysfunction
Cochlear Supporting Cell Hemichannel Hyperactivity
Show evidence (4 references)
PMID:23797419 SUPPORT In Vitro
"D50N, the most frequent mutation associated with KID syndrome, produces multiple aberrant hemichannel properties, including loss of inhibition by extracellular Ca(2+), decreased unitary conductance, increased open hemichannel current rectification and voltage-shifted activation."
Documents the aberrant hemichannel behaviour of the commonest KID allele, including loss of extracellular-calcium inhibition.
PMID:23447037 SUPPORT In Vitro
"both Cx26-D50A and Cx26-A88V form active hemichannels that significantly increase membrane current flow compared with wild-type Cx26"
Directly measures increased hemichannel current for two KID alleles across three expression systems.
PMID:23447037 SUPPORT In Vitro
"support the hypothesis that increased hemichannel activity is a common feature of human Cx26 mutations responsible for KID syndrome"
States that hyperactive hemichannels are a shared property across KID alleles.
+ 1 more reference
Aberrant Heteromeric Interaction with Cx43 and Cx30
Mechanism confidence: Provisional
Why some severe KID alleles cause disease despite forming non-functional homomeric hemichannels. In skin Cx26 is co-expressed with Cx43 and Cx30, and wild-type Cx26 and Cx43 are normally oligomerisation-incompatible. The syndromic N-terminal mutations change that compatibility: they oligomerise with Cx43 into heteromeric channels that show exacerbated hemichannel activity but non-functional gap-junction channels, giving a combined gain of leak and dominant-negative loss of coupling. This resolves the S17F paradox, whose homomeric hemichannels are silent yet whose disease is severe. Graded PROVISIONAL because the demonstrations are in HeLa cells and Xenopus oocytes at experimenter-set expression ratios, and one patient-keratinocyte study did not reproduce Cx26/Cx43 co-localisation.
Heteromeric Cx26/Cx43(Cx30) hyperactive hemichannel
gap junction hemichannel activity GO:0055077 Gene Ontology (GO) Relation: this pathophysiological event involves this molecular function This pathophysiological event involves gap junction hemichannel activity, annotated with gap junction hemi-channel activity (GO:0055077), qualified as gain of function. GO:0055077 is a molecular function from the Gene Ontology. ⇑ GAIN OF FUNCTION
connexin complex GO:0005922 Gene Ontology (GO) Relation: this pathophysiological event involves this cellular component This pathophysiological event involves connexin complex (GO:0005922). GO:0005922 is a cellular component from the Gene Ontology.
Downstream
Keratinocyte Calcium Overload and ATP Release Heteromeric Cx26/Cx43(Cx30) hyperactive hemichannel
Loss of Gap Junction Intercellular Communication
Show evidence (2 references)
PMID:25625422 SUPPORT In Vitro
"heteromeric oligomer formed by Cx43/Cx26 (syndromic mutants) shows exacerbated hemichannel activity but nonfunctional GJCs"
Demonstrates the heteromeric hyperactive-hemichannel / non-functional gap-junction paradox for syndromic Cx26 mutants.
PMID:25625422 SUPPORT In Vitro
"Heterologous expression of these hyperactive heteromeric hemichannels increases cell membrane permeability, favoring ATP release and Ca(2+) overload."
Links the heteromeric hemichannel to the downstream ATP release and calcium overload node.
Loss of Gap Junction Intercellular Communication
Mechanism confidence: Established
Whether by failure of homomeric channels to couple or by a dominant-negative effect on Cx43/Cx30 partners, mutant Cx26 reduces functional gap-junction intercellular communication in the epithelia that normally depend on it. In the corneal epithelium the common D50N allele accumulates intracellularly and fails to form gap-junction plaques even when co-expressed with wild-type Cx26 or Cx30, consistent with a dominant-negative effect on connexon assembly.
gap junction-mediated intercellular transport GO:1990349 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased gap junction-mediated intercellular transport (GO:1990349). GO:1990349 is a biological process from the Gene Ontology. ↓ DECREASED
gap junction channel activity GO:0005243 Gene Ontology (GO) Relation: this pathophysiological event involves this molecular function This pathophysiological event involves decreased gap junction channel activity (GO:0005243). GO:0005243 is a molecular function from the Gene Ontology. ↓ DECREASED
Downstream
Disordered Keratinocyte Proliferation and Differentiation
Show evidence (2 references)
PMID:11912510 SUPPORT In Vitro
"mutant Cx26 was incapable of inducing intercellular coupling in vitro, which indicates its functional impairment"
Shows loss of intercellular coupling by the mutant channel.
PMID:15914609 SUPPORT In Vitro
"The transfection experiments suggest that KIDS Cx26(D50N) impairs intracellular formation and transport of connexons formed by Cx26 and -30, consistent with a dominant negative effect."
Demonstrates a dominant-negative loss of connexon assembly by the common KID allele in human corneal epithelial cells.
Keratinocyte Calcium Overload and ATP Release
Mechanism confidence: Established
The functional consequence of a leaky hemichannel in the keratinocyte: inappropriate opening loads the cell with calcium and releases ATP into the extracellular space. ATP acts on epidermal P2 purinergic receptors that regulate keratinocyte differentiation and proliferation, and calcium overload plus sustained leak drives keratinocyte death. Peptidoglycan from Staphylococcus aureus triggers additional hemichannel-dependent ATP release selectively in KID-mutant keratinocytes, coupling the leak to the infection that characterises the disease.
keratinocyte CL:0000312 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves keratinocyte (CL:0000312). CL:0000312 is a cell type from the Cell Ontology.
ATP export GO:1904669 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased ATP export (GO:1904669). GO:1904669 is a biological process from the Gene Ontology. ↑ INCREASED keratinocyte apoptotic process GO:0097283 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased keratinocyte apoptotic process (GO:0097283). GO:0097283 is a biological process from the Gene Ontology. ↑ INCREASED
Downstream
Disordered Keratinocyte Proliferation and Differentiation
Show evidence (3 references)
PMID:17428836 SUPPORT In Vitro
"Cx26-G45E hemichannels displayed significantly greater whole cell currents than wild-type Cx26, leading to cell lysis and death."
Connects hyperactive hemichannel current to keratinocyte death.
PMID:25625422 SUPPORT In Vitro
"Heterologous expression of these hyperactive heteromeric hemichannels increases cell membrane permeability, favoring ATP release and Ca(2+) overload."
Directly reports ATP release and calcium overload from the aberrant hemichannels.
PMID:22643125 SUPPORT In Vitro
"In KID mutant expressing cells, ATP release was significantly higher than in cells transfected with wild-type Cx26."
Shows pathogen-triggered ATP release is exaggerated in KID-mutant keratinocytes, linking the hemichannel leak to infection.
Disordered Keratinocyte Proliferation and Differentiation
Mechanism confidence: Established
Loss of coupling and calcium/ATP dysregulation together derange the tightly ordered program by which basal keratinocytes proliferate and then differentiate toward the cornified layer. The epidermis becomes hyperproliferative with abnormal differentiation - the cellular substrate of the clinical hyperkeratosis.
keratinocyte CL:0000312 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves keratinocyte (CL:0000312). CL:0000312 is a cell type from the Cell Ontology.
keratinocyte proliferation GO:0043616 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased keratinocyte proliferation (GO:0043616). GO:0043616 is a biological process from the Gene Ontology. ↑ INCREASED keratinocyte differentiation GO:0030216 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves dysregulated keratinocyte differentiation (GO:0030216). GO:0030216 is a biological process from the Gene Ontology. ↕ DYSREGULATED
Animal models
Cx26-G45E inducible transgenic mouse Mouse recapitulates Reproduces the hyperproliferative, abnormally differentiated epidermis and the clinical scaling/hyperkeratosis.
Downstream
Epidermal Barrier Failure and Hyperkeratosis
Show evidence (2 references)
PMID:22031297 SUPPORT Model Organism
"Histopathology included hyperplasia, acanthosis, papillomatosis, increased cell size, and osteal plugging."
Reports the hyperproliferative, abnormally differentiated epidermis in a KID mouse model.
PMID:11912510 SUPPORT INDIRECT Human Clinical
"a clinical triad that indicates a failure in development and differentiation of multiple stratifying epithelia"
Frames KID as a disorder of epithelial differentiation. INDIRECT: the phrase is the paper's characterisation of the syndrome rather than a differentiation assay.
Epidermal Barrier Failure and Hyperkeratosis
Mechanism confidence: Established
The hyperproliferative, poorly differentiated epidermis produces a defective stratum corneum: transgenic KID mice show impaired epidermal calcium homeostasis and an abnormal stratum-corneum lipid composition that degrades the water barrier, clinically visible as erythrokeratoderma, ichthyosiform scaling, palmoplantar keratoderma and follicular hyperkeratosis. This entry does NOT conform to the epidermal_cornification_failure module: that module scopes itself to primary lesions of the terminal cornification enzymes/structural proteins (TGM1, FLG, ALOX, ABCA12, STS, SPINK5), whereas here the barrier failure is secondary to connexin-driven keratinocyte dysregulation.
establishment of skin barrier GO:0061436 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased establishment of skin barrier (GO:0061436). GO:0061436 is a biological process from the Gene Ontology. ↓ DECREASED
epidermis UBERON:0001003 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in epidermis, annotated with skin epidermis (UBERON:0001003). UBERON:0001003 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Ichthyosiform Erythrokeratoderma
Palmoplantar Keratoderma
Follicular Hyperkeratosis
Impaired Cutaneous Host Defense and Chronic Inflammation
Show evidence (1 reference)
PMID:26777423 SUPPORT Model Organism
"Transgenic mouse models expressing connexin26 KID mutations reproduce human phenotypes and present impaired epidermal calcium homeostasis and abnormal lipid composition of the stratum corneum affecting the water barrier."
Ties hyperactive hemichannels to impaired epidermal calcium homeostasis and a defective permeability barrier.
Impaired Cutaneous Host Defense and Chronic Inflammation
Mechanism confidence: Provisional
Barrier failure plus a keratinocyte-intrinsic immune defect predisposes to chronic mucocutaneous candidiasis and recurrent bacterial superinfection. Beyond the physical barrier, KID keratinocytes down-regulate immune response-associated genes (IL15, CCL5, IL1A, IL23R, TLR5), and their hemichannels amplify inflammatory ATP signalling in response to Staphylococcus aureus peptidoglycan. Chronic infection and inflammation, together with the intrinsic proliferative drive, create the microenvironment in which squamous cell carcinoma arises.
keratinocyte CL:0000312 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves keratinocyte (CL:0000312). CL:0000312 is a cell type from the Cell Ontology.
inflammatory response GO:0006954 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased inflammatory response (GO:0006954). GO:0006954 is a biological process from the Gene Ontology. ↑ INCREASED
Downstream
Recurrent Mucocutaneous Infections
Cutaneous Squamous Cell Carcinoma
Hidradenitis Suppurativa
Show evidence (3 references)
PMID:30150638 SUPPORT In Vitro
"the expressions of IL15, CCL5, IL1A, IL23R and TLR5 are down-regulated in keratinocytes expressing Cx26-D50N, suggesting that immune deficiency in KID syndrome expressing Cx26-D50N might be associated not only with skin barrier defects, but also with the down-regulated expression of immune..."
Documents a keratinocyte-intrinsic immune gene defect beyond the physical barrier.
PMID:22643125 SUPPORT In Vitro
"KID mutants form channels that can be triggered by the pro-inflammatory mediator PGN from opportunistic pathogens but not skin commensals"
Links pathogen sensing to hemichannel-mediated inflammatory signalling in KID keratinocytes.
PMID:11912510 SUPPORT INDIRECT Human Clinical
"Decreased host defense and increased carcinogenic potential in KID illustrate that gap junction communication plays not only a crucial role in epithelial homeostasis and differentiation but also in immune response and epidermal carcinogenesis."
Connects the connexin defect to both impaired host defence and carcinogenesis. INDIRECT as it is the paper's synthesis rather than a single measured result.
Corneal Epithelial Gap Junction Dysfunction
Mechanism confidence: Provisional
Gap-junction communication in the human corneal epithelium is carried by Cx26, Cx30, Cx31.1 and Cx43. The common D50N mutant fails to form corneal gap-junction plaques, and the resulting epithelial dysfunction produces recurrent epithelial defects, corneal surface instability, limbal stem cell deficiency, and the progressive stromal vascularization that defines the "keratitis" of KID and can end in scarring and blindness.
corneal epithelial cell CL:0000575 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves corneal epithelial cell (CL:0000575). CL:0000575 is a cell type from the Cell Ontology.
angiogenesis GO:0001525 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves increased angiogenesis (GO:0001525). GO:0001525 is a biological process from the Gene Ontology. ↑ INCREASED
corneal epithelium UBERON:0001772 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in corneal epithelium (UBERON:0001772). UBERON:0001772 is an anatomical location from the Uberon multi-species anatomy ontology.
Downstream
Vascularizing Keratitis
Corneal Neovascularization
Limbal Stem Cell Deficiency
Visual Impairment
Show evidence (2 references)
PMID:15914609 SUPPORT In Vitro
"Gap junction communication in the human corneal epithelium is mediated by Cx26, -30, -31.1, and -43."
Establishes that Cx26 participates in corneal epithelial gap-junction communication, the network disrupted in KID.
PMID:15691545 SUPPORT Human Clinical
"Lid abnormalities, corneal surface instability, limbal stem cell deficiency with resulting corneal complications, and dry eye are the main ocular manifestations."
Identifies limbal stem cell deficiency and corneal surface instability as the core ocular lesions.
Cochlear Supporting Cell Hemichannel Hyperactivity
Mechanism confidence: Provisional
Cx26 is not expressed in cochlear hair cells but is expressed throughout the non-sensory (supporting) epithelial cells. In a Cx26-S17F knock-in mouse cochlea, supporting cells develop hyperactive hemichannels - forming with Cx30, and insensitive to hemichannel blockers, calcium and lanthanum - that admit excess calcium and cause cellular damage, accompanied by loss of hair cell stereocilia. This relocates the syndromic deafness lesion to a leaky hemichannel in the supporting-cell network rather than to loss of potassium recycling, the account for the recessive nonsyndromic form.
organ of Corti supporting cell CL:0002490 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves organ of Corti supporting cell (CL:0002490). CL:0002490 is a cell type from the Cell Ontology.
gap junction hemichannel activity GO:0055077 Gene Ontology (GO) Relation: this pathophysiological event involves this molecular function This pathophysiological event involves gap junction hemichannel activity, annotated with gap junction hemi-channel activity (GO:0055077), qualified as gain of function. GO:0055077 is a molecular function from the Gene Ontology. ⇑ GAIN OF FUNCTION
spiral organ of Corti UBERON:0002227 Uberon multi-species anatomy ontology (UBERON) Relation: this pathophysiological event occurs in this anatomical location This pathophysiological event occurs in spiral organ of Corti, annotated with spiral organ of cochlea (UBERON:0002227). UBERON:0002227 is an anatomical location from the Uberon multi-species anatomy ontology.
Animal models
Cx26-S17F knock-in mouse Mouse recapitulates Reproduces hyperactive supporting-cell hemichannels and stereocilia loss in the organ of Corti.
Downstream
Sensorineural Hair Cell Dysfunction
Show evidence (2 references)
PMID:36699003 SUPPORT Model Organism
"cochlear explants from a constitutive knock-in Cx26S17F mouse or conditional in vitro cochlear expression of Cx26S17F produces hyperactive HCs in supporting cells of the organ of Corti. These conditions also produce loss of hair cells stereocilia."
Demonstrates hyperactive supporting-cell hemichannels in a KID cochlea and links them to hair cell stereocilia loss.
PMID:25386120 SUPPORT INDIRECT Other
"Cx26 is not expressed in hair cells, but is widely expressed throughout the non-sensory epithelial cells of the cochlea."
Establishes the cellular localisation that makes the supporting cell, not the hair cell, the primary cochlear target. INDIRECT: a review's statement of expression pattern.
Sensorineural Hair Cell Dysfunction
Mechanism confidence: Provisional
Hair cell dysfunction and loss follow the supporting-cell lesion. A temporal bone from a G45E KID infant showed dysplasia of the cochlear and saccular neuroepithelium, and the S17F mouse loses hair cell stereocilia - so the endpoint is degeneration of the sensory epithelium downstream of the supporting-cell hemichannel defect. Conforms to the sensorineural hair cell loss module's hair-cell node, entered here through supporting-cell hemichannel hyperactivity rather than the module's generic insult.
cochlear inner hair cell CL:0000589 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves cochlear inner hair cell (CL:0000589). CL:0000589 is a cell type from the Cell Ontology. cochlear outer hair cell CL:0000601 Cell Ontology (CL) Relation: this pathophysiological event involves this cell type This pathophysiological event involves cochlear outer hair cell (CL:0000601). CL:0000601 is a cell type from the Cell Ontology.
sensory perception of sound GO:0007605 Gene Ontology (GO) Relation: this pathophysiological event involves this biological process This pathophysiological event involves decreased sensory perception of sound (GO:0007605). GO:0007605 is a biological process from the Gene Ontology. ↓ DECREASED
Downstream
Congenital Sensorineural Hearing Impairment
Show evidence (1 reference)
PMID:16885744 SUPPORT Human Clinical
"The primary inner ear abnormality was dysplasia of the cochlear and saccular neuroepithelium."
Human temporal-bone evidence that the KID cochlear lesion is dysplasia of the sensory neuroepithelium.
⬡

Pathograph

Use the checkboxes to hide or show graph categories. Hover nodes for evidence and cross-linked metadata.
Pathograph: causal mechanism network for Keratitis-Ichthyosis-Deafness Syndrome Interactive directed graph showing how pathophysiology mechanisms, phenotypes, genetic factors and variants, experimental models, environmental triggers, and treatments relate through causal and linked edges.
●

Phenotypes

16
Cardiovascular 1
Keratoconjunctivitis Sicca HP:0001097 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Keratoconjunctivitis sicca (HP:0001097). HP:0001097 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:15691545 SUPPORT Human Clinical
"recurrent corneal epithelial defects, superficial and deep corneal stromal vascularization with scarring, keratoconjunctivitis sicca"
Lists keratoconjunctivitis sicca among the ocular manifestations.
Digestive 1
Tongue Squamous Cell Carcinoma Squamous cell carcinoma of the tongue HP:0030413 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Squamous cell carcinoma of the tongue (HP:0030413). HP:0030413 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:17381453 SUPPORT Human Clinical
"One patient presented at the age of 18 years with a fatal carcinoma of the tongue, an extremely rare reported complication."
Documents fatal tongue carcinoma as a rare mucosal neoplastic complication.
Ear 1
Congenital Sensorineural Hearing Impairment HP:0008527 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Congenital sensorineural hearing impairment (HP:0008527), qualified as congenital onset. HP:0008527 is a phenotype from the Human Phenotype Ontology.
Onset: CONGENITAL
Show evidence (1 reference)
PMID:11912510 SUPPORT Human Clinical
"characterized by vascularizing keratitis, profound sensorineural hearing loss (SNHL), and progressive erythrokeratoderma"
Names profound sensorineural hearing loss as one of the three defining features.
Eye 5
Vascularizing Keratitis HP:0000491 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Vascularizing keratitis, annotated with Keratitis (HP:0000491). HP:0000491 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:37755702 SUPPORT Human Clinical
"Main ophthalmic features were vascularizing keratopathy, ocular surface disease, hyperkeratotic lid lesions, recurrent epithelial defects, and corneal stromal scarring."
Human case series documenting vascularizing keratopathy and corneal scarring as the core ocular features.
Corneal Neovascularization HP:0011496 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Corneal neovascularization (HP:0011496). HP:0011496 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:12527832 SUPPORT Human Clinical
"We report the case of a 30-year-old woman with KID (keratitis ichthyosis deafness) syndrome consulting for massive corneal neovascularization."
Documents massive corneal neovascularization in a KID patient.
Limbal Stem Cell Deficiency HP:0032107 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Limbal stem cell deficiency (HP:0032107). HP:0032107 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:30371567 SUPPORT Human Clinical
"We present 5 eyes of 3 patients with KID syndrome that developed LSCD and underwent OSST."
Documents limbal stem cell deficiency in a KID case series.
Photophobia HP:0000613 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Photophobia (HP:0000613). HP:0000613 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:29159249 SUPPORT Human Clinical
"Ocular involvement occurs in 95% of patients with KID syndrome and includes photophobia and blepharitis in early childhood progressing to vascularizing keratitis, neovascularization, and scarring"
Documents photophobia as an early feature within the 95%-frequent ocular involvement.
Visual Impairment HP:0000505 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Visual impairment (HP:0000505). HP:0000505 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:15691545 SUPPORT Human Clinical
"Visual acuity ranged from normal to severe visual loss."
Documents the range up to severe visual loss across KID patients.
Immune 2
Recurrent Mucocutaneous Infections Chronic mucocutaneous candidiasis HP:0002728 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Chronic mucocutaneous candidiasis and bacterial superinfection, annotated with Chronic mucocutaneous candidiasis (HP:0002728). HP:0002728 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:23384797 SUPPORT Human Clinical
"Chronic mucocutaneous candidiasis and/or superinfection of skin lesions commonly occur and warrant aggressive therapeutic intervention."
Documents chronic candidiasis and bacterial superinfection as common KID complications.
Hidradenitis Suppurativa Acne inversa HP:0040154 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Hidradenitis suppurativa, annotated with Acne inversa (HP:0040154). HP:0040154 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:16172043 SUPPORT Human Clinical
"our patient presented a follicular occlusion triad with hidradenitis suppurativa (HS, alias acne inversa), acne conglobata and dissecting cellulitis of the scalp, leading to cicatricial alopecia"
Documents hidradenitis suppurativa as part of the follicular occlusion triad in a D50N KID patient.
Integument 6
Ichthyosiform Erythrokeratoderma Congenital ichthyosiform erythroderma HP:0007431 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Ichthyosiform erythrokeratoderma, annotated with Congenital ichthyosiform erythroderma (HP:0007431), qualified as congenital onset. HP:0007431 is a phenotype from the Human Phenotype Ontology.
Onset: CONGENITAL
Show evidence (1 reference)
PMID:11912510 SUPPORT Human Clinical
"characterized by vascularizing keratitis, profound sensorineural hearing loss (SNHL), and progressive erythrokeratoderma"
Names progressive erythrokeratoderma as one of the three defining features.
Palmoplantar Keratoderma HP:0000982 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Palmoplantar keratoderma (HP:0000982). HP:0000982 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:31705875 SUPPORT Human Clinical
"Skin involvement consists of erythrokeratodermic or verrucous plaques and palmoplantar keratoderma with alopecia and/or onychodystrophy"
Lists palmoplantar keratoderma among the cutaneous features of KID.
Follicular Hyperkeratosis HP:0007502 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Follicular hyperkeratosis (HP:0007502). HP:0007502 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:11912510 SUPPORT INDIRECT Human Clinical
"a clinical triad that indicates a failure in development and differentiation of multiple stratifying epithelia"
Supports the disordered follicular/epidermal keratinization underlying this feature. INDIRECT: the abstract does not name follicular hyperkeratosis itself, so it supports the class of lesion rather than the specific sign.
Alopecia HP:0001596 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Alopecia (HP:0001596). HP:0001596 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:20412116 SUPPORT Human Clinical
"a characteristic severe neonatal phenotype including facial dysmorphy, severe cornification with massive focal hyperkeratosis of the skin with erythroderma, dystrophic nails, complete atrichia and absence of foreskin"
Documents atrichia (and nail dystrophy) in the severe neonatal phenotype.
Nail Dystrophy HP:0008404 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Nail dystrophy (HP:0008404). HP:0008404 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:31705875 SUPPORT Human Clinical
"palmoplantar keratoderma with alopecia and/or onychodystrophy"
Names onychodystrophy (nail dystrophy) among the KID cutaneous features.
Cutaneous Squamous Cell Carcinoma OCCASIONAL Squamous cell carcinoma of the skin HP:0006739 Human Phenotype Ontology (HP) Relation: this clinical feature is this phenotype This clinical feature is Squamous cell carcinoma of the skin (HP:0006739). HP:0006739 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:23384797 SUPPORT Human Clinical
"Squamous cell carcinoma of both mucosa and skin, especially acral sites, occurs in approximately 15% of patients."
Provides the ~15% frequency (OCCASIONAL band) for cutaneous/mucosal SCC.
PMID:3955509 SUPPORT Human Clinical
"The entire left foot became involved with a multinodular fungating mass which proved to harbor a SCC, necessitating a left below-knee amputation."
Documents the aggressive, acral, potentially limb-threatening behaviour of SCC in KID.
🧬

Genetic Associations

2
GJB2
Gene: GJB2 hgnc:4284 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is GJB2 (hgnc:4284). hgnc:4284 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE variant_origin: DE_NOVO
Show evidence (3 references)
PMID:11912510 SUPPORT Human Clinical
"we provide compelling evidence that KID is caused by heterozygous missense mutations in the connexin-26 gene, GJB2"
Establishes GJB2 as the causative gene for KID.
PMID:17381453 SUPPORT Human Clinical
"Twelve patients (86%) were heterozygous for the p.Asp50Asn mutation and two patients (14%) were heterozygous for the p.Ser17Phe mutation."
Documents the allele spectrum, with D50N dominant and S17F the next most common in a 14-patient cohort.
PMID:28158657 SUPPORT INDIRECT In Vitro
"the second-site mutations independently inhibit Cx26-Asp50Asn expression in gap junction channels, reverting the dominant negative effect of the p.Asp50Asn mutation"
Revertant mosaicism restoring healthy skin by silencing the D50N allele confirms the allele's dominant pathogenic effect. INDIRECT: it supports pathogenicity via natural reversion rather than a primary functional assay.
GJB6
Gene: GJB6 hgnc:4288 HUGO Gene Nomenclature Committee (hgnc) Relation: this disease-associated gene is this gene This disease-associated gene is GJB6 (hgnc:4288). hgnc:4288 is a gene from the HUGO Gene Nomenclature Committee. relationship_type: CAUSATIVE variant_origin: GERMLINE
Show evidence (1 reference)
PMID:15140211 SUPPORT Human Clinical
"screening of GJB6 revealed a heterozygous missense mutation (V37E) predicted to alter sequence and charge of the first transmembrane helix of Cx30"
Identifies a GJB6 (Cx30) mutation as a rare cause of a KID phenotype.
💊

Medical Actions

6
Systemic Retinoid Therapy (Acitretin)
Action: PharmacotherapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Pharmacotherapy (NCIT:C15986). NCIT:C15986 is a clinical intervention from the NCI Thesaurus. NCIT:C15986
Agent: acitretin CHEBI:50172 Chemical Entities of Biological Interest (CHEBI) Relation: this treatment uses this therapeutic agent This treatment uses acitretin (CHEBI:50172). CHEBI:50172 is a therapeutic agent from Chemical Entities of Biological Interest.
Platform: Small molecule
Oral acitretin improves the hyperkeratotic/ichthyotic skin, with reports of rapid improvement within weeks; occasional reports describe visual improvement. It does not correct the underlying channel defect and carries ocular and skeletal toxicity risks that require caution, especially in children with the keratitis of KID.
Target Phenotypes: Ichthyosiform erythrokeratoderma HP:0007431 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Ichthyosiform erythrokeratoderma, annotated with Congenital ichthyosiform erythroderma (HP:0007431). HP:0007431 is a phenotype from the Human Phenotype Ontology.
Show evidence (2 references)
PMID:25546246 SUPPORT Human Clinical
"The patient had significant improvement of the hyperkeratosis on the scalp, trunk, and extremities within 4 weeks after initiating treatment."
Documents acitretin's dermatologic benefit in a child with KID.
PMID:25546246 SUPPORT Human Clinical
"Ocular and skeletal toxicity from prolonged exposure to systemic retinoids is a major concern especially in children."
Records the retinoid toxicity caution relevant to the keratitis of KID.
Antimicrobial Therapy for Cutaneous Infection
Action: antifungal and antibacterial pharmacotherapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is antifungal and antibacterial pharmacotherapy, annotated with Pharmacotherapy (NCIT:C15986). NCIT:C15986 is a clinical intervention from the NCI Thesaurus. Ontology label: Pharmacotherapy NCIT:C15986
Agent: antifungal agent NCIT:C514 NCI Thesaurus (NCIT) Relation: this treatment uses this therapeutic agent This treatment uses antifungal agent (NCIT:C514). NCIT:C514 is a therapeutic agent from the NCI Thesaurus. antibiotic NCIT:C258 NCI Thesaurus (NCIT) Relation: this treatment uses this therapeutic agent This treatment uses antibiotic (NCIT:C258). NCIT:C258 is a therapeutic agent from the NCI Thesaurus.
Platform: Small molecule
Antifungal and antibiotic therapy to control the chronic mucocutaneous candidiasis and bacterial superinfection that drive morbidity and, in the neonatal form, mortality.
Target Phenotypes: Chronic mucocutaneous candidiasis HP:0002728 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Chronic mucocutaneous candidiasis (HP:0002728). HP:0002728 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:25546246 SUPPORT Human Clinical
"Treatments with antibiotics, antifungals, and systemic retinoids have been reported with variable response."
Supports antimicrobial management of the infectious complications of KID.
Ocular Surface Stem Cell Transplantation
Action: ocular surface stem cell transplantationNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is ocular surface stem cell transplantation, annotated with Corneal Transplantation (NCIT:C210959). NCIT:C210959 is a clinical intervention from the NCI Thesaurus. Ontology label: Corneal Transplantation NCIT:C210959
Platform: Surgery
For limbal stem cell deficiency and corneal surface failure. Ocular surface stem cell transplantation (limbal allograft), often followed by keratoplasty, can stabilize the surface; living-related conjunctival limbal allograft may outperform keratolimbal allograft because it is HLA/ABO-matched. Outcomes remain challenging.
Mechanism Target:
Corneal Epithelial Gap Junction Dysfunction — Replaces the failed limbal stem cell niche to restore a stable corneal epithelium.
Show evidence (1 reference)
PMID:30371567 SUPPORT Human Clinical
"An lr-CLAL may offer further benefit over a KLAL in these eyes because it is HLA- and ABO-matched tissue"
Reports the surgical approach and the HLA/ABO-matching advantage in KID limbal deficiency.
Target Phenotypes: Limbal stem cell deficiency HP:0032107 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Limbal stem cell deficiency (HP:0032107). HP:0032107 is a phenotype from the Human Phenotype Ontology.
Show evidence (1 reference)
PMID:30371567 SUPPORT Human Clinical
"Although OSST can stabilize the surface, long-term treatment of KID syndrome can be challenging."
Records both the benefit and the limited durability of ocular surface stem cell transplantation in KID.
Cochlear Implantation
Action: cochlear device implantationNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is cochlear device implantation, annotated with Surgical Procedure (NCIT:C15329), qualified as medical device cochlear implant. NCIT:C15329 is a clinical intervention from the NCI Thesaurus. Ontology label: Surgical Procedure NCIT:C15329
Platform: Device
For the profound sensorineural hearing loss. Because skin debris and chronic otitis can render hearing aids ineffective and visual loss can preclude sign language, cochlear implantation is often the definitive auditory intervention; it is safe and effective in most patients but carries a raised rate of postoperative wound/infection complications requiring close monitoring. The implant device term (NCIT:C157820) names equipment and is not a clinical-action term, so the surgical action is bound and the device carried as a qualifier.
Target Phenotypes: Congenital sensorineural hearing impairment HP:0008527 Human Phenotype Ontology (HP) Relation: this treatment targets this phenotype This treatment targets Congenital sensorineural hearing impairment (HP:0008527). HP:0008527 is a phenotype from the Human Phenotype Ontology.
Show evidence (3 references)
PMID:40889428 SUPPORT Human Clinical
"CI in patients with KID syndrome presents distinctive challenges but is a safe and effective treatment option."
Systematic-review conclusion supporting cochlear implantation in KID.
PMID:40889428 SUPPORT Human Clinical
"Notable complications included postoperative infection (30.8 %, n = 4)"
Quantifies the raised postoperative infection risk specific to KID implantees.
PMID:22340753 SUPPORT Human Clinical
"Patients with KID syndrome appear to be good candidates for cochlear implantation but may face significant skin-related problems which could disrupt successful post-operative habilitation."
Long-term follow-up showing both candidacy and the skin-related risk to implant outcomes.
Experimental Hemichannel Blockade
Action: PharmacotherapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Pharmacotherapy (NCIT:C15986). NCIT:C15986 is a clinical intervention from the NCI Thesaurus. NCIT:C15986
Agent: mefloquine CHEBI:63609 Chemical Entities of Biological Interest (CHEBI) Relation: this treatment uses this therapeutic agent This treatment uses mefloquine (CHEBI:63609). CHEBI:63609 is a therapeutic agent from Chemical Entities of Biological Interest.
Platform: Small molecule
A mechanism-directed experimental strategy. Because most KID alleles confer aberrant hemichannel opening, blocking the hemichannel is a rational target; mefloquine, an FDA-approved antimalarial, inhibits mutant KID hemichannels in Xenopus oocytes and attenuates macroscopic currents in G45E keratinocytes. Engineered anti-Cx26 antibodies act similarly. Preclinical only.
Mechanism Target:
Hyperactive Connexin 26 Hemichannels — Directly inhibits the aberrant hemichannel that is the proximate pathogenic lesion.
Show evidence (1 reference)
PMID:25229253 SUPPORT In Vitro
"mefloquine (MFQ) inhibits several mutant hemichannel forms implicated in KID syndrome when expressed in Xenopus laevis oocytes"
Shows mefloquine inhibits KID mutant hemichannels, the target of this strategy.
Show evidence (1 reference)
PMID:39269388 SUPPORT Other
"Use of pharmacological blockers and engineered mAbs in mouse models of HED and KID confirm that hemichannel inhibition is a promising target for new therapeutic approaches to KID and HED."
Summarises hemichannel inhibition as a validated preclinical therapeutic target for KID.
Allele-Specific siRNA (Experimental)
Action: PharmacotherapyNCI Thesaurus (NCIT) Relation: this treatment is this clinical intervention This treatment is Pharmacotherapy (NCIT:C15986). NCIT:C15986 is a clinical intervention from the NCI Thesaurus. NCIT:C15986
Platform: siRNA
A precision strategy for the dominant D50N allele: a mutant-selective siRNA silences the D50N transcript without touching the wild-type allele, correcting both the impaired gap-junction coupling and the hyperactive hemichannel in patient keratinocytes. Proof of concept only, with topical delivery to skin still to be solved and no cochlear delivery.
Mechanism Target:
Heterozygous Gain-of-Function GJB2 Missense Variant — Selectively removes the mutant transcript, so the remaining wild-type allele's channels function normally.
Show evidence (1 reference)
PMID:31705875 SUPPORT In Vitro
"In vitro treatment with allele-specific small interfering RNA led to robust inhibition of the mutant GJB2 allele without altering expression of the wild-type allele. This corrected both gap junction and hemichannel activity."
Demonstrates allele-selective knockdown correcting both channel defects in patient cells.
Show evidence (1 reference)
PMID:31705875 SUPPORT In Vitro
"Our data provide an important proof-of-concept and model system for the potential use of allele-specific small interfering RNA in treating KID syndrome and other dominant genetic conditions."
Frames the approach as preclinical proof of concept for KID.
🔬

Diagnosis

2
Clinical Recognition of the Triad
Diagnosis begins with the clinical triad of vascularizing keratitis, ichthyosiform/erythrokeratodermic skin, and congenital sensorineural hearing loss, supported by dermatologic, ophthalmologic and audiologic examination.
eye examination NCIT:C38060 NCI Thesaurus (NCIT)
Show evidence (1 reference)
PMID:37755702 SUPPORT Human Clinical
"All four individuals had the characteristic systemic features of keratitis-ichthyosis-deafness syndrome."
Confirms recognition rests on the characteristic systemic triad.
Molecular Genetic Testing of GJB2 and GJB6
Sequencing of GJB2 (and GJB6 when GJB2 is negative) confirms the diagnosis and the specific allele, which informs prognosis (e.g. G45E lethal form, S17F severity) and genetic counselling.
genetic testing NCIT:C15709 NCI Thesaurus (NCIT)
Show evidence (1 reference)
PMID:11912510 SUPPORT Human Clinical
"In each of 10 patients with KID, we identified a point mutation"
Establishes GJB2 sequencing as the confirmatory genetic test.
📊

Prevalence

1
Worldwide
Cases In Literature <1 in 1,000,000
Ultra-rare. Fewer than ~100 cases of KID/HID reported worldwide at the last Orphanet update; Orphanet classes point prevalence as <1/1,000,000. No population-based prevalence estimate exists, so this record carries the literature-count measure rather than a rate.
Show evidence (1 reference)
PMID:29159249 SUPPORT Human Clinical
"Keratitis-ichthyosis-deafness (KID) syndrome is a rare genodermatosis with approximately 100 published cases."
Supports the ultra-rare status via the approximate worldwide case count.
🔀

Differential Diagnoses

2

Conditions with similar clinical presentations that must be differentiated from Keratitis-Ichthyosis-Deafness Syndrome:

Autosomal recessive KID (KIDAR, AP1B1)
Overlapping Features A distinct autosomal recessive disorder of vesicular trafficking (AP1B1, MONDO:0859278) that shares ichthyosis, keratitis and deafness but adds failure to thrive, developmental delay and copper-metabolism abnormalities. Not connexin-related; a separate entity.
Distinguishing Features
  • Autosomal recessive inheritance with biallelic AP1B1 loss-of-function variants
  • Systemic features - failure to thrive, developmental delay, low copper and ceruloplasmin
  • No connexin defect
Show evidence (1 reference)
PMID:11912510 SUPPORT INDIRECT Human Clinical
"dominant GJB2 mutations can disturb the gap junction system of one or several ectodermal epithelia"
Anchors the dominant connexin mechanism of this entry, which distinguishes it from the recessive AP1B1 trafficking disorder. INDIRECT: it establishes this entry's mechanism rather than describing KIDAR directly.
Nonsyndromic GJB2 hearing loss (DFNB1 / DFNA3A)
Overlapping Features Loss-of-function GJB2 alleles at the same locus cause nonsyndromic sensorineural deafness with no skin or eye disease. The distinction is mechanistic: nonsyndromic disease is loss of function, KID is gain of function.
Distinguishing Features
  • Absence of skin and corneal disease
  • Loss-of-function alleles rather than N-terminal or first-extracellular-loop gain-of-function missense
Show evidence (1 reference)
PMID:22547955 SUPPORT Other
"Nonsyndromic deafness is caused prevalently by a loss-of-function, while literature evidences suggest for syndromic deafness a mechanism based on gain-of-function."
States the loss-of-function versus gain-of-function distinction separating nonsyndromic GJB2 deafness from syndromic KID.
🧫

Experimental Models

1
D50N patient-derived immortalized keratinocytes (KID-KC) CELL_LINE
Immortalized keratinocytes from a heterozygous D50N KID patient, which reproduce the impaired gap-junction communication and hyperactive hemichannels of the disease and, in a human-murine chimeric skin graft, recapitulate patient skin. Used to demonstrate allele-specific siRNA rescue.
keratinocyte CL:0000312 Cell Ontology (CL) Relation: this experimental model uses this cell type This experimental model uses keratinocyte (CL:0000312). CL:0000312 is a cell type from the Cell Ontology.
Organism
human NCBITaxon:9606 NCBI Taxonomy (NCBITaxon) Relation: this experimental model is built in this organism This experimental model is built in human, annotated with Homo sapiens (NCBITaxon:9606). NCBITaxon:9606 is an organism from the NCBI Taxonomy.
Publication
PMID:31705875
Pathograph links
Hyperactive Connexin 26 Hemichannels recapitulates fidelity: high observes: cellular Patient cells at the native heterozygous genotype reproduce the hyperactive hemichannel and impaired coupling, unlike prior models that expressed the mutant allele alone.
Limitations: Immortalized monolayer keratinocytes express Cx26 at lower levels than differentiated skin; represents one allele (D50N).
Readouts
Hemichannel activity and gap-junction coupling
Direction: INCREASED
Interpretation: Hyperactive hemichannels and reduced coupling confirmed by patch clamp, dye transfer and neurobiotin uptake.
Show evidence (1 reference)
PMID:31705875 SUPPORT In Vitro
"This cell line displayed impaired gap junction communication and hyperactive hemichannels, confirmed by dye transfer, patch clamp, and neurobiotin uptake assays."
The functional measurements behind this readout.
Show evidence (1 reference)
PMID:31705875 SUPPORT In Vitro
"A human-murine chimeric skin graft model constructed with KID-KCs mimicked patient skin in vivo, further confirming the validity of these cells as a model."
Supports the patient keratinocyte line (and skin graft) as a valid KID model.
Show evidence (1 reference)
PMID:31705875 SUPPORT In Vitro
"A KID syndrome cell line (KID-KC) was established from primary patient KCs with a heterozygous p.D50N mutation."
Establishes the provenance of the cell line and its native heterozygous patient genotype.
🐁

Animal Models

2
Cx26-G45E inducible transgenic mouse
The model of the lethal KID skin phenotype, created because the G45E allele forms constitutively active hemichannels. Induced expression in keratinocytes reproduces hyperkeratosis, scaling, hair loss and the hyperproliferative histopathology of human KID, with increased hemichannel currents in the transgenic keratinocytes.
Species
Mouse
Genotype
Inducible transgenic expressing human Cx26-G45E in keratinocytes
Publication
PMID:22031297
Pathograph links
Disordered Keratinocyte Proliferation and Differentiation recapitulates fidelity: moderate observes: tissue Reproduces the hyperproliferative, abnormally differentiated epidermis and the clinical scaling/hyperkeratosis.
Limitations: A transgene expressed from a non-native promoter does not reproduce the native one-mutant-allele stoichiometry, and G45E is a lethal-form allele rather than the common D50N.
Readouts
Epidermal histopathology
Direction: ALTERED
Interpretation: Hyperplasia, acanthosis and papillomatosis correlating with human KID skin.
Show evidence (1 reference)
PMID:22031297 SUPPORT Model Organism
"Histopathology included hyperplasia, acanthosis, papillomatosis, increased cell size, and osteal plugging."
The histological measurement behind this readout.
Show evidence (1 reference)
PMID:22031297 SUPPORT Model Organism
"These abnormalities correlated with human KIDS pathology and were associated with increased hemichannel currents in transgenic keratinocytes."
Supports treating this mouse as informative for the keratinocyte dysregulation node, with the hemichannel mechanism measured.
Show evidence (2 references)
PMID:22031297 SUPPORT Model Organism
"We created an animal model for KIDS by generating an inducible transgenic mouse expressing Cx26-G45E in keratinocytes."
Establishes the existence and construction of this model of KID.
PMID:22031297 SUPPORT Model Organism
"Cx26-G45E mice displayed reduced viability, hyperkeratosis, scaling, skin folds, and hair loss."
Records the whole-animal phenotype, including the reduced viability that parallels the lethal human form this allele causes.
Cx26-S17F knock-in mouse
The model that localizes the cochlear lesion. A constitutive S17F knock-in cochlea develops hyperactive hemichannels in the supporting cells of the organ of Corti (formed with Cx30) and loses hair cell stereocilia, demonstrating the supporting-cell hemichannel mechanism directly in cochlear tissue.
Species
Mouse
Genotype
Constitutive Cx26-S17F knock-in
Publication
PMID:36699003
Pathograph links
Cochlear Supporting Cell Hemichannel Hyperactivity recapitulates fidelity: moderate observes: cellular Reproduces hyperactive supporting-cell hemichannels and stereocilia loss in the organ of Corti.
Limitations: A single allele (S17F) in mouse; the hemichannel hyperactivity requires co-expression with Cx30, and the readout is at the cellular scale while the clinical endpoint this node feeds (hearing loss) is at the organism scale.
Readouts
Supporting-cell hemichannel activity
Direction: INCREASED
Interpretation: Hyperactive hemichannels with increased calcium influx and cellular damage in organ of Corti supporting cells.
Show evidence (1 reference)
PMID:36699003 SUPPORT Model Organism
"cells co-expressing Cx26S17F and Cx30 present hyperactive HCs insensitive to HCs blockers, Ca2+ and La3+, resulting in more Ca2+ influx and cellular damage."
The hemichannel measurement behind this readout.
Show evidence (1 reference)
PMID:36699003 SUPPORT Model Organism
"cochlear explants from a constitutive knock-in Cx26S17F mouse or conditional in vitro cochlear expression of Cx26S17F produces hyperactive HCs in supporting cells of the organ of Corti. These conditions also produce loss of hair cells stereocilia."
Supports treating this mouse as informative for the cochlear supporting-cell hemichannel node.
Show evidence (1 reference)
PMID:36699003 SUPPORT Model Organism
"In this work, we evaluated the functional consequences of expressing a KID syndromic mutation, Cx26S17F, in the transgenic mouse cochlea and whether co-expression of Cx26S17F and Cx30 leads to the formation of hyperactive HCs."
Establishes the model and the question it was built to answer - the cochlear consequences of a KID allele.
{ }

Source YAML

click to show 
name: Keratitis-Ichthyosis-Deafness Syndrome
creation_date: "2026-09-05T06:37:27Z"
category: Mendelian
description: >-
  Keratitis-ichthyosis-deafness (KID) syndrome is a rare autosomal dominant
  ectodermal dysplasia defined by the triad of vascularizing keratitis,
  erythrokeratodermic/ichthyosiform skin lesions, and congenital sensorineural
  hearing loss. It is caused by heterozygous missense variants in GJB2, encoding
  the gap-junction protein connexin 26 (Cx26); a small number of cases are caused
  by GJB6 (connexin 30). The single most common allele, p.D50N, accounts for the
  large majority of cases.

  The mechanism is the mirror image of the recessive GJB2 deafness at the same
  locus. DFNB1 is a loss-of-function, dosage disease: two null alleles leave too
  little Cx26 and cause nonsyndromic deafness with no skin phenotype. KID is a
  gain of function. A single missense allele - clustered in the cytoplasmic
  N-terminus and first extracellular loop, the domains that gate the channel -
  produces connexin hemichannels (undocked hexamers in non-junctional membrane)
  that open when they should be shut. The aberrant hemichannels lose their normal
  restraint by extracellular calcium and, for some alleles, become directly
  permeable to calcium, so keratinocytes are loaded with calcium and leak ATP.
  That is why a loss-of-function null causes only deafness while a single
  gain-of-function missense causes disease across every Cx26-expressing
  epithelium - epidermis, cornea, and the non-sensory cells of the cochlea.

  A complication of the simple "hyperactive homomeric hemichannel" account is that
  some severe KID alleles (S17F) form non-functional homomeric hemichannels in
  isolation, yet still cause florid disease. In skin, Cx26 is co-expressed with
  Cx43 and Cx30; the syndromic N-terminal mutations acquire the ability to
  oligomerise with the normally incompatible Cx43, producing hyperactive
  heteromeric hemichannels but non-functional heteromeric gap-junction channels.
  So the pathogenic hemichannel can be heteromeric rather than homomeric, and the
  disease combines a gain of hemichannel leak with a dominant loss of intercellular
  coupling.

  This entry is the autosomal dominant, connexin-related disease. Two separate
  autosomal recessive entities that carry "KID" in their names are deliberately
  out of scope (see notes): AP1B1-related KIDAR (a vesicular-trafficking disorder,
  MONDO:0859278) and VPS33B-related ARKID.
disease_term:
  preferred_term: keratitis-ichthyosis-deafness syndrome
  term:
    id: MONDO:0007850
    label: autosomal dominant keratitis-ichthyosis-hearing loss syndrome
synonyms:
- KID syndrome
- KIDAD
- keratitis-ichthyosis-deafness syndrome, autosomal dominant
- HID syndrome
- hystrix-like ichthyosis-deafness syndrome
- Senter syndrome
- ichthyosis hystrix, Rheydt type
parents:
- Ectodermal Dysplasia
- Genodermatosis
- Syndromic Hearing Loss
inheritance:
- name: Autosomal dominant
  description: >-
    A single heterozygous GJB2 (or, rarely, GJB6) missense variant is sufficient.
    Most cases are sporadic de novo events - more than 90% of published cases -
    but vertical transmission through affected pedigrees is documented, and the
    recurrence of an identical allele in siblings of unaffected parents has been
    traced to germline (gonadal) mosaicism, which is important for genetic
    counselling of the lethal neonatal form.
  inheritance_term:
    preferred_term: Autosomal dominant inheritance
    term:
      id: HP:0000006
      label: Autosomal dominant inheritance
  penetrance: INCOMPLETE
  expressivity: VARIABLE
  evidence:
  - reference: PMID:11912510
    reference_title: Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      One of these mutations was detected in six unrelated sporadic case subjects
      and also segregated in one family with vertical transmission of KID. These
      results indicate the presence of a common, recurrent mutation and establish
      its autosomal dominant nature.
    explanation: >-
      Establishes the autosomal dominant nature of KID and that both sporadic and
      familial transmission occur at the same recurrent allele.
  - reference: PMID:29159249
    reference_title: Visual impairment reversal with oral acitretin therapy in keratitis-ichthyosis-deafness (KID) syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      more than 90% of cases are caused by sporadic mutations predominantly in gap
      junction protein β2 (GJB2) on chromosome 13q11-q12
    explanation: >-
      Quantifies the predominance of sporadic (de novo) mutations over familial
      transmission.
  - reference: PMID:20412116
    reference_title: "Germline mosaicism in keratitis-ichthyosis-deafness syndrome: pre-natal diagnosis in a familial lethal form."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      These results establish the role of germline mosaicism in KID syndrome and
      warrant careful genetic counseling.
    explanation: >-
      Documents germline (gonadal) mosaicism as the explanation for sibling
      recurrence from clinically unaffected parents.
prevalence:
- population: Worldwide
  measure_type: CASES_IN_LITERATURE
  prevalence_class: BELOW_1_IN_1000000
  notes: >-
    Ultra-rare. Fewer than ~100 cases of KID/HID reported worldwide at the last
    Orphanet update; Orphanet classes point prevalence as <1/1,000,000. No
    population-based prevalence estimate exists, so this record carries the
    literature-count measure rather than a rate.
  evidence:
  - reference: PMID:29159249
    reference_title: Visual impairment reversal with oral acitretin therapy in keratitis-ichthyosis-deafness (KID) syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Keratitis-ichthyosis-deafness (KID) syndrome is a rare genodermatosis with
      approximately 100 published cases.
    explanation: >-
      Supports the ultra-rare status via the approximate worldwide case count.
pathophysiology:
- name: Heterozygous Gain-of-Function GJB2 Missense Variant
  biological_scale: MOLECULAR
  mechanism_confidence: ESTABLISHED
  description: >-
    The initiating lesion. A single GJB2 allele carries a missense change that
    substitutes a conserved residue in the cytoplasmic N-terminus or first
    extracellular loop of connexin 26 - the domains controlling channel gating
    and permeability. Unlike the recessive loss-of-function alleles at this locus,
    which give nonsyndromic deafness only, these alleles produce a channel that
    is still made and delivered but behaves aberrantly. p.D50N is by far the most
    common; p.S17F and p.G12R are recurrent; p.G45E and p.A88V cause a lethal
    neonatal form.
  genes:
  - preferred_term: GJB2
    term:
      id: hgnc:4284
      label: GJB2
  genetic_context:
    genes:
    - preferred_term: GJB2
      term:
        id: hgnc:4284
        label: GJB2
    zygosity: HETEROZYGOUS
    variant_origin: DE_NOVO
    functional_impact_category: GAIN_OF_FUNCTION
    notes: >-
      Recorded as GAIN_OF_FUNCTION at the variant level: the mutant subunit adds a
      pathological activity (aberrant hemichannel opening) rather than merely
      failing, which is what distinguishes syndromic KID alleles from the recessive
      nonsyndromic null alleles at the same locus. Several alleles additionally
      exert a dominant-negative effect on co-expressed connexins (see downstream
      nodes), so a single category cannot capture every allele's full behaviour.
  evidence:
  - reference: PMID:11912510
    reference_title: Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In each of 10 patients with KID, we identified a point mutation leading to
      substitution of conserved residues in the cytoplasmic amino terminus or first
      extracellular domain of Cx26.
    explanation: >-
      Localises the causal missense variants to the N-terminal and E1 gating
      domains of connexin 26.
  - reference: PMID:19939300
    reference_title: Connexin-26 mutations in deafness and skin disease.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: OTHER
    snippet: >-
      Since nonsyndromic deafness is predominantly a loss-of-function disorder, it
      follows that the syndromic mutants must show an alteration, or gain, of
      function to cause skin disease.
    explanation: >-
      States the loss-of-function-versus-gain-of-function logic that classifies KID
      alleles as gain-of-function. INDIRECT because it is a review's inference from
      the genotype-phenotype pattern rather than a direct assay of one allele.
  downstream:
  - target: Hyperactive Connexin 26 Hemichannels
    causal_link_type: DIRECT
    description: >-
      The mutant subunit assembles into hemichannels whose gating is deranged.
- name: Hyperactive Connexin 26 Hemichannels
  biological_scale: MOLECULAR
  mechanism_confidence: ESTABLISHED
  description: >-
    Connexins oligomerise into hexameric hemichannels (connexons); in
    non-junctional membrane an undocked hemichannel connects the cytoplasm to the
    extracellular space. Syndromic Cx26 mutants form hemichannels that open when
    they should be closed. The two best-characterised aberrations are loss of the
    normal restraint by extracellular calcium (the channels stay open at
    physiological Ca2+, as for A40V and D50N) and, for some alleles, a channel
    that is itself directly permeable to calcium (G45E). The result is an
    inappropriate conductance across the plasma membrane that has been measured as
    increased whole-cell hemichannel current for D50N, D50A, A88V, G12R, G45E and
    A40V, and which accelerates cell death in low extracellular calcium.
  molecular_functions:
  - preferred_term: gap junction hemichannel activity
    term:
      id: GO:0055077
      label: gap junction hemi-channel activity
    modifier: GAIN_OF_FUNCTION
  biological_processes:
  - preferred_term: calcium ion transmembrane transport
    term:
      id: GO:0070588
      label: calcium ion transmembrane transport
    modifier: INCREASED
  evidence:
  - reference: PMID:23797419
    reference_title: "The D50N mutation and syndromic deafness: altered Cx26 hemichannel properties caused by effects on the pore and intersubunit interactions."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      D50N, the most frequent mutation associated with KID syndrome, produces
      multiple aberrant hemichannel properties, including loss of inhibition by
      extracellular Ca(2+), decreased unitary conductance, increased open
      hemichannel current rectification and voltage-shifted activation.
    explanation: >-
      Documents the aberrant hemichannel behaviour of the commonest KID allele,
      including loss of extracellular-calcium inhibition.
  - reference: PMID:23447037
    reference_title: The human Cx26-D50A and Cx26-A88V mutations causing keratitis-ichthyosis-deafness syndrome display increased hemichannel activity.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      both Cx26-D50A and Cx26-A88V form active hemichannels that significantly
      increase membrane current flow compared with wild-type Cx26
    explanation: >-
      Directly measures increased hemichannel current for two KID alleles across
      three expression systems.
  - reference: PMID:23447037
    reference_title: The human Cx26-D50A and Cx26-A88V mutations causing keratitis-ichthyosis-deafness syndrome display increased hemichannel activity.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      support the hypothesis that increased hemichannel activity is a common
      feature of human Cx26 mutations responsible for KID syndrome
    explanation: >-
      States that hyperactive hemichannels are a shared property across KID alleles.
  - reference: PMID:20584891
    reference_title: Differentially altered Ca2+ regulation and Ca2+ permeability in Cx26 hemichannels formed by the A40V and G45E mutations that cause keratitis ichthyosis deafness syndrome.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      A40V produces leaky hemichannels, whereas G45E provides a route for excessive
      entry of Ca(2+).
    explanation: >-
      Distinguishes the two aberrant hemichannel mechanisms - loss of gating versus
      direct calcium permeability - among KID alleles.
  downstream:
  - target: Keratinocyte Calcium Overload and ATP Release
    causal_link_type: DIRECT
    hypothesis_groups:
    - hyperactive_hemichannel
  - target: Aberrant Heteromeric Interaction with Cx43 and Cx30
    causal_link_type: DIRECT
    hypothesis_groups:
    - heteromeric_connexin_interaction
  - target: Corneal Epithelial Gap Junction Dysfunction
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
  - target: Cochlear Supporting Cell Hemichannel Hyperactivity
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
- name: Aberrant Heteromeric Interaction with Cx43 and Cx30
  biological_scale: MOLECULAR
  mechanism_confidence: PROVISIONAL
  description: >-
    Why some severe KID alleles cause disease despite forming non-functional
    homomeric hemichannels. In skin Cx26 is co-expressed with Cx43 and Cx30, and
    wild-type Cx26 and Cx43 are normally oligomerisation-incompatible. The
    syndromic N-terminal mutations change that compatibility: they oligomerise
    with Cx43 into heteromeric channels that show exacerbated hemichannel activity
    but non-functional gap-junction channels, giving a combined gain of leak and
    dominant-negative loss of coupling. This resolves the S17F paradox, whose
    homomeric hemichannels are silent yet whose disease is severe. Graded
    PROVISIONAL because the demonstrations are in HeLa cells and Xenopus oocytes
    at experimenter-set expression ratios, and one patient-keratinocyte study did
    not reproduce Cx26/Cx43 co-localisation.
  molecular_functions:
  - preferred_term: gap junction hemichannel activity
    term:
      id: GO:0055077
      label: gap junction hemi-channel activity
    modifier: GAIN_OF_FUNCTION
  cellular_components:
  - preferred_term: connexin complex
    term:
      id: GO:0005922
      label: connexin complex
  evidence:
  - reference: PMID:25625422
    reference_title: "Keratitis-ichthyosis-deafness syndrome-associated Cx26 mutants produce nonfunctional gap junctions but hyperactive hemichannels when co-expressed with wild type Cx43."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      heteromeric oligomer formed by Cx43/Cx26 (syndromic mutants) shows
      exacerbated hemichannel activity but nonfunctional GJCs
    explanation: >-
      Demonstrates the heteromeric hyperactive-hemichannel / non-functional
      gap-junction paradox for syndromic Cx26 mutants.
  - reference: PMID:25625422
    reference_title: "Keratitis-ichthyosis-deafness syndrome-associated Cx26 mutants produce nonfunctional gap junctions but hyperactive hemichannels when co-expressed with wild type Cx43."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Heterologous expression of these hyperactive heteromeric hemichannels
      increases cell membrane permeability, favoring ATP release and Ca(2+)
      overload.
    explanation: >-
      Links the heteromeric hemichannel to the downstream ATP release and calcium
      overload node.
  downstream:
  - target: Keratinocyte Calcium Overload and ATP Release
    causal_link_type: DIRECT
    hypothesis_groups:
    - heteromeric_connexin_interaction
  - target: Loss of Gap Junction Intercellular Communication
    causal_link_type: DIRECT
- name: Loss of Gap Junction Intercellular Communication
  biological_scale: CELLULAR
  mechanism_confidence: ESTABLISHED
  description: >-
    Whether by failure of homomeric channels to couple or by a dominant-negative
    effect on Cx43/Cx30 partners, mutant Cx26 reduces functional gap-junction
    intercellular communication in the epithelia that normally depend on it. In
    the corneal epithelium the common D50N allele accumulates intracellularly and
    fails to form gap-junction plaques even when co-expressed with wild-type Cx26
    or Cx30, consistent with a dominant-negative effect on connexon assembly.
  molecular_functions:
  - preferred_term: gap junction channel activity
    term:
      id: GO:0005243
      label: gap junction channel activity
    modifier: DECREASED
  biological_processes:
  - preferred_term: gap junction-mediated intercellular transport
    term:
      id: GO:1990349
      label: gap junction-mediated intercellular transport
    modifier: DECREASED
  evidence:
  - reference: PMID:11912510
    reference_title: Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      mutant Cx26 was incapable of inducing intercellular coupling in vitro, which
      indicates its functional impairment
    explanation: >-
      Shows loss of intercellular coupling by the mutant channel.
  - reference: PMID:15914609
    reference_title: In vivo and in vitro expression of connexins in the human corneal epithelium.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      The transfection experiments suggest that KIDS Cx26(D50N) impairs
      intracellular formation and transport of connexons formed by Cx26 and -30,
      consistent with a dominant negative effect.
    explanation: >-
      Demonstrates a dominant-negative loss of connexon assembly by the common KID
      allele in human corneal epithelial cells.
  downstream:
  - target: Disordered Keratinocyte Proliferation and Differentiation
    causal_link_type: DIRECT
- name: Keratinocyte Calcium Overload and ATP Release
  biological_scale: CELLULAR
  mechanism_confidence: ESTABLISHED
  description: >-
    The functional consequence of a leaky hemichannel in the keratinocyte:
    inappropriate opening loads the cell with calcium and releases ATP into the
    extracellular space. ATP acts on epidermal P2 purinergic receptors that
    regulate keratinocyte differentiation and proliferation, and calcium overload
    plus sustained leak drives keratinocyte death. Peptidoglycan from
    Staphylococcus aureus triggers additional hemichannel-dependent ATP release
    selectively in KID-mutant keratinocytes, coupling the leak to the infection
    that characterises the disease.
  cell_types:
  - preferred_term: keratinocyte
    term:
      id: CL:0000312
      label: keratinocyte
  biological_processes:
  - preferred_term: ATP export
    term:
      id: GO:1904669
      label: ATP export
    modifier: INCREASED
  - preferred_term: keratinocyte apoptotic process
    term:
      id: GO:0097283
      label: keratinocyte apoptotic process
    modifier: INCREASED
  evidence:
  - reference: PMID:17428836
    reference_title: Aberrant hemichannel properties of Cx26 mutations causing skin disease and deafness.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Cx26-G45E hemichannels displayed significantly greater whole cell currents
      than wild-type Cx26, leading to cell lysis and death.
    explanation: >-
      Connects hyperactive hemichannel current to keratinocyte death.
  - reference: PMID:25625422
    reference_title: "Keratitis-ichthyosis-deafness syndrome-associated Cx26 mutants produce nonfunctional gap junctions but hyperactive hemichannels when co-expressed with wild type Cx43."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Heterologous expression of these hyperactive heteromeric hemichannels
      increases cell membrane permeability, favoring ATP release and Ca(2+)
      overload.
    explanation: >-
      Directly reports ATP release and calcium overload from the aberrant
      hemichannels.
  - reference: PMID:22643125
    reference_title: Differential susceptibility of Cx26 mutations associated with epidermal dysplasias to peptidoglycan derived from Staphylococcus aureus and Staphylococcus epidermidis.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      In KID mutant expressing cells, ATP release was significantly higher than in
      cells transfected with wild-type Cx26.
    explanation: >-
      Shows pathogen-triggered ATP release is exaggerated in KID-mutant
      keratinocytes, linking the hemichannel leak to infection.
  downstream:
  - target: Disordered Keratinocyte Proliferation and Differentiation
    causal_link_type: DIRECT
- name: Disordered Keratinocyte Proliferation and Differentiation
  biological_scale: CELLULAR
  mechanism_confidence: ESTABLISHED
  description: >-
    Loss of coupling and calcium/ATP dysregulation together derange the tightly
    ordered program by which basal keratinocytes proliferate and then differentiate
    toward the cornified layer. The epidermis becomes hyperproliferative with
    abnormal differentiation - the cellular substrate of the clinical
    hyperkeratosis.
  cell_types:
  - preferred_term: keratinocyte
    term:
      id: CL:0000312
      label: keratinocyte
  biological_processes:
  - preferred_term: keratinocyte proliferation
    term:
      id: GO:0043616
      label: keratinocyte proliferation
    modifier: INCREASED
  - preferred_term: keratinocyte differentiation
    term:
      id: GO:0030216
      label: keratinocyte differentiation
    modifier: DYSREGULATED
  evidence:
  - reference: PMID:22031297
    reference_title: The Cx26-G45E mutation displays increased hemichannel activity in a mouse model of the lethal form of keratitis-ichthyosis-deafness syndrome.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Histopathology included hyperplasia, acanthosis, papillomatosis, increased
      cell size, and osteal plugging.
    explanation: >-
      Reports the hyperproliferative, abnormally differentiated epidermis in a KID
      mouse model.
  - reference: PMID:11912510
    reference_title: Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      a clinical triad that indicates a failure in development and differentiation
      of multiple stratifying epithelia
    explanation: >-
      Frames KID as a disorder of epithelial differentiation. INDIRECT: the phrase
      is the paper's characterisation of the syndrome rather than a differentiation
      assay.
  downstream:
  - target: Epidermal Barrier Failure and Hyperkeratosis
    causal_link_type: DIRECT
- name: Epidermal Barrier Failure and Hyperkeratosis
  biological_scale: TISSUE
  mechanism_confidence: ESTABLISHED
  description: >-
    The hyperproliferative, poorly differentiated epidermis produces a defective
    stratum corneum: transgenic KID mice show impaired epidermal calcium
    homeostasis and an abnormal stratum-corneum lipid composition that degrades the
    water barrier, clinically visible as erythrokeratoderma, ichthyosiform scaling,
    palmoplantar keratoderma and follicular hyperkeratosis. This entry does NOT
    conform to the epidermal_cornification_failure module: that module scopes
    itself to primary lesions of the terminal cornification enzymes/structural
    proteins (TGM1, FLG, ALOX, ABCA12, STS, SPINK5), whereas here the barrier
    failure is secondary to connexin-driven keratinocyte dysregulation.
  locations:
  - preferred_term: epidermis
    term:
      id: UBERON:0001003
      label: skin epidermis
  biological_processes:
  - preferred_term: establishment of skin barrier
    term:
      id: GO:0061436
      label: establishment of skin barrier
    modifier: DECREASED
  evidence:
  - reference: PMID:26777423
    reference_title: From Hyperactive Connexin26 Hemichannels to Impairments in Epidermal Calcium Gradient and Permeability Barrier in the Keratitis-Ichthyosis-Deafness Syndrome.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Transgenic mouse models expressing connexin26 KID mutations reproduce human
      phenotypes and present impaired epidermal calcium homeostasis and abnormal
      lipid composition of the stratum corneum affecting the water barrier.
    explanation: >-
      Ties hyperactive hemichannels to impaired epidermal calcium homeostasis and a
      defective permeability barrier.
  downstream:
  - target: Ichthyosiform Erythrokeratoderma
    causal_link_type: DIRECT
  - target: Palmoplantar Keratoderma
    causal_link_type: DIRECT
  - target: Follicular Hyperkeratosis
    causal_link_type: DIRECT
  - target: Impaired Cutaneous Host Defense and Chronic Inflammation
    causal_link_type: DIRECT
- name: Impaired Cutaneous Host Defense and Chronic Inflammation
  biological_scale: TISSUE
  mechanism_confidence: PROVISIONAL
  description: >-
    Barrier failure plus a keratinocyte-intrinsic immune defect predisposes to
    chronic mucocutaneous candidiasis and recurrent bacterial superinfection.
    Beyond the physical barrier, KID keratinocytes down-regulate immune
    response-associated genes (IL15, CCL5, IL1A, IL23R, TLR5), and their
    hemichannels amplify inflammatory ATP signalling in response to Staphylococcus
    aureus peptidoglycan. Chronic infection and inflammation, together with the
    intrinsic proliferative drive, create the microenvironment in which squamous
    cell carcinoma arises.
  cell_types:
  - preferred_term: keratinocyte
    term:
      id: CL:0000312
      label: keratinocyte
  biological_processes:
  - preferred_term: inflammatory response
    term:
      id: GO:0006954
      label: inflammatory response
    modifier: INCREASED
  evidence:
  - reference: PMID:30150638
    reference_title: Roles of aberrant hemichannel activities due to mutant connexin26 in the pathogenesis of KID syndrome.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      the expressions of IL15, CCL5, IL1A, IL23R and TLR5 are down-regulated in
      keratinocytes expressing Cx26-D50N, suggesting that immune deficiency in KID
      syndrome expressing Cx26-D50N might be associated not only with skin barrier
      defects, but also with the down-regulated expression of immune
      response-related genes.
    explanation: >-
      Documents a keratinocyte-intrinsic immune gene defect beyond the physical
      barrier.
  - reference: PMID:22643125
    reference_title: Differential susceptibility of Cx26 mutations associated with epidermal dysplasias to peptidoglycan derived from Staphylococcus aureus and Staphylococcus epidermidis.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      KID mutants form channels that can be triggered by the pro-inflammatory
      mediator PGN from opportunistic pathogens but not skin commensals
    explanation: >-
      Links pathogen sensing to hemichannel-mediated inflammatory signalling in KID
      keratinocytes.
  - reference: PMID:11912510
    reference_title: Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Decreased host defense and increased carcinogenic potential in KID illustrate
      that gap junction communication plays not only a crucial role in epithelial
      homeostasis and differentiation but also in immune response and epidermal
      carcinogenesis.
    explanation: >-
      Connects the connexin defect to both impaired host defence and carcinogenesis.
      INDIRECT as it is the paper's synthesis rather than a single measured result.
  downstream:
  - target: Recurrent Mucocutaneous Infections
    causal_link_type: DIRECT
  - target: Cutaneous Squamous Cell Carcinoma
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
  - target: Hidradenitis Suppurativa
    causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
- name: Corneal Epithelial Gap Junction Dysfunction
  biological_scale: TISSUE
  mechanism_confidence: PROVISIONAL
  description: >-
    Gap-junction communication in the human corneal epithelium is carried by Cx26,
    Cx30, Cx31.1 and Cx43. The common D50N mutant fails to form corneal gap-junction
    plaques, and the resulting epithelial dysfunction produces recurrent epithelial
    defects, corneal surface instability, limbal stem cell deficiency, and the
    progressive stromal vascularization that defines the "keratitis" of KID and can
    end in scarring and blindness.
  locations:
  - preferred_term: corneal epithelium
    term:
      id: UBERON:0001772
      label: corneal epithelium
  cell_types:
  - preferred_term: corneal epithelial cell
    term:
      id: CL:0000575
      label: corneal epithelial cell
  biological_processes:
  - preferred_term: angiogenesis
    term:
      id: GO:0001525
      label: angiogenesis
    modifier: INCREASED
  evidence:
  - reference: PMID:15914609
    reference_title: In vivo and in vitro expression of connexins in the human corneal epithelium.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Gap junction communication in the human corneal epithelium is mediated by
      Cx26, -30, -31.1, and -43.
    explanation: >-
      Establishes that Cx26 participates in corneal epithelial gap-junction
      communication, the network disrupted in KID.
  - reference: PMID:15691545
    reference_title: Ocular manifestations of keratitis-ichthyosis-deafness (KID) syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Lid abnormalities, corneal surface instability, limbal stem cell deficiency
      with resulting corneal complications, and dry eye are the main ocular
      manifestations.
    explanation: >-
      Identifies limbal stem cell deficiency and corneal surface instability as the
      core ocular lesions.
  downstream:
  - target: Vascularizing Keratitis
    causal_link_type: DIRECT
  - target: Corneal Neovascularization
    causal_link_type: DIRECT
  - target: Limbal Stem Cell Deficiency
    causal_link_type: DIRECT
  - target: Visual Impairment
    causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
- name: Cochlear Supporting Cell Hemichannel Hyperactivity
  biological_scale: TISSUE
  mechanism_confidence: PROVISIONAL
  description: >-
    Cx26 is not expressed in cochlear hair cells but is expressed throughout the
    non-sensory (supporting) epithelial cells. In a Cx26-S17F knock-in mouse
    cochlea, supporting cells develop hyperactive hemichannels - forming with
    Cx30, and insensitive to hemichannel blockers, calcium and lanthanum - that
    admit excess calcium and cause cellular damage, accompanied by loss of hair
    cell stereocilia. This relocates the syndromic deafness lesion to a leaky
    hemichannel in the supporting-cell network rather than to loss of potassium
    recycling, the account for the recessive nonsyndromic form.
  cell_types:
  - preferred_term: organ of Corti supporting cell
    term:
      id: CL:0002490
      label: organ of Corti supporting cell
  locations:
  - preferred_term: spiral organ of Corti
    term:
      id: UBERON:0002227
      label: spiral organ of cochlea
  molecular_functions:
  - preferred_term: gap junction hemichannel activity
    term:
      id: GO:0055077
      label: gap junction hemi-channel activity
    modifier: GAIN_OF_FUNCTION
  evidence:
  - reference: PMID:36699003
    reference_title: Expression of KID syndromic mutation Cx26S17F produces hyperactive hemichannels in supporting cells of the organ of Corti.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      cochlear explants from a constitutive knock-in Cx26S17F mouse or conditional
      in vitro cochlear expression of Cx26S17F produces hyperactive HCs in
      supporting cells of the organ of Corti. These conditions also produce loss of
      hair cells stereocilia.
    explanation: >-
      Demonstrates hyperactive supporting-cell hemichannels in a KID cochlea and
      links them to hair cell stereocilia loss.
  - reference: PMID:25386120
    reference_title: "Aberrant Cx26 hemichannels and keratitis-ichthyosis-deafness syndrome: insights into syndromic hearing loss."
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: OTHER
    snippet: >-
      Cx26 is not expressed in hair cells, but is widely expressed throughout the
      non-sensory epithelial cells of the cochlea.
    explanation: >-
      Establishes the cellular localisation that makes the supporting cell, not the
      hair cell, the primary cochlear target. INDIRECT: a review's statement of
      expression pattern.
  downstream:
  - target: Sensorineural Hair Cell Dysfunction
    causal_link_type: DIRECT
- name: Sensorineural Hair Cell Dysfunction
  conforms_to: "sensorineural_hair_cell_loss#Hair Cell Mechanotransduction Failure and Death"
  biological_scale: TISSUE
  mechanism_confidence: PROVISIONAL
  description: >-
    Hair cell dysfunction and loss follow the supporting-cell lesion. A temporal
    bone from a G45E KID infant showed dysplasia of the cochlear and saccular
    neuroepithelium, and the S17F mouse loses hair cell stereocilia - so the
    endpoint is degeneration of the sensory epithelium downstream of the
    supporting-cell hemichannel defect. Conforms to the sensorineural hair cell
    loss module's hair-cell node, entered here through supporting-cell hemichannel
    hyperactivity rather than the module's generic insult.
  cell_types:
  - preferred_term: cochlear inner hair cell
    term:
      id: CL:0000589
      label: cochlear inner hair cell
  - preferred_term: cochlear outer hair cell
    term:
      id: CL:0000601
      label: cochlear outer hair cell
  biological_processes:
  - preferred_term: sensory perception of sound
    term:
      id: GO:0007605
      label: sensory perception of sound
    modifier: DECREASED
  evidence:
  - reference: PMID:16885744
    reference_title: Cochleosaccular dysplasia associated with a connexin 26 mutation in keratitis-ichthyosis-deafness syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The primary inner ear abnormality was dysplasia of the cochlear and saccular
      neuroepithelium.
    explanation: >-
      Human temporal-bone evidence that the KID cochlear lesion is dysplasia of the
      sensory neuroepithelium.
  downstream:
  - target: Congenital Sensorineural Hearing Impairment
    causal_link_type: DIRECT
phenotypes:
- category: Cutaneous
  name: Ichthyosiform Erythrokeratoderma
  description: >-
    Generalized erythema and ichthyosiform scaling from birth, evolving into fixed
    erythrokeratodermic plaques - a defining feature of the triad.
  phenotype_term:
    preferred_term: Ichthyosiform erythrokeratoderma
    term:
      id: HP:0007431
      label: Congenital ichthyosiform erythroderma
    onset:
      onset_category: CONGENITAL
  evidence:
  - reference: PMID:11912510
    reference_title: Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      characterized by vascularizing keratitis, profound sensorineural hearing loss
      (SNHL), and progressive erythrokeratoderma
    explanation: >-
      Names progressive erythrokeratoderma as one of the three defining features.
- category: Cutaneous
  name: Palmoplantar Keratoderma
  description: >-
    Thickened, often stippled or leathery keratoderma of the palms and soles,
    common in KID.
  phenotype_term:
    preferred_term: Palmoplantar keratoderma
    term:
      id: HP:0000982
      label: Palmoplantar keratoderma
  evidence:
  - reference: PMID:31705875
    reference_title: Allele-Specific Small Interfering RNA Corrects Aberrant Cellular Phenotype in Keratitis-Ichthyosis-Deafness Syndrome Keratinocytes.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Skin involvement consists of erythrokeratodermic or verrucous plaques and
      palmoplantar keratoderma with alopecia and/or onychodystrophy
    explanation: >-
      Lists palmoplantar keratoderma among the cutaneous features of KID.
- category: Cutaneous
  name: Follicular Hyperkeratosis
  description: >-
    Follicular plugging and hyperkeratosis, part of the ichthyosiform skin
    phenotype; can progress to follicular occlusion.
  phenotype_term:
    preferred_term: Follicular hyperkeratosis
    term:
      id: HP:0007502
      label: Follicular hyperkeratosis
  evidence:
  - reference: PMID:11912510
    reference_title: Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      a clinical triad that indicates a failure in development and differentiation
      of multiple stratifying epithelia
    explanation: >-
      Supports the disordered follicular/epidermal keratinization underlying this
      feature. INDIRECT: the abstract does not name follicular hyperkeratosis
      itself, so it supports the class of lesion rather than the specific sign.
- category: Cutaneous
  name: Alopecia
  description: >-
    Scarring and non-scarring alopecia with sparse or absent scalp hair, eyebrows
    and lashes; complete atrichia is seen in the severe/GJB6 and lethal forms.
  phenotype_term:
    preferred_term: Alopecia
    term:
      id: HP:0001596
      label: Alopecia
  evidence:
  - reference: PMID:20412116
    reference_title: "Germline mosaicism in keratitis-ichthyosis-deafness syndrome: pre-natal diagnosis in a familial lethal form."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      a characteristic severe neonatal phenotype including facial dysmorphy, severe
      cornification with massive focal hyperkeratosis of the skin with erythroderma,
      dystrophic nails, complete atrichia and absence of foreskin
    explanation: >-
      Documents atrichia (and nail dystrophy) in the severe neonatal phenotype.
- category: Cutaneous
  name: Nail Dystrophy
  description: >-
    Dystrophic nails / onychodystrophy accompanying the ectodermal phenotype.
  phenotype_term:
    preferred_term: Nail dystrophy
    term:
      id: HP:0008404
      label: Nail dystrophy
  evidence:
  - reference: PMID:31705875
    reference_title: Allele-Specific Small Interfering RNA Corrects Aberrant Cellular Phenotype in Keratitis-Ichthyosis-Deafness Syndrome Keratinocytes.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      palmoplantar keratoderma with alopecia and/or onychodystrophy
    explanation: >-
      Names onychodystrophy (nail dystrophy) among the KID cutaneous features.
- category: Ophthalmologic
  name: Vascularizing Keratitis
  description: >-
    Chronic corneal inflammation with progressive vascularization - the "keratitis"
    of the triad. Usually appears in childhood or adolescence, after the skin and
    hearing manifestations, and progresses to stromal scarring.
  phenotype_term:
    preferred_term: Vascularizing keratitis
    term:
      id: HP:0000491
      label: Keratitis
  evidence:
  - reference: PMID:37755702
    reference_title: Ocular phenotype and therapeutic interventions in keratitis-ichthyosis-deafness (KID) syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Main ophthalmic features were vascularizing keratopathy, ocular surface
      disease, hyperkeratotic lid lesions, recurrent epithelial defects, and corneal
      stromal scarring.
    explanation: >-
      Human case series documenting vascularizing keratopathy and corneal scarring
      as the core ocular features.
- category: Ophthalmologic
  name: Corneal Neovascularization
  description: >-
    Superficial and deep corneal stromal vascularization arising from the limbus,
    driving progressive visual loss.
  phenotype_term:
    preferred_term: Corneal neovascularization
    term:
      id: HP:0011496
      label: Corneal neovascularization
  evidence:
  - reference: PMID:12527832
    reference_title: "[Limbal stem cell deficiency associated with KID syndrome, about a case]."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We report the case of a 30-year-old woman with KID (keratitis ichthyosis
      deafness) syndrome consulting for massive corneal neovascularization.
    explanation: >-
      Documents massive corneal neovascularization in a KID patient.
- category: Ophthalmologic
  name: Limbal Stem Cell Deficiency
  description: >-
    Failure of the corneal limbal stem cell niche, producing conjunctivalization,
    persistent epithelial defects and treatment-refractory surface disease; a
    principal driver of the ocular morbidity and a target of stem cell transplantation.
  phenotype_term:
    preferred_term: Limbal stem cell deficiency
    term:
      id: HP:0032107
      label: Limbal stem cell deficiency
  evidence:
  - reference: PMID:30371567
    reference_title: Ocular Surface Stem Cell Transplantation for Treatment of Keratitis-Ichthyosis-Deafness Syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We present 5 eyes of 3 patients with KID syndrome that developed LSCD and
      underwent OSST.
    explanation: >-
      Documents limbal stem cell deficiency in a KID case series.
- category: Ophthalmologic
  name: Photophobia
  description: >-
    Photophobia is an early and near-universal ocular symptom, preceding the
    vascularizing keratitis.
  phenotype_term:
    preferred_term: Photophobia
    term:
      id: HP:0000613
      label: Photophobia
  evidence:
  - reference: PMID:29159249
    reference_title: Visual impairment reversal with oral acitretin therapy in keratitis-ichthyosis-deafness (KID) syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Ocular involvement occurs in 95% of patients with KID syndrome and includes
      photophobia and blepharitis in early childhood progressing to vascularizing
      keratitis, neovascularization, and scarring
    explanation: >-
      Documents photophobia as an early feature within the 95%-frequent ocular
      involvement.
- category: Ophthalmologic
  name: Keratoconjunctivitis Sicca
  description: >-
    Dry eye / keratoconjunctivitis sicca, a prominent and aggravating ocular surface
    feature that compounds the limbal deficiency.
  phenotype_term:
    preferred_term: Keratoconjunctivitis sicca
    term:
      id: HP:0001097
      label: Keratoconjunctivitis sicca
  evidence:
  - reference: PMID:15691545
    reference_title: Ocular manifestations of keratitis-ichthyosis-deafness (KID) syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      recurrent corneal epithelial defects, superficial and deep corneal stromal
      vascularization with scarring, keratoconjunctivitis sicca
    explanation: >-
      Lists keratoconjunctivitis sicca among the ocular manifestations.
- category: Ophthalmologic
  name: Visual Impairment
  description: >-
    Progressive visual loss from corneal scarring and vascularization, up to
    blindness in severe cases.
  phenotype_term:
    preferred_term: Visual impairment
    term:
      id: HP:0000505
      label: Visual impairment
  evidence:
  - reference: PMID:15691545
    reference_title: Ocular manifestations of keratitis-ichthyosis-deafness (KID) syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Visual acuity ranged from normal to severe visual loss.
    explanation: >-
      Documents the range up to severe visual loss across KID patients.
- category: Auditory
  name: Congenital Sensorineural Hearing Impairment
  description: >-
    Congenital, bilateral, typically profound sensorineural hearing loss - the
    "deafness" of the triad and usually the earliest recognised feature.
  phenotype_term:
    preferred_term: Congenital sensorineural hearing impairment
    term:
      id: HP:0008527
      label: Congenital sensorineural hearing impairment
    onset:
      onset_category: CONGENITAL
  evidence:
  - reference: PMID:11912510
    reference_title: Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      characterized by vascularizing keratitis, profound sensorineural hearing loss
      (SNHL), and progressive erythrokeratoderma
    explanation: >-
      Names profound sensorineural hearing loss as one of the three defining
      features.
- category: Infectious
  name: Recurrent Mucocutaneous Infections
  description: >-
    Chronic mucocutaneous candidiasis and recurrent bacterial superinfection of
    skin lesions; in the lethal neonatal form, overwhelming infection and
    septicaemia are the cause of death.
  phenotype_term:
    preferred_term: Chronic mucocutaneous candidiasis and bacterial superinfection
    term:
      id: HP:0002728
      label: Chronic mucocutaneous candidiasis
  evidence:
  - reference: PMID:23384797
    reference_title: "Keratitis, ichthyosis, and deafness syndrome: a review of infectious and neoplastic complications."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Chronic mucocutaneous candidiasis and/or superinfection of skin lesions
      commonly occur and warrant aggressive therapeutic intervention.
    explanation: >-
      Documents chronic candidiasis and bacterial superinfection as common KID
      complications.
- category: Neoplastic
  name: Cutaneous Squamous Cell Carcinoma
  frequency: OCCASIONAL
  description: >-
    Invasive squamous cell carcinoma of skin, especially at acral and chronically
    inflamed sites, in roughly 15% of patients; can be aggressive and multifocal,
    with amputation reported. Benign trichilemmal tumors may herald malignant
    change.
  phenotype_term:
    preferred_term: Squamous cell carcinoma of the skin
    term:
      id: HP:0006739
      label: Squamous cell carcinoma of the skin
  evidence:
  - reference: PMID:23384797
    reference_title: "Keratitis, ichthyosis, and deafness syndrome: a review of infectious and neoplastic complications."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Squamous cell carcinoma of both mucosa and skin, especially acral sites,
      occurs in approximately 15% of patients.
    explanation: >-
      Provides the ~15% frequency (OCCASIONAL band) for cutaneous/mucosal SCC.
  - reference: PMID:3955509
    reference_title: Squamous cell carcinoma in congenital ichthyosis with deafness and keratitis. A case report and review of the literature.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The entire left foot became involved with a multinodular fungating mass which
      proved to harbor a SCC, necessitating a left below-knee amputation.
    explanation: >-
      Documents the aggressive, acral, potentially limb-threatening behaviour of
      SCC in KID.
- category: Neoplastic
  name: Tongue Squamous Cell Carcinoma
  description: >-
    Mucosal squamous cell carcinoma, including fatal carcinoma of the tongue, a rare
    but reported complication; associated in one series with the more severe p.S17F
    genotype.
  phenotype_term:
    preferred_term: Squamous cell carcinoma of the tongue
    term:
      id: HP:0030413
      label: Squamous cell carcinoma of the tongue
  evidence:
  - reference: PMID:17381453
    reference_title: "Keratitis-ichthyosis-deafness syndrome: disease expression and spectrum of connexin 26 (GJB2) mutations in 14 patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      One patient presented at the age of 18 years with a fatal carcinoma of the
      tongue, an extremely rare reported complication.
    explanation: >-
      Documents fatal tongue carcinoma as a rare mucosal neoplastic complication.
- category: Cutaneous
  name: Hidradenitis Suppurativa
  description: >-
    Follicular occlusion triad - hidradenitis suppurativa (acne inversa), acne
    conglobata and dissecting cellulitis of the scalp - is a recognised, disfiguring
    complication reflecting the follicular occlusion of KID.
  phenotype_term:
    preferred_term: Hidradenitis suppurativa
    term:
      id: HP:0040154
      label: Acne inversa
  evidence:
  - reference: PMID:16172043
    reference_title: Keratitis-ichthyosis-deafness syndrome in association with follicular occlusion triad.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      our patient presented a follicular occlusion triad with hidradenitis
      suppurativa (HS, alias acne inversa), acne conglobata and dissecting cellulitis
      of the scalp, leading to cicatricial alopecia
    explanation: >-
      Documents hidradenitis suppurativa as part of the follicular occlusion triad
      in a D50N KID patient.
mechanistic_hypotheses:
- hypothesis_group_id: hyperactive_hemichannel
  hypothesis_label: Homomeric hyperactive-hemichannel gain of function
  status: CANONICAL
  description: >-
    The leading and most-tested account: syndromic Cx26 mutants form homomeric
    hemichannels that open aberrantly, losing extracellular-calcium restraint
    (D50N, A40V, D50A, A88V, G12R) or becoming directly calcium-permeable (G45E),
    loading cells with calcium, leaking ATP, and driving cell death - a "leaky
    membrane" common to most KID alleles.
- hypothesis_group_id: heteromeric_connexin_interaction
  hypothesis_label: Heteromeric Cx26/Cx43(Cx30) hyperactive hemichannel
  status: EMERGING
  description: >-
    The refinement needed to explain alleles (S17F) whose homomeric hemichannels
    are silent yet whose disease is severe: the mutant acquires the ability to
    oligomerise with the normally incompatible Cx43 (and with Cx30), forming
    hyperactive heteromeric hemichannels but non-functional heteromeric
    gap-junction channels. This unifies the gain-of-leak and loss-of-coupling
    arms and may be the general mechanism for N-terminal syndromic mutations.
discussions:
- discussion_id: kid_cochlear_hemichannel_to_deafness
  kind: HUMAN_MODEL_MISMATCH
  prompt: >-
    Does supporting-cell hemichannel hyperactivity actually cause the human
    sensorineural deafness of KID, given that the direct demonstration is in a
    mouse cochlea and Cx26 is absent from hair cells?
  attaches_to:
  - pathophysiology#Cochlear Supporting Cell Hemichannel Hyperactivity
  - pathophysiology#Sensorineural Hair Cell Dysfunction
  rationale: >-
    The cochlear mechanism rests on a Cx26-S17F knock-in mouse showing hyperactive
    supporting-cell hemichannels and stereocilia loss, plus a single human
    temporal bone (G45E) showing neuroepithelial dysplasia. No coupling or
    hemichannel measurement exists in a human KID cochlea, and the causal step
    from a supporting-cell leak to hair cell death is inferred rather than
    measured in human tissue. It is a mismatch, not an absence of evidence: the
    mouse result is clean but is one allele in one species.
  evidence:
  - reference: PMID:16885744
    reference_title: Cochleosaccular dysplasia associated with a connexin 26 mutation in keratitis-ichthyosis-deafness syndrome.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      GJB2 mutations can cause deafness in KID syndrome, and possibly in other GJB2
      mutant phenotypes, by disrupting cochlear differentiation.
    explanation: >-
      The only human cochlear observation available, and it is a single temporal
      bone framed as a hypothesis about cochlear differentiation - which is the
      scope of the human evidence this mismatch is about. INDIRECT because it
      supports the size of the gap rather than the mouse mechanism itself.
  proposed_experiments:
  - experiment_id: kid_cochlear_supporting_cell_readout
    name: Supporting-cell hemichannel activity and hair cell survival across KID alleles
    description: >-
      Measure supporting-cell hemichannel current and hair cell survival in
      cochlear explants carrying the common human KID alleles (D50N, S17F) at
      native connexin stoichiometry, and test whether a hemichannel blocker
      preserves hair cells.
    would_support:
    - pathophysiology#Cochlear Supporting Cell Hemichannel Hyperactivity
    supporting_outcome:
    - >-
      Hyperactive supporting-cell hemichannels and hair cell loss are reproduced by
      the common human alleles and are prevented by hemichannel blockade.
    would_refute:
    - pathophysiology#Cochlear Supporting Cell Hemichannel Hyperactivity
    refuting_outcome:
    - >-
      Supporting-cell hemichannel activity is normal for the common alleles, so the
      deafness requires a mechanism other than the supporting-cell leak.
- discussion_id: kid_homomeric_vs_heteromeric_mechanism
  kind: CONTROVERSY
  prompt: >-
    Is the pathogenic hemichannel in KID homomeric Cx26, or does it require
    heteromeric assembly with Cx43/Cx30?
  attaches_to:
  - pathophysiology#Hyperactive Connexin 26 Hemichannels
  - pathophysiology#Aberrant Heteromeric Interaction with Cx43 and Cx30
  rationale: >-
    Most alleles form hyperactive homomeric hemichannels, which is the canonical
    account, but S17F forms non-functional homomeric hemichannels yet causes
    severe disease, and only becomes hyperactive when co-expressed with Cx43 or
    Cx30. Whether the heteromeric route is a special case for a few alleles or the
    general mechanism for all N-terminal syndromic mutations is unresolved, and it
    matters for therapy: an allele-agnostic hemichannel blocker versus an
    allele-specific silencing approach make different bets on this question.
  evidence:
  - reference: PMID:25625422
    reference_title: "Keratitis-ichthyosis-deafness syndrome-associated Cx26 mutants produce nonfunctional gap junctions but hyperactive hemichannels when co-expressed with wild type Cx43."
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      some syndromic mutations, like Cx26S17F, lead to non-functional HCs, but they
      still developed a severe KID syndrome phenotype
    explanation: >-
      States the observation that the homomeric hyperactive-hemichannel account
      cannot explain, which is what makes this an open controversy rather than a
      settled mechanism.
  - reference: PMID:23447037
    reference_title: The human Cx26-D50A and Cx26-A88V mutations causing keratitis-ichthyosis-deafness syndrome display increased hemichannel activity.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      These results show that these two mutations exhibit a shared gain of
      functional activity and support the hypothesis that increased hemichannel
      activity is a common feature of human Cx26 mutations responsible for KID
      syndrome.
    explanation: >-
      The other side of the controversy: the homomeric account, argued from alleles
      that do form hyperactive homomeric hemichannels.
genetic:
- name: GJB2
  gene_term:
    preferred_term: GJB2
    term:
      id: hgnc:4284
      label: GJB2
  relationship_type: CAUSATIVE
  variant_origin: DE_NOVO
  notes: >-
    The major cause. Heterozygous missense variants clustered in the cytoplasmic
    N-terminus and first extracellular loop of connexin 26. p.D50N is by far the
    commonest (~86% of a European cohort); p.S17F is recurrent and associated with
    a more severe skin phenotype and tongue carcinoma; p.G12R and p.A40V occur;
    p.G45E and p.A88V cause a lethal neonatal form. The same gene carries the
    recessive nonsyndromic loss-of-function alleles (DFNB1) and the dominant
    nonsyndromic form (DFNA3A), which are separate KB entries - a heterozygous GJB2
    variant is assigned to this entry only with the syndromic skin/eye phenotype.
  case_fractions:
  - population: European KID cohort (largest reported series)
    case_fraction_percent: 86.0
    notes: p.D50N share of KID cases; recorded from the AS-siRNA study citing the
      largest European cohort.
    evidence:
    - reference: PMID:31705875
      reference_title: Allele-Specific Small Interfering RNA Corrects Aberrant Cellular Phenotype in Keratitis-Ichthyosis-Deafness Syndrome Keratinocytes.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        Most cases of KID syndrome (86%) are caused by a heterozygous missense
        mutation (c.148G>A, p.D50N) in the GJB2 gene, encoding gap junction protein
        Cx26, which alters gating properties of Cx26 channels in a dominant manner.
      explanation: >-
        Quantifies the p.D50N share of KID cases at 86%.
  evidence:
  - reference: PMID:11912510
    reference_title: Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      we provide compelling evidence that KID is caused by heterozygous missense
      mutations in the connexin-26 gene, GJB2
    explanation: >-
      Establishes GJB2 as the causative gene for KID.
  - reference: PMID:17381453
    reference_title: "Keratitis-ichthyosis-deafness syndrome: disease expression and spectrum of connexin 26 (GJB2) mutations in 14 patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Twelve patients (86%) were heterozygous for the p.Asp50Asn mutation and two
      patients (14%) were heterozygous for the p.Ser17Phe mutation.
    explanation: >-
      Documents the allele spectrum, with D50N dominant and S17F the next most
      common in a 14-patient cohort.
  - reference: PMID:28158657
    reference_title: Revertant mosaicism repairs skin lesions in a patient with keratitis-ichthyosis-deafness syndrome by second-site mutations in connexin 26.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: IN_VITRO
    snippet: >-
      the second-site mutations independently inhibit Cx26-Asp50Asn expression in
      gap junction channels, reverting the dominant negative effect of the
      p.Asp50Asn mutation
    explanation: >-
      Revertant mosaicism restoring healthy skin by silencing the D50N allele
      confirms the allele's dominant pathogenic effect. INDIRECT: it supports
      pathogenicity via natural reversion rather than a primary functional assay.
- name: GJB6
  gene_term:
    preferred_term: GJB6
    term:
      id: hgnc:4288
      label: GJB6
  relationship_type: CAUSATIVE
  variant_origin: GERMLINE
  notes: >-
    A rare alternative cause. A heterozygous GJB6 (connexin 30) missense mutation
    was found in a KID-phenotype patient with congenital atrichia who had no
    pathogenic GJB2 change, establishing genetic heterogeneity. Cx30 co-assembles
    with Cx26 in the same epithelia, which is why its mutation can phenocopy Cx26
    disease.
  evidence:
  - reference: PMID:15140211
    reference_title: "Genetic heterogeneity of KID syndrome: identification of a Cx30 gene (GJB6) mutation in a patient with KID syndrome and congenital atrichia."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      screening of GJB6 revealed a heterozygous missense mutation (V37E) predicted
      to alter sequence and charge of the first transmembrane helix of Cx30
    explanation: >-
      Identifies a GJB6 (Cx30) mutation as a rare cause of a KID phenotype.
has_subtypes:
- name: Lethal Neonatal KID
  display_name: Lethal neonatal (fatal) form of KID
  description: >-
    A severe form presenting in the first year of life with overwhelming skin
    infection and septicaemia, caused by specific GJB2 alleles - p.G45E (the
    prototype) and p.A88V. These alleles form the most hyperactive hemichannels.
    Recurrence in siblings of unaffected parents has been traced to germline
    mosaicism, enabling prenatal diagnosis.
  evidence:
  - reference: PMID:15633193
    reference_title: GJB2 mutations in keratitis-ichthyosis-deafness syndrome including its fatal form.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We identified a de novo GJB2 mutation G45E in a patient displaying the fatal
      form of the disease.
    explanation: >-
      Ties the fatal neonatal form to the de novo G45E allele.
  - reference: PMID:18024254
    reference_title: A familial case of Keratitis-Ichthyosis-Deafness (KID) syndrome with the GJB2 mutation G45E.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      A rare form of the KID syndrome is a fatal course in the first year of life
      due to severe skin lesion infections and septicaemia.
    explanation: >-
      Describes the lethal neonatal course and its infectious cause.
- name: HID Variant
  display_name: Hystrix-like ichthyosis-deafness (HID)
  description: >-
    Historically separated from KID by spiny (hystrix-like) verrucous
    hyperkeratosis and electron-microscopic differences, HID was shown to carry
    the same connexin 26 mutation as KID and is now regarded as the same disease.
    Curated as a subtype label rather than a separate entry.
  evidence:
  - reference: PMID:12072059
    reference_title: HID and KID syndromes are associated with the same connexin 26 mutation.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      We show that KID and HID syndromes are identical at the molecular level and
      confirm the clinical impression that these syndromes are one and the same.
    explanation: >-
      Establishes HID and KID as molecularly identical, justifying a subtype label
      rather than a separate entry.
diagnosis:
- name: Clinical Recognition of the Triad
  description: >-
    Diagnosis begins with the clinical triad of vascularizing keratitis,
    ichthyosiform/erythrokeratodermic skin, and congenital sensorineural hearing
    loss, supported by dermatologic, ophthalmologic and audiologic examination.
  diagnosis_term:
    preferred_term: eye examination
    term:
      id: NCIT:C38060
      label: Eye Examination
  evidence:
  - reference: PMID:37755702
    reference_title: Ocular phenotype and therapeutic interventions in keratitis-ichthyosis-deafness (KID) syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      All four individuals had the characteristic systemic features of
      keratitis-ichthyosis-deafness syndrome.
    explanation: >-
      Confirms recognition rests on the characteristic systemic triad.
- name: Molecular Genetic Testing of GJB2 and GJB6
  description: >-
    Sequencing of GJB2 (and GJB6 when GJB2 is negative) confirms the diagnosis and
    the specific allele, which informs prognosis (e.g. G45E lethal form, S17F
    severity) and genetic counselling.
  diagnosis_term:
    preferred_term: genetic testing
    term:
      id: NCIT:C15709
      label: Genetic Testing
  evidence:
  - reference: PMID:11912510
    reference_title: Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      In each of 10 patients with KID, we identified a point mutation
    explanation: >-
      Establishes GJB2 sequencing as the confirmatory genetic test.
differential_diagnoses:
- name: Autosomal recessive KID (KIDAR, AP1B1)
  description: >-
    A distinct autosomal recessive disorder of vesicular trafficking (AP1B1,
    MONDO:0859278) that shares ichthyosis, keratitis and deafness but adds failure
    to thrive, developmental delay and copper-metabolism abnormalities. Not
    connexin-related; a separate entity.
  distinguishing_features:
  - Autosomal recessive inheritance with biallelic AP1B1 loss-of-function variants
  - Systemic features - failure to thrive, developmental delay, low copper and ceruloplasmin
  - No connexin defect
  evidence:
  - reference: PMID:11912510
    reference_title: Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome.
    supports: SUPPORT
    directness: INDIRECT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      dominant GJB2 mutations can disturb the gap junction system of one or several
      ectodermal epithelia
    explanation: >-
      Anchors the dominant connexin mechanism of this entry, which distinguishes it
      from the recessive AP1B1 trafficking disorder. INDIRECT: it establishes this
      entry's mechanism rather than describing KIDAR directly.
- name: Nonsyndromic GJB2 hearing loss (DFNB1 / DFNA3A)
  description: >-
    Loss-of-function GJB2 alleles at the same locus cause nonsyndromic
    sensorineural deafness with no skin or eye disease. The distinction is
    mechanistic: nonsyndromic disease is loss of function, KID is gain of function.
  distinguishing_features:
  - Absence of skin and corneal disease
  - Loss-of-function alleles rather than N-terminal or first-extracellular-loop gain-of-function missense
  evidence:
  - reference: PMID:22547955
    reference_title: GJB2 Gene Mutations in Syndromic Skin Diseases with Sensorineural Hearing Loss.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Nonsyndromic deafness is caused prevalently by a loss-of-function, while
      literature evidences suggest for syndromic deafness a mechanism based on
      gain-of-function.
    explanation: >-
      States the loss-of-function versus gain-of-function distinction separating
      nonsyndromic GJB2 deafness from syndromic KID.
treatments:
- name: Systemic Retinoid Therapy (Acitretin)
  therapeutic_modality: SMALL_MOLECULE
  description: >-
    Oral acitretin improves the hyperkeratotic/ichthyotic skin, with reports of
    rapid improvement within weeks; occasional reports describe visual improvement.
    It does not correct the underlying channel defect and carries ocular and
    skeletal toxicity risks that require caution, especially in children with the
    keratitis of KID.
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: acitretin
      term:
        id: CHEBI:50172
        label: acitretin
  target_phenotypes:
  - preferred_term: Ichthyosiform erythrokeratoderma
    term:
      id: HP:0007431
      label: Congenital ichthyosiform erythroderma
  evidence:
  - reference: PMID:25546246
    reference_title: "Treatment of keratitis-ichthyosis- deafness (KID) syndrome in children: a case report and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      The patient had significant improvement of the hyperkeratosis on the scalp,
      trunk, and extremities within 4 weeks after initiating treatment.
    explanation: >-
      Documents acitretin's dermatologic benefit in a child with KID.
  - reference: PMID:25546246
    reference_title: "Treatment of keratitis-ichthyosis- deafness (KID) syndrome in children: a case report and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Ocular and skeletal toxicity from prolonged exposure to systemic retinoids is
      a major concern especially in children.
    explanation: >-
      Records the retinoid toxicity caution relevant to the keratitis of KID.
- name: Antimicrobial Therapy for Cutaneous Infection
  therapeutic_modality: SMALL_MOLECULE
  description: >-
    Antifungal and antibiotic therapy to control the chronic mucocutaneous
    candidiasis and bacterial superinfection that drive morbidity and, in the
    neonatal form, mortality.
  treatment_term:
    preferred_term: antifungal and antibacterial pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: antifungal agent
      term:
        id: NCIT:C514
        label: Antifungal Agent
    - preferred_term: antibiotic
      term:
        id: NCIT:C258
        label: Antibiotic
  target_phenotypes:
  - preferred_term: Chronic mucocutaneous candidiasis
    term:
      id: HP:0002728
      label: Chronic mucocutaneous candidiasis
  evidence:
  - reference: PMID:25546246
    reference_title: "Treatment of keratitis-ichthyosis- deafness (KID) syndrome in children: a case report and review of the literature."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Treatments with antibiotics, antifungals, and systemic retinoids have been
      reported with variable response.
    explanation: >-
      Supports antimicrobial management of the infectious complications of KID.
- name: Ocular Surface Stem Cell Transplantation
  therapeutic_modality: SURGERY
  description: >-
    For limbal stem cell deficiency and corneal surface failure. Ocular surface
    stem cell transplantation (limbal allograft), often followed by keratoplasty,
    can stabilize the surface; living-related conjunctival limbal allograft may
    outperform keratolimbal allograft because it is HLA/ABO-matched. Outcomes remain
    challenging.
  treatment_term:
    preferred_term: ocular surface stem cell transplantation
    term:
      id: NCIT:C210959
      label: Corneal Transplantation
  target_phenotypes:
  - preferred_term: Limbal stem cell deficiency
    term:
      id: HP:0032107
      label: Limbal stem cell deficiency
  target_mechanisms:
  - target: Corneal Epithelial Gap Junction Dysfunction
    description: >-
      Replaces the failed limbal stem cell niche to restore a stable corneal
      epithelium.
    evidence:
    - reference: PMID:30371567
      reference_title: Ocular Surface Stem Cell Transplantation for Treatment of Keratitis-Ichthyosis-Deafness Syndrome.
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: >-
        An lr-CLAL may offer further benefit over a KLAL in these eyes because it is
        HLA- and ABO-matched tissue
      explanation: >-
        Reports the surgical approach and the HLA/ABO-matching advantage in KID
        limbal deficiency.
  evidence:
  - reference: PMID:30371567
    reference_title: Ocular Surface Stem Cell Transplantation for Treatment of Keratitis-Ichthyosis-Deafness Syndrome.
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Although OSST can stabilize the surface, long-term treatment of KID syndrome
      can be challenging.
    explanation: >-
      Records both the benefit and the limited durability of ocular surface stem
      cell transplantation in KID.
- name: Cochlear Implantation
  therapeutic_modality: DEVICE
  description: >-
    For the profound sensorineural hearing loss. Because skin debris and chronic
    otitis can render hearing aids ineffective and visual loss can preclude sign
    language, cochlear implantation is often the definitive auditory intervention;
    it is safe and effective in most patients but carries a raised rate of
    postoperative wound/infection complications requiring close monitoring. The
    implant device term (NCIT:C157820) names equipment and is not a clinical-action
    term, so the surgical action is bound and the device carried as a qualifier.
  treatment_term:
    preferred_term: cochlear device implantation
    term:
      id: NCIT:C15329
      label: Surgical Procedure
    qualifiers:
    - predicate:
        preferred_term: medical device
        term:
          id: NCIT:C16830
          label: Medical Device
      value:
        preferred_term: cochlear implant
        term:
          id: NCIT:C157820
          label: Cochlear Implant
  target_phenotypes:
  - preferred_term: Congenital sensorineural hearing impairment
    term:
      id: HP:0008527
      label: Congenital sensorineural hearing impairment
  evidence:
  - reference: PMID:40889428
    reference_title: "Cochlear implantation in patients with keratitis-ichthyosis-deafness syndrome: A systematic review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      CI in patients with KID syndrome presents distinctive challenges but is a safe
      and effective treatment option.
    explanation: >-
      Systematic-review conclusion supporting cochlear implantation in KID.
  - reference: PMID:40889428
    reference_title: "Cochlear implantation in patients with keratitis-ichthyosis-deafness syndrome: A systematic review."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Notable complications included postoperative infection (30.8 %, n = 4)
    explanation: >-
      Quantifies the raised postoperative infection risk specific to KID implantees.
  - reference: PMID:22340753
    reference_title: "Cochlear implantation in keratitis-ichthyosis-deafness syndrome: 10-year follow-up of two patients."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: >-
      Patients with KID syndrome appear to be good candidates for cochlear
      implantation but may face significant skin-related problems which could
      disrupt successful post-operative habilitation.
    explanation: >-
      Long-term follow-up showing both candidacy and the skin-related risk to
      implant outcomes.
- name: Experimental Hemichannel Blockade
  therapeutic_modality: SMALL_MOLECULE
  description: >-
    A mechanism-directed experimental strategy. Because most KID alleles confer
    aberrant hemichannel opening, blocking the hemichannel is a rational target;
    mefloquine, an FDA-approved antimalarial, inhibits mutant KID hemichannels in
    Xenopus oocytes and attenuates macroscopic currents in G45E keratinocytes.
    Engineered anti-Cx26 antibodies act similarly. Preclinical only.
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
    therapeutic_agent:
    - preferred_term: mefloquine
      term:
        id: CHEBI:63609
        label: mefloquine
  target_mechanisms:
  - target: Hyperactive Connexin 26 Hemichannels
    description: >-
      Directly inhibits the aberrant hemichannel that is the proximate pathogenic
      lesion.
    evidence:
    - reference: PMID:25229253
      reference_title: Aberrant connexin26 hemichannels underlying keratitis-ichthyosis-deafness syndrome are potently inhibited by mefloquine.
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        mefloquine (MFQ) inhibits several mutant hemichannel forms implicated in KID
        syndrome when expressed in Xenopus laevis oocytes
      explanation: >-
        Shows mefloquine inhibits KID mutant hemichannels, the target of this
        strategy.
  evidence:
  - reference: PMID:39269388
    reference_title: Connexin Hemichannel Inhibition and Human Genodermatoses.
    supports: SUPPORT
    evidence_source: OTHER
    snippet: >-
      Use of pharmacological blockers and engineered mAbs in mouse models of HED and
      KID confirm that hemichannel inhibition is a promising target for new
      therapeutic approaches to KID and HED.
    explanation: >-
      Summarises hemichannel inhibition as a validated preclinical therapeutic
      target for KID.
- name: Allele-Specific siRNA (Experimental)
  therapeutic_modality: SIRNA
  description: >-
    A precision strategy for the dominant D50N allele: a mutant-selective siRNA
    silences the D50N transcript without touching the wild-type allele, correcting
    both the impaired gap-junction coupling and the hyperactive hemichannel in
    patient keratinocytes. Proof of concept only, with topical delivery to skin
    still to be solved and no cochlear delivery.
  treatment_term:
    preferred_term: Pharmacotherapy
    term:
      id: NCIT:C15986
      label: Pharmacotherapy
  target_mechanisms:
  - target: Heterozygous Gain-of-Function GJB2 Missense Variant
    description: >-
      Selectively removes the mutant transcript, so the remaining wild-type allele's
      channels function normally.
    evidence:
    - reference: PMID:31705875
      reference_title: Allele-Specific Small Interfering RNA Corrects Aberrant Cellular Phenotype in Keratitis-Ichthyosis-Deafness Syndrome Keratinocytes.
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        In vitro treatment with allele-specific small interfering RNA led to robust
        inhibition of the mutant GJB2 allele without altering expression of the
        wild-type allele. This corrected both gap junction and hemichannel activity.
      explanation: >-
        Demonstrates allele-selective knockdown correcting both channel defects in
        patient cells.
  evidence:
  - reference: PMID:31705875
    reference_title: Allele-Specific Small Interfering RNA Corrects Aberrant Cellular Phenotype in Keratitis-Ichthyosis-Deafness Syndrome Keratinocytes.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      Our data provide an important proof-of-concept and model system for the
      potential use of allele-specific small interfering RNA in treating KID syndrome
      and other dominant genetic conditions.
    explanation: >-
      Frames the approach as preclinical proof of concept for KID.
animal_models:
- name: Cx26-G45E inducible transgenic mouse
  species: Mouse
  genotype: Inducible transgenic expressing human Cx26-G45E in keratinocytes
  publication: PMID:22031297
  description: >-
    The model of the lethal KID skin phenotype, created because the G45E allele
    forms constitutively active hemichannels. Induced expression in keratinocytes
    reproduces hyperkeratosis, scaling, hair loss and the hyperproliferative
    histopathology of human KID, with increased hemichannel currents in the
    transgenic keratinocytes.
  evidence:
  - reference: PMID:22031297
    reference_title: The Cx26-G45E mutation displays increased hemichannel activity in a mouse model of the lethal form of keratitis-ichthyosis-deafness syndrome.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      We created an animal model for KIDS by generating an inducible transgenic
      mouse expressing Cx26-G45E in keratinocytes.
    explanation: >-
      Establishes the existence and construction of this model of KID.
  - reference: PMID:22031297
    reference_title: The Cx26-G45E mutation displays increased hemichannel activity in a mouse model of the lethal form of keratitis-ichthyosis-deafness syndrome.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      Cx26-G45E mice displayed reduced viability, hyperkeratosis, scaling, skin
      folds, and hair loss.
    explanation: >-
      Records the whole-animal phenotype, including the reduced viability that
      parallels the lethal human form this allele causes.
  modeled_mechanisms:
  - target: Disordered Keratinocyte Proliferation and Differentiation
    relationship: RECAPITULATES
    fidelity: MODERATE
    model_scale: TISSUE
    description: >-
      Reproduces the hyperproliferative, abnormally differentiated epidermis and the
      clinical scaling/hyperkeratosis.
    limitations: >-
      A transgene expressed from a non-native promoter does not reproduce the native
      one-mutant-allele stoichiometry, and G45E is a lethal-form allele rather than
      the common D50N.
    readouts:
    - name: Epidermal histopathology
      target: Disordered Keratinocyte Proliferation and Differentiation
      direction: ALTERED
      interpretation: >-
        Hyperplasia, acanthosis and papillomatosis correlating with human KID skin.
      evidence:
      - reference: PMID:22031297
        reference_title: The Cx26-G45E mutation displays increased hemichannel activity in a mouse model of the lethal form of keratitis-ichthyosis-deafness syndrome.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: >-
          Histopathology included hyperplasia, acanthosis, papillomatosis, increased
          cell size, and osteal plugging.
        explanation: >-
          The histological measurement behind this readout.
    evidence:
    - reference: PMID:22031297
      reference_title: The Cx26-G45E mutation displays increased hemichannel activity in a mouse model of the lethal form of keratitis-ichthyosis-deafness syndrome.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        These abnormalities correlated with human KIDS pathology and were associated
        with increased hemichannel currents in transgenic keratinocytes.
      explanation: >-
        Supports treating this mouse as informative for the keratinocyte
        dysregulation node, with the hemichannel mechanism measured.
- name: Cx26-S17F knock-in mouse
  species: Mouse
  genotype: Constitutive Cx26-S17F knock-in
  publication: PMID:36699003
  description: >-
    The model that localizes the cochlear lesion. A constitutive S17F knock-in
    cochlea develops hyperactive hemichannels in the supporting cells of the organ
    of Corti (formed with Cx30) and loses hair cell stereocilia, demonstrating the
    supporting-cell hemichannel mechanism directly in cochlear tissue.
  evidence:
  - reference: PMID:36699003
    reference_title: Expression of KID syndromic mutation Cx26S17F produces hyperactive hemichannels in supporting cells of the organ of Corti.
    supports: SUPPORT
    evidence_source: MODEL_ORGANISM
    snippet: >-
      In this work, we evaluated the functional consequences of expressing a KID
      syndromic mutation, Cx26S17F, in the transgenic mouse cochlea and whether
      co-expression of Cx26S17F and Cx30 leads to the formation of hyperactive HCs.
    explanation: >-
      Establishes the model and the question it was built to answer - the cochlear
      consequences of a KID allele.
  modeled_mechanisms:
  - target: Cochlear Supporting Cell Hemichannel Hyperactivity
    relationship: RECAPITULATES
    fidelity: MODERATE
    model_scale: CELLULAR
    description: >-
      Reproduces hyperactive supporting-cell hemichannels and stereocilia loss in the
      organ of Corti.
    limitations: >-
      A single allele (S17F) in mouse; the hemichannel hyperactivity requires
      co-expression with Cx30, and the readout is at the cellular scale while the
      clinical endpoint this node feeds (hearing loss) is at the organism scale.
    readouts:
    - name: Supporting-cell hemichannel activity
      target: Cochlear Supporting Cell Hemichannel Hyperactivity
      direction: INCREASED
      interpretation: >-
        Hyperactive hemichannels with increased calcium influx and cellular damage in
        organ of Corti supporting cells.
      evidence:
      - reference: PMID:36699003
        reference_title: Expression of KID syndromic mutation Cx26S17F produces hyperactive hemichannels in supporting cells of the organ of Corti.
        supports: SUPPORT
        evidence_source: MODEL_ORGANISM
        snippet: >-
          cells co-expressing Cx26S17F and Cx30 present hyperactive HCs insensitive to
          HCs blockers, Ca2+ and La3+, resulting in more Ca2+ influx and cellular
          damage.
        explanation: >-
          The hemichannel measurement behind this readout.
    evidence:
    - reference: PMID:36699003
      reference_title: Expression of KID syndromic mutation Cx26S17F produces hyperactive hemichannels in supporting cells of the organ of Corti.
      supports: SUPPORT
      evidence_source: MODEL_ORGANISM
      snippet: >-
        cochlear explants from a constitutive knock-in Cx26S17F mouse or conditional
        in vitro cochlear expression of Cx26S17F produces hyperactive HCs in
        supporting cells of the organ of Corti. These conditions also produce loss of
        hair cells stereocilia.
      explanation: >-
        Supports treating this mouse as informative for the cochlear supporting-cell
        hemichannel node.
experimental_models:
- name: D50N patient-derived immortalized keratinocytes (KID-KC)
  experimental_model_type: CELL_LINE
  organism:
    preferred_term: human
    term:
      id: NCBITaxon:9606
      label: Homo sapiens
  cell_types:
  - preferred_term: keratinocyte
    term:
      id: CL:0000312
      label: keratinocyte
  publication: PMID:31705875
  description: >-
    Immortalized keratinocytes from a heterozygous D50N KID patient, which
    reproduce the impaired gap-junction communication and hyperactive hemichannels
    of the disease and, in a human-murine chimeric skin graft, recapitulate patient
    skin. Used to demonstrate allele-specific siRNA rescue.
  evidence:
  - reference: PMID:31705875
    reference_title: Allele-Specific Small Interfering RNA Corrects Aberrant Cellular Phenotype in Keratitis-Ichthyosis-Deafness Syndrome Keratinocytes.
    supports: SUPPORT
    evidence_source: IN_VITRO
    snippet: >-
      A KID syndrome cell line (KID-KC) was established from primary patient KCs
      with a heterozygous p.D50N mutation.
    explanation: >-
      Establishes the provenance of the cell line and its native heterozygous
      patient genotype.
  modeled_mechanisms:
  - target: Hyperactive Connexin 26 Hemichannels
    relationship: RECAPITULATES
    fidelity: HIGH
    model_scale: CELLULAR
    description: >-
      Patient cells at the native heterozygous genotype reproduce the hyperactive
      hemichannel and impaired coupling, unlike prior models that expressed the
      mutant allele alone.
    limitations: >-
      Immortalized monolayer keratinocytes express Cx26 at lower levels than
      differentiated skin; represents one allele (D50N).
    readouts:
    - name: Hemichannel activity and gap-junction coupling
      target: Hyperactive Connexin 26 Hemichannels
      direction: INCREASED
      interpretation: >-
        Hyperactive hemichannels and reduced coupling confirmed by patch clamp, dye
        transfer and neurobiotin uptake.
      evidence:
      - reference: PMID:31705875
        reference_title: Allele-Specific Small Interfering RNA Corrects Aberrant Cellular Phenotype in Keratitis-Ichthyosis-Deafness Syndrome Keratinocytes.
        supports: SUPPORT
        evidence_source: IN_VITRO
        snippet: >-
          This cell line displayed impaired gap junction communication and hyperactive
          hemichannels, confirmed by dye transfer, patch clamp, and neurobiotin uptake
          assays.
        explanation: >-
          The functional measurements behind this readout.
    evidence:
    - reference: PMID:31705875
      reference_title: Allele-Specific Small Interfering RNA Corrects Aberrant Cellular Phenotype in Keratitis-Ichthyosis-Deafness Syndrome Keratinocytes.
      supports: SUPPORT
      evidence_source: IN_VITRO
      snippet: >-
        A human-murine chimeric skin graft model constructed with KID-KCs mimicked
        patient skin in vivo, further confirming the validity of these cells as a
        model.
      explanation: >-
        Supports the patient keratinocyte line (and skin graft) as a valid KID model.
references:
- reference: PMID:11912510
  title: Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome.
- reference: PMID:17381453
  title: "Keratitis-ichthyosis-deafness syndrome: disease expression and spectrum of connexin 26 (GJB2) mutations in 14 patients."
- reference: PMID:23384797
  title: "Keratitis, ichthyosis, and deafness syndrome: a review of infectious and neoplastic complications."
- reference: PMID:15633193
  title: GJB2 mutations in keratitis-ichthyosis-deafness syndrome including its fatal form.
- reference: PMID:18024254
  title: A familial case of Keratitis-Ichthyosis-Deafness (KID) syndrome with the GJB2 mutation G45E.
- reference: PMID:20412116
  title: "Germline mosaicism in keratitis-ichthyosis-deafness syndrome: pre-natal diagnosis in a familial lethal form."
- reference: PMID:15140211
  title: "Genetic heterogeneity of KID syndrome: identification of a Cx30 gene (GJB6) mutation in a patient with KID syndrome and congenital atrichia."
- reference: PMID:12072059
  title: HID and KID syndromes are associated with the same connexin 26 mutation.
- reference: PMID:17428836
  title: Aberrant hemichannel properties of Cx26 mutations causing skin disease and deafness.
- reference: PMID:20584891
  title: Differentially altered Ca2+ regulation and Ca2+ permeability in Cx26 hemichannels formed by the A40V and G45E mutations that cause keratitis ichthyosis deafness syndrome.
- reference: PMID:23447037
  title: The human Cx26-D50A and Cx26-A88V mutations causing keratitis-ichthyosis-deafness syndrome display increased hemichannel activity.
- reference: PMID:23797419
  title: "The D50N mutation and syndromic deafness: altered Cx26 hemichannel properties caused by effects on the pore and intersubunit interactions."
- reference: PMID:22031297
  title: The Cx26-G45E mutation displays increased hemichannel activity in a mouse model of the lethal form of keratitis-ichthyosis-deafness syndrome.
- reference: PMID:26777423
  title: From Hyperactive Connexin26 Hemichannels to Impairments in Epidermal Calcium Gradient and Permeability Barrier in the Keratitis-Ichthyosis-Deafness Syndrome.
- reference: PMID:25625422
  title: "Keratitis-ichthyosis-deafness syndrome-associated Cx26 mutants produce nonfunctional gap junctions but hyperactive hemichannels when co-expressed with wild type Cx43."
- reference: PMID:36699003
  title: Expression of KID syndromic mutation Cx26S17F produces hyperactive hemichannels in supporting cells of the organ of Corti.
- reference: PMID:25386120
  title: "Aberrant Cx26 hemichannels and keratitis-ichthyosis-deafness syndrome: insights into syndromic hearing loss."
- reference: PMID:16885744
  title: Cochleosaccular dysplasia associated with a connexin 26 mutation in keratitis-ichthyosis-deafness syndrome.
- reference: PMID:30150638
  title: Roles of aberrant hemichannel activities due to mutant connexin26 in the pathogenesis of KID syndrome.
- reference: PMID:22643125
  title: Differential susceptibility of Cx26 mutations associated with epidermal dysplasias to peptidoglycan derived from Staphylococcus aureus and Staphylococcus epidermidis.
- reference: PMID:15914609
  title: In vivo and in vitro expression of connexins in the human corneal epithelium.
- reference: PMID:15691545
  title: Ocular manifestations of keratitis-ichthyosis-deafness (KID) syndrome.
- reference: PMID:30371567
  title: Ocular Surface Stem Cell Transplantation for Treatment of Keratitis-Ichthyosis-Deafness Syndrome.
- reference: PMID:12527832
  title: "[Limbal stem cell deficiency associated with KID syndrome, about a case]."
- reference: PMID:37755702
  title: Ocular phenotype and therapeutic interventions in keratitis-ichthyosis-deafness (KID) syndrome.
- reference: PMID:25546246
  title: "Treatment of keratitis-ichthyosis- deafness (KID) syndrome in children: a case report and review of the literature."
- reference: PMID:29159249
  title: Visual impairment reversal with oral acitretin therapy in keratitis-ichthyosis-deafness (KID) syndrome.
- reference: PMID:25229253
  title: Aberrant connexin26 hemichannels underlying keratitis-ichthyosis-deafness syndrome are potently inhibited by mefloquine.
- reference: PMID:31705875
  title: Allele-Specific Small Interfering RNA Corrects Aberrant Cellular Phenotype in Keratitis-Ichthyosis-Deafness Syndrome Keratinocytes.
- reference: PMID:39269388
  title: Connexin Hemichannel Inhibition and Human Genodermatoses.
- reference: PMID:40889428
  title: "Cochlear implantation in patients with keratitis-ichthyosis-deafness syndrome: A systematic review."
- reference: PMID:22340753
  title: "Cochlear implantation in keratitis-ichthyosis-deafness syndrome: 10-year follow-up of two patients."
- reference: PMID:16172043
  title: Keratitis-ichthyosis-deafness syndrome in association with follicular occlusion triad.
- reference: PMID:3955509
  title: Squamous cell carcinoma in congenital ichthyosis with deafness and keratitis. A case report and review of the literature.
- reference: PMID:19939300
  title: Connexin-26 mutations in deafness and skin disease.
- reference: PMID:22547955
  title: GJB2 Gene Mutations in Syndromic Skin Diseases with Sensorineural Hearing Loss.
- reference: PMID:28158657
  title: Revertant mosaicism repairs skin lesions in a patient with keratitis-ichthyosis-deafness syndrome by second-site mutations in connexin 26.
notes: >-
  Lump/split decision. ONE Disease entry for autosomal dominant, connexin-related
  KID (MONDO:0007850), the syndromic gain-of-function counterpart of the
  nonsyndromic GJB2 hearing loss already curated
  (Autosomal_Dominant_Nonsyndromic_Hearing_Loss_3A, and DFNB1). Rationale: the
  mechanism is genuinely different from the nonsyndromic forms at the same locus -
  gain-of-function aberrant hemichannels versus loss-of-function - which is the
  whole reason the skin and eye phenotypes appear, so it is not a severity variant
  of the nonsyndromic entries.

  Kept inside this entry rather than split out. The lethal neonatal form (p.G45E,
  p.A88V) and the HID (hystrix-like ichthyosis-deafness) variant are curated as
  has_subtypes, not separate entries: HID was shown to carry the same GJB2 mutation
  as KID (PMID:12072059) and is the same disease, and the lethal form is an allelic
  severity extreme. GJB6 (connexin 30) is a rare alternative cause and is curated
  as a second genetic entry, not a separate disease.

  Deliberately out of scope, mentioned but not curated here. Autosomal recessive KID
  (KIDAR, AP1B1, MONDO:0859278) is a vesicular-trafficking disorder with
  copper-metabolism features - a different mechanism and a separate MONDO concept.
  The Perplexity report spent more text on AP1B1 (56 mentions) than on GJB2 (40),
  and just preflight-dr WARNed on exactly this rival-gene mixing; the AP1B1 and
  VPS33B (ARKID) material was excluded, as was VPS33B-related ARKID itself.

  Module conformance. The cochlear arm conforms to
  sensorineural_hair_cell_loss#Hair Cell Mechanotransduction Failure and Death,
  entered through supporting-cell hemichannel hyperactivity rather than the
  module's generic insult. The skin arm deliberately does NOT conform to
  epidermal_cornification_failure: that module scopes itself to primary lesions of
  the terminal cornification machinery (TGM1/FLG/ALOX/ABCA12/STS/SPINK5), whereas
  here the barrier failure is a secondary consequence of connexin-driven
  keratinocyte dysregulation.

  Deep-research provenance and its limits. A Perplexity (sonar-deep-research) report
  was used as a lead source. Its citations were sound (11/11 verified, 8 on topic)
  but term_validation.needs_review was true with 18 mislabelled CURIEs, 3 invented
  HP terms (HP:0007393, HP:0001021, HP:0002727) and 1 obsolete UBERON term - so
  every ontology term in this entry was re-selected from scratch with OAK (ols:*)
  rather than copied from the report. Notably the report's HP:0012114 "Keratitis"
  is actually Endometrial carcinoma, HP:0007470 "Erythrokeratoderma" is
  Periarticular subcutaneous nodules, and UBERON:0001442 "cornea" is skeleton of
  manus; none were used. The terms bound instead are HP:0000491 (Keratitis),
  HP:0007431 (for the erythrokeratoderma presentation) and UBERON:0001772 (corneal
  epithelium). The report also gave GJB6 as HGNC:4289; the repository's HGNC cache
  resolves GJB6 to hgnc:4288, which is what is bound here.

  Evidence base. Human data are case series and case reports, with no cohort large
  enough for most frequencies, so most phenotypes carry no frequency value; SCC is
  OCCASIONAL (~15%, PMID:23384797) and the ~86% p.D50N case share is recorded as a
  genetic case_fraction rather than a phenotype frequency. Much of the mechanism
  rests on IN_VITRO work (Xenopus oocyte, HeLa and keratinocyte hemichannel
  electrophysiology) or MODEL_ORGANISM work (the G45E and S17F mice), graded
  accordingly; the two nodes with no human measurement - the cochlear
  supporting-cell node and the heteromeric Cx43 interaction - are PROVISIONAL, and
  the model-to-human gap is filed as a HUMAN_MODEL_MISMATCH discussion rather than
  papered over. ORPHA:477 could not be cited: `just fetch-reference ORPHA:477`
  reports no source for the reference type in this checkout, and the Orphadata XML
  it would be built from is not present.
📚

References & Deep Research

References

37
PMID:11912510
Missense mutations in GJB2 encoding connexin-26 cause the ectodermal dysplasia keratitis-ichthyosis-deafness syndrome.
No top-level findings curated for this source.
PMID:17381453
Keratitis-ichthyosis-deafness syndrome: disease expression and spectrum of connexin 26 (GJB2) mutations in 14 patients.
No top-level findings curated for this source.
PMID:23384797
Keratitis, ichthyosis, and deafness syndrome: a review of infectious and neoplastic complications.
No top-level findings curated for this source.
PMID:15633193
GJB2 mutations in keratitis-ichthyosis-deafness syndrome including its fatal form.
No top-level findings curated for this source.
PMID:18024254
A familial case of Keratitis-Ichthyosis-Deafness (KID) syndrome with the GJB2 mutation G45E.
No top-level findings curated for this source.
PMID:20412116
Germline mosaicism in keratitis-ichthyosis-deafness syndrome: pre-natal diagnosis in a familial lethal form.
No top-level findings curated for this source.
PMID:15140211
Genetic heterogeneity of KID syndrome: identification of a Cx30 gene (GJB6) mutation in a patient with KID syndrome and congenital atrichia.
No top-level findings curated for this source.
PMID:12072059
HID and KID syndromes are associated with the same connexin 26 mutation.
No top-level findings curated for this source.
PMID:17428836
Aberrant hemichannel properties of Cx26 mutations causing skin disease and deafness.
No top-level findings curated for this source.
PMID:20584891
Differentially altered Ca2+ regulation and Ca2+ permeability in Cx26 hemichannels formed by the A40V and G45E mutations that cause keratitis ichthyosis deafness syndrome.
No top-level findings curated for this source.
PMID:23447037
The human Cx26-D50A and Cx26-A88V mutations causing keratitis-ichthyosis-deafness syndrome display increased hemichannel activity.
No top-level findings curated for this source.
PMID:23797419
The D50N mutation and syndromic deafness: altered Cx26 hemichannel properties caused by effects on the pore and intersubunit interactions.
No top-level findings curated for this source.
PMID:22031297
The Cx26-G45E mutation displays increased hemichannel activity in a mouse model of the lethal form of keratitis-ichthyosis-deafness syndrome.
No top-level findings curated for this source.
PMID:26777423
From Hyperactive Connexin26 Hemichannels to Impairments in Epidermal Calcium Gradient and Permeability Barrier in the Keratitis-Ichthyosis-Deafness Syndrome.
No top-level findings curated for this source.
PMID:25625422
Keratitis-ichthyosis-deafness syndrome-associated Cx26 mutants produce nonfunctional gap junctions but hyperactive hemichannels when co-expressed with wild type Cx43.
No top-level findings curated for this source.
PMID:36699003
Expression of KID syndromic mutation Cx26S17F produces hyperactive hemichannels in supporting cells of the organ of Corti.
No top-level findings curated for this source.
PMID:25386120
Aberrant Cx26 hemichannels and keratitis-ichthyosis-deafness syndrome: insights into syndromic hearing loss.
No top-level findings curated for this source.
PMID:16885744
Cochleosaccular dysplasia associated with a connexin 26 mutation in keratitis-ichthyosis-deafness syndrome.
No top-level findings curated for this source.
PMID:30150638
Roles of aberrant hemichannel activities due to mutant connexin26 in the pathogenesis of KID syndrome.
No top-level findings curated for this source.
PMID:22643125
Differential susceptibility of Cx26 mutations associated with epidermal dysplasias to peptidoglycan derived from Staphylococcus aureus and Staphylococcus epidermidis.
No top-level findings curated for this source.
PMID:15914609
In vivo and in vitro expression of connexins in the human corneal epithelium.
No top-level findings curated for this source.
PMID:15691545
Ocular manifestations of keratitis-ichthyosis-deafness (KID) syndrome.
No top-level findings curated for this source.
PMID:30371567
Ocular Surface Stem Cell Transplantation for Treatment of Keratitis-Ichthyosis-Deafness Syndrome.
No top-level findings curated for this source.
PMID:12527832
[Limbal stem cell deficiency associated with KID syndrome, about a case].
No top-level findings curated for this source.
PMID:37755702
Ocular phenotype and therapeutic interventions in keratitis-ichthyosis-deafness (KID) syndrome.
No top-level findings curated for this source.
PMID:25546246
Treatment of keratitis-ichthyosis- deafness (KID) syndrome in children: a case report and review of the literature.
No top-level findings curated for this source.
PMID:29159249
Visual impairment reversal with oral acitretin therapy in keratitis-ichthyosis-deafness (KID) syndrome.
No top-level findings curated for this source.
PMID:25229253
Aberrant connexin26 hemichannels underlying keratitis-ichthyosis-deafness syndrome are potently inhibited by mefloquine.
No top-level findings curated for this source.
PMID:31705875
Allele-Specific Small Interfering RNA Corrects Aberrant Cellular Phenotype in Keratitis-Ichthyosis-Deafness Syndrome Keratinocytes.
No top-level findings curated for this source.
PMID:39269388
Connexin Hemichannel Inhibition and Human Genodermatoses.
No top-level findings curated for this source.
PMID:40889428
Cochlear implantation in patients with keratitis-ichthyosis-deafness syndrome: A systematic review.
No top-level findings curated for this source.
PMID:22340753
Cochlear implantation in keratitis-ichthyosis-deafness syndrome: 10-year follow-up of two patients.
No top-level findings curated for this source.
PMID:16172043
Keratitis-ichthyosis-deafness syndrome in association with follicular occlusion triad.
No top-level findings curated for this source.
PMID:3955509
Squamous cell carcinoma in congenital ichthyosis with deafness and keratitis. A case report and review of the literature.
No top-level findings curated for this source.
PMID:19939300
Connexin-26 mutations in deafness and skin disease.
No top-level findings curated for this source.
PMID:22547955
GJB2 Gene Mutations in Syndromic Skin Diseases with Sensorineural Hearing Loss.
No top-level findings curated for this source.
PMID:28158657
Revertant mosaicism repairs skin lesions in a patient with keratitis-ichthyosis-deafness syndrome by second-site mutations in connexin 26.
No top-level findings curated for this source.

Deep Research

1

Deep research results are used as seeds for research; they do not undergo the same validation as the main records and may contain errors. How we use deep research.

Evaluations and curation notes (2)

Record notes

Lump/split decision. ONE Disease entry for autosomal dominant, connexin-related KID (MONDO:0007850), the syndromic gain-of-function counterpart of the nonsyndromic GJB2 hearing loss already curated (Autosomal_Dominant_Nonsyndromic_Hearing_Loss_3A, and DFNB1). Rationale: the mechanism is genuinely different from the nonsyndromic forms at the same locus - gain-of-function aberrant hemichannels versus loss-of-function - which is the whole reason the skin and eye phenotypes appear, so it is not a severity variant of the nonsyndromic entries. Kept inside this entry rather than split out. The lethal neonatal form (p.G45E, p.A88V) and the HID (hystrix-like ichthyosis-deafness) variant are curated as has_subtypes, not separate entries: HID was shown to carry the same GJB2 mutation as KID (PMID:12072059) and is the same disease, and the lethal form is an allelic severity extreme. GJB6 (connexin 30) is a rare alternative cause and is curated as a second genetic entry, not a separate disease. Deliberately out of scope, mentioned but not curated here. Autosomal recessive KID (KIDAR, AP1B1, MONDO:0859278) is a vesicular-trafficking disorder with copper-metabolism features - a different mechanism and a separate MONDO concept. The Perplexity report spent more text on AP1B1 (56 mentions) than on GJB2 (40), and just preflight-dr WARNed on exactly this rival-gene mixing; the AP1B1 and VPS33B (ARKID) material was excluded, as was VPS33B-related ARKID itself. Module conformance. The cochlear arm conforms to sensorineural_hair_cell_loss#Hair Cell Mechanotransduction Failure and Death, entered through supporting-cell hemichannel hyperactivity rather than the module's generic insult. The skin arm deliberately does NOT conform to epidermal_cornification_failure: that module scopes itself to primary lesions of the terminal cornification machinery (TGM1/FLG/ALOX/ABCA12/STS/SPINK5), whereas here the barrier failure is a secondary consequence of connexin-driven keratinocyte dysregulation. Deep-research provenance and its limits. A Perplexity (sonar-deep-research) report was used as a lead source. Its citations were sound (11/11 verified, 8 on topic) but term_validation.needs_review was true with 18 mislabelled CURIEs, 3 invented HP terms (HP:0007393, HP:0001021, HP:0002727) and 1 obsolete UBERON term - so every ontology term in this entry was re-selected from scratch with OAK (ols:*) rather than copied from the report. Notably the report's HP:0012114 "Keratitis" is actually Endometrial carcinoma, HP:0007470 "Erythrokeratoderma" is Periarticular subcutaneous nodules, and UBERON:0001442 "cornea" is skeleton of manus; none were used. The terms bound instead are HP:0000491 (Keratitis), HP:0007431 (for the erythrokeratoderma presentation) and UBERON:0001772 (corneal epithelium). The report also gave GJB6 as HGNC:4289; the repository's HGNC cache resolves GJB6 to hgnc:4288, which is what is bound here. Evidence base. Human data are case series and case reports, with no cohort large enough for most frequencies, so most phenotypes carry no frequency value; SCC is OCCASIONAL (~15%, PMID:23384797) and the ~86% p.D50N case share is recorded as a genetic case_fraction rather than a phenotype frequency. Much of the mechanism rests on IN_VITRO work (Xenopus oocyte, HeLa and keratinocyte hemichannel electrophysiology) or MODEL_ORGANISM work (the G45E and S17F mice), graded accordingly; the two nodes with no human measurement - the cochlear supporting-cell node and the heteromeric Cx43 interaction - are PROVISIONAL, and the model-to-human gap is filed as a HUMAN_MODEL_MISMATCH discussion rather than papered over. ORPHA:477 could not be cited: `just fetch-reference ORPHA:477` reports no source for the reference type in this checkout, and the Orphadata XML it would be built from is not present.

Create: Keratitis-Ichthyosis-Deafness Syndrome · 2026-09-05T18:33:05Z · View source

De novo curation of autosomal dominant KID syndrome (MONDO:0007850, GJB2/connexin 26; rare GJB6). Built an 11-node causal chain from the heterozygous gain-of-function missense variant through hyperactive Cx26 hemichannels (loss of extracellular-Ca2+ restraint; direct Ca2+ permeability for G45E) and the heteromeric Cx43/Cx30 route, into three organ arms: keratinocyte Ca2+ overload/ATP release to epidermal barrier failure, infection and SCC; corneal epithelial gap-junction dysfunction to vascularizing keratitis and limbal stem cell deficiency; and cochlear supporting-cell hemichannel hyperactivity to hair cell dysfunction (conforms_to sensorineural_hair_cell_loss). 16 phenotypes, 2 genes, 2 subtypes (lethal neonatal G45E/A88V; HID), 6 treatments, 2 mouse models, 1 patient keratinocyte line, 2 mechanistic hypotheses and 2 discussions (HUMAN_MODEL_MISMATCH on the cochlear arm; CONTROVERSY on homomeric vs heteromeric hemichannel). 37 references, 82/82 evidence snippets verified against cached references. Perplexity sonar-deep-research was the lead source; its citations validated 11/11 but term_validation.needs_review was true with 18 mislabelled CURIEs, 3 nonexistent HP terms (HP:0007393, HP:0001021, HP:0002727) and 1 obsolete UBERON term, so every ontology term was re-selected independently with OAK via the ols adapter and none of the report's CURIEs were copied. preflight-dr returned WARN because the report discusses AP1B1 (56 mentions) more than GJB2 (40); the AP1B1 (KIDAR) and VPS33B (ARKID) recessive material was excluded as separate diseases and recorded in notes and differential_diagnoses. Report content not used: the AP1B1/VPS33B sections (wrong disease), PMID:35144013 and PMID:41453769 (both AP1B1 KIDAR), PMID:37555193 (no abstract cached), and PMID:36444857/DOI:10.1111/pde.15201 (one-sentence abstract with no quotable finding). Validation run: just validate (schema, terms, references) passed; count-verified-snippets 82/82; check-entity-refs, check-causal-targets, check-duplicate-keys, check-qualifier-terms (plus the online variant), check-enum-values, check-folded-hyphens, check-snippet-length, check-title-snippets, check-snippet-grading and check-reference-titles all passed; compliance 88.1 percent; validate-disorders run as the final gate.

Perplexity ▸
1. Disease Information
sonar-deep-research 22 citations 2026-09-05T06:53:24.570056

1. Disease Information

1.1 Overview and Clinical Definition

Keratitis–ichthyosis–deafness syndrome is classically defined as a congenital ectodermal dysplasia characterized by vascularizing keratitis, hyperkeratotic or erythrokeratotic skin lesions, and sensorineural deafness.[2][5][6] The Orphanet disease definition succinctly captures this concept, describing KID as “a rare congenital ectodermal disorder characterized by vascularizing keratitis, hyperkeratotic skin lesions and hearing loss,” with neonatal onset and fewer than 100 reported cases worldwide, underscoring both its rarity and early presentation.[5] OMIM similarly defines KID (MIM 148210) as an ectodermal dysplasia with sensorineural hearing loss, photophobia and corneal vascularization, hyperkeratosis of the palms and soles, erythrokeratoderma, follicular hyperkeratosis, and recurrent bacterial and fungal infections, emphasizing additional cutaneous and infectious manifestations beyond the triad.[2] A more recent pediatric dermatology review describes KID as “a rare genetic disease presenting with cutaneous, ocular, and otic defects” and elaborates on histopathology and treatment options, thereby integrating the triad with broader systemic involvement.[8][9]

Clinically, patients usually present at birth or in the neonatal period with generalized erythema and ichthyosiform scaling, progressive sensorineural hearing loss, and later development of keratitis with corneal neovascularization leading to visual impairment.[2][5][6][9] Skin findings encompass generalized erythrokeratoderma, palmoplantar keratoderma, follicular hyperkeratosis, and often alopecia or sparse hair, all reflecting abnormal keratinization and barrier dysfunction.[2][5][8][9] The syndrome is associated with chronic mucocutaneous candidiasis and bacterial superinfection of skin lesions, sometimes complicated by hidradenitis suppurativa, as well as an elevated lifetime risk of both benign trichilemmal tumors and invasive squamous cell carcinoma (SCC) of skin and mucosa, particularly at acral and chronically inflamed sites.[6][10][14][15] Quality of life impact is substantial, given the combination of early‑onset deafness, progressive visual loss, chronic dermatologic symptoms, infection burden, and risk of malignancy, often leading to developmental delay and psychosocial challenges.[2][5][6][9]

From an ontological perspective, KID syndrome corresponds to MONDO:0007850 (keratitis–ichthyosis–deafness syndrome) within the Mondo Disease Ontology, falls under the broader category of Mendelian ectodermal dysplasias, and maps to Orphanet ORPHA:477 and SNOMED CT concepts such as 2625009 and 403780007 for different subtypes.[2][3][4][5] It can be categorized within the Human Phenotype Ontology as a multi‑system disorder involving HP terms such as “Vascularizing keratitis,” “Hyperkeratosis,” “Palmoplantar keratoderma,” “Sensorineural hearing impairment,” and “Recurrent skin infections.”[2][5][6][8] In ICD‑10‑CM, KID syndrome is typically coded using combinations of ectodermal dysplasia, hereditary deafness, and corneal disease codes, while ICD‑11 provides more granular representation of genetic ectodermal dysplasias, although specific KID codes are not yet universally standardized.

1.2 Key Identifiers and Synonyms

KID syndrome has several key identifiers across major databases, reflecting its recognition in multiple rare disease registries. In OMIM, autosomal dominant KID syndrome is entry 148210, designated as “KERATITIS‑ICHTHYOSIS‑DEAFNESS SYNDROME; KIDAD,” with GJB2 as the primary causal gene on chromosome 13q12.11.[2] The autosomal recessive form is entry 242150, “KERATITIS‑ICHTHYOSIS‑DEAFNESS SYNDROME, AUTOSOMAL RECESSIVE; KIDAR,” associated with AP1B1 on chromosome 22q12.2.[3][4] Orphanet lists KID under ORPHA:477, classified as a rare congenital disorder with prevalence <1/1,000,000 and neonatal onset, and synonyms including “KID/HID syndrome,” “Keratitis‑ichthyosis‑deafness/Hystrix‑like ichthyosis‑deafness syndrome,” “Senter syndrome,” “Ichthyosis hystrix Rheydt type,” and “Keratitis‑ichthyosis‑hearing loss/Hystrix‑like ichthyosis‑hearing loss syndrome,” reflecting historical nomenclature and overlapping phenotypes.[5]

SNOMED CT maps include 2625009 and 403780007 for KID syndromes, while the Disease Ontology (DOID:0060871) aligns with OMIM 148210 as “keratitis‑ichthyosis‑deafness syndrome.”[2][3][4] At the gene‑level, GJB2 (HGNC:4284; OMIM 121011) and GJB6 (HGNC:4289; OMIM 604418) encode connexin 26 and connexin 30, respectively, whereas AP1B1 (HGNC:564; OMIM 600157) encodes the AP‑1 β1 subunit and is linked to recessive KIDAR.[2][3][11][12] Related but distinct is autosomal recessive keratoderma–ichthyosis–deafness (ARKID) syndrome caused by VPS33B mutations (OMIM 608552), an entity that shares skin and hearing features but lacks the classical vascularizing keratitis of KID.[18]

Common synonyms and alternative names for KID include “KID/HID syndrome,” emphasizing overlap with hystrix‑like ichthyosis‑deafness (HID), and “Senter syndrome,” reflecting early case descriptions.[5] “Ichthyosis hystrix Rheydt type” and “hystrix‑like ichthyosis‑hearing loss syndrome” highlight the spiky, verrucous skin phenotype seen in some individuals, whereas “keratitis‑ichthyosis‑hearing loss” underscores ocular and auditory components.[5][8] In the recessive context, “KIDAR” is now a widely used acronym for autosomal recessive keratitis‑ichthyosis‑deafness due to AP1B1 mutations.[3][12][16][17] These overlapping names must be carefully disambiguated in knowledge bases to avoid conflating dominant GJB2‑related KID with recessive AP1B1‑related KIDAR and VPS33B‑related ARKID, which differ in pathophysiology and associated systemic features.[2][3][18]

1.3 Nature of Available Information

Information about KID syndrome derives overwhelmingly from aggregated disease‑level resources and case‑based clinical literature rather than large cohort studies or EHR‑based analytics, reflecting its ultra‑rare frequency.[2][5][6][8][9] OMIM entries summarize genetic, clinical, and inheritance information synthesized from original case reports and small series, including the landmark identification of GJB2 mutations as causative and subsequent recognition of AP1B1 in KIDAR.[2][3][7][11][12] Orphanet provides a curated clinical summary with emphasis on prevalence, inheritance, clinical manifestations, and management, based on expert review and literature up to 2009, with some later updates.[5] PubMed‑indexed case reports, series, and reviews—such as Coggshall et al.’s 2013 review of infectious and neoplastic complications, Alsabbagh et al.’s 2023 comprehensive dermatologic review, and recent AP1B1 case descriptions—constitute the primary evidence base.[6][8][9][11][12][13][16][17][19]

Because fewer than 100 cases of KID/HID had been described as of the last Orphanet update, and only nine KIDAR patients reported in the literature by 2023, the evidence is largely descriptive and anecdotal, though increasingly supported by molecular diagnostics.[5][16][17] There are no large randomized trials or population‑based registries specific to KID, and quality‑of‑life metrics are seldom systematically reported. However, the accumulated case reports allow reasonably robust characterization of core phenotypes, natural history, and major complications, and provide sufficient detail to map phenotypes to HPO terms and anatomical structures to UBERON terms. Future EHR or registry‑based data may refine frequencies and prognostic estimates, but for now most information is derived from aggregated expert synthesis of individual patient data.

2. Etiology

2.1 Primary Causal Factors: Genetic Basis

KID syndrome is fundamentally a Mendelian genetic disorder rooted in abnormalities of proteins that maintain epithelial cell connectivity and polarized trafficking. The classical autosomal dominant form is caused by heterozygous missense mutations in GJB2, encoding connexin 26, and rarely GJB6, encoding connexin 30, both gap junction β proteins that form intercellular channels critical for electrical and metabolic coupling in the epidermis, cornea, and inner ear.[2][5][7][10] OMIM notes that autosomal dominant KID (KIDAD) is caused by heterozygous GJB2 mutation on chromosome 13q12, with most patients harboring missense variants in the N‑terminus and first extracellular loop of connexin 26, regions crucial for channel gating and permeability.[2][5][7] A subset of patients with KID and atrichia carry mutations in GJB6, demonstrating that connexin 30 dysfunction can phenocopy connexin 26 defects in this context.[5][10]

Several specific GJB2 mutations have been associated with distinct clinical courses. Germline missense mutations were first identified in 14 unrelated juvenile and adult KID patients, and the common D50N mutation has been repeatedly reported in association with both typical KID and an increased risk of aggressive SCC of the skin.[7][15] Another variant, G45E, was identified de novo in a patient with a fatal form of KID presenting in the first year of life, and this same mutation is known as a relatively frequent cause of autosomal recessive non‑syndromic hearing loss in Japanese populations, illustrating that identical amino acid changes can produce different phenotypic outcomes depending on genetic background and mode of inheritance.[7] Coggshall et al. and later reviews emphasize that KID’s pathogenesis can be partially explained by connexin 26’s role in intercellular communication and carcinogenesis, although precise mechanistic pathways remain incompletely defined.[6][8][10]

The autosomal recessive keratitis–ichthyosis–deafness syndrome (KIDAR) represents a distinct etiologic category, caused by homozygous or compound heterozygous loss‑of‑function variants in AP1B1, located on chromosome 22q12.2.[3][11][12][16][17] AP1B1 encodes the large β1 subunit of the AP‑1 adaptor protein complex, which is crucial for clathrin‑associated vesicle formation and for the basolateral trafficking of cargo proteins, including the copper transporter ATP7A.[11][16][17] In affected keratinocytes from KIDAR patients, AP‑1 β subunit is lost and the γ subunit greatly reduced, leading to destabilization of the AP‑1 complex, accumulation of abnormal vesicles, hyperproliferation, abnormal epidermal differentiation, and derangement of intercellular junction proteins.[11][12] Boyden et al. demonstrated that transduction of affected cells with wild‑type AP1B1 rescues the vesicular phenotype, providing direct functional evidence that loss of AP1B1 causes this neurocutaneous disorder.[11] Subsequent cases and phenotypic spectrum studies have confirmed that AP1B1 loss‑of‑function variants underlie a syndrome of ichthyosis, erythroderma, deafness, photophobia, failure to thrive, developmental delay, and later keratitis, collectively classified as KIDAR.[12][16][17]

A related but distinct autosomal recessive disorder, ARKID syndrome, involves biallelic mutations in VPS33B, encoding a Sec1/Munc18 family protein that interacts with Rab11a and Rab25 and is involved in trafficking of the collagen‑modifying enzyme LH3.[18] Gruber et al. showed that a homozygous p.Gly131Glu variant in VPS33B disrupts Rab interactions and LH3 trafficking, leading to impaired epidermal structure, aberrant lamellar body secretion, palmoplantar keratoderma, ichthyosis, and sensorineural deafness.[18] While ARKID shares keratoderma, ichthyosis, and deafness with KID, it generally lacks the defining vascularizing keratitis and is better conceptualized as a separate entity with overlapping phenotype and pathomechanism of intracellular trafficking and collagen modification.[18]

Thus, the primary causal factors in KID syndromes are genetic: missense gain‑of‑function or dominant‑negative variants in connexins (GJB2 and GJB6) for autosomal dominant KID, and loss‑of‑function variants in a vesicular trafficking adaptor (AP1B1) for autosomal recessive KIDAR.[2][3][5][7][11][12][16][17] Environmental or infectious influences may modulate disease expression and complication risk, particularly carcinogenesis, but do not constitute primary causation.

2.2 Genetic Risk Factors and Modifier Effects

Within the spectrum of connexin‑related KID, specific variants appear to act as major risk factors for severe manifestations and malignant complications. The missense D50N mutation in GJB2 has been repeatedly associated with KID syndrome and a heightened risk of SCC, particularly of acral skin and chronically inflamed areas.[7][15] One review suggested that D50N is “strongly connected with the development of skin SCC” in KID, although not every case develops malignancies.[15] The D50N mutation locates within the first extracellular loop of connexin 26, which is critical for hemichannel gating and interactions with adjacent connexins, and functional studies in other contexts indicate that such variants can produce aberrant hemichannel opening, increased cell permeability, and susceptibility to cytotoxicity and inflammation.[6][10] In knowledge base terms, D50N can be annotated as a high‑risk missense variant (ACMG pathogenic) associated with increased malignant potential (prognostic biomarker).

The G45E variant, identified de novo in a fatal KID case, illustrates genotype–phenotype variability, acting as a recessive allele causing non‑syndromic hearing loss in some populations but as a dominant allele causing syndromic KID in others.[7] This supports the concept of genetic background and allelic context as modifiers of clinical expression. A 2024 study on genotype–phenotype correlations in KID further elaborates that different GJB2 mutations (e.g., D50N, G12R, A40V) associate with variable severity of skin, ocular, and auditory manifestations, although the detailed findings are beyond the scope of the provided abstract.[19] These variant‑specific associations can be encoded in disease knowledge bases as modifier relationships, with HPO terms for SCC risk (e.g., “Squamous cell carcinoma of the skin”) linked at higher probability to D50N carriers.

In KIDAR, all reported AP1B1 variants are loss‑of‑function (nonsense, frameshift, or critical missense), but specific alleles may modulate severity of copper metabolism abnormalities, thrombocytopenia, and developmental delay.[11][12][16][17] Boyden et al. described patients with compound heterozygous mutations (e.g., c.430T>C; c.2335delC) presenting with ichthyosis, failure to thrive, thrombocytopenia, photophobia, and progressive hearing loss, but without intellectual impairment, while other cases documented mild developmental delay and hypotonia.[11][12][16][17] Alsaif et al. and Faghihi et al. suggested that variants affecting AP1B1’s ability to support ATP7A trafficking may correspond with lower plasma copper and ceruloplasmin, manifesting as a MEDNIK‑like phenotype and potentially modifying neurological outcomes.[3][16][17] These genotype–phenotype relationships can be represented in the knowledge base as potential modifiers with evidence codes reflecting small case series.

Beyond causal and major modifier variants, no genome‑wide association studies or polygenic susceptibility loci have been reported for KID, consistent with its monogenic nature and rarity.[2][5][6] The role of genetic background (e.g., other connexin genes, immune response genes, DNA repair pathways) in modulating infection susceptibility or carcinoma risk remains speculative, with no robust data yet. As such, disease entries should emphasize primary causal variants and a small number of variant‑specific modifiers, while noting the absence of broader susceptibility data.

2.3 Environmental and Lifestyle Risk Factors

Environmental and lifestyle factors do not appear to cause KID syndrome per se but may influence the severity of complications, particularly infections and malignancies. Chronic mucocutaneous candidiasis and bacterial superinfection of skin lesions are common in KID and necessitate aggressive therapeutic intervention, as emphasized by Coggshall et al.[6] This predisposition is likely intrinsic to barrier dysfunction and abnormal immune signaling in the epidermis, but environmental exposures such as poor hygiene, humid climates, and chronic occlusion can exacerbate infection risk, although these have not been systematically quantified.[6][8][9] For knowledge base purposes, recurrent infections can be modeled as downstream clinical features rather than independent risk factors.

Squamous cell carcinoma of skin and mucosa occurs in approximately 15% of KID patients, with reports dating back to 1986 and more recent case series documenting aggressive, multifocal SCC at acral sites and in areas of chronic inflammation.[6][14][15] Environmental carcinogens such as ultraviolet (UV) radiation, smoking, and chronic mechanical trauma may contribute to carcinogenesis in KID, as in other SCC contexts, but specific studies on KID populations are lacking. One case report suggested that severe bacterial infection might be one of the reasons for establishment of aggressive skin cancer, implying that chronic infection‑associated inflammation is an important environmental modifier of SCC risk in KID.[15] Thus, chronic infection and inflammation can be conceptualized as environmental or acquired risk factors that, in combination with a genetically driven carcinogenic microenvironment due to connexin dysfunction, increase the probability of SCC.

Lifestyle factors such as sun exposure patterns, occupational exposure to irritants, and adherence to skin care regimens may influence individual trajectories but have not been systematically studied in these rare cohorts.[6][8][9] Given the lack of formal evidence, disease knowledge bases should treat environmental risk factors for KID’s core triad as negligible, while recognizing environmental contributions to specific complications like SCC and severe infection.

2.4 Protective Factors and Gene–Environment Interactions

Protective factors in KID syndrome are largely inferential and relate to early diagnosis, vigilant infection control, sun protection, and surveillance for malignancy rather than intrinsic biological modifiers. No genetic protective variants have been described that reduce KID risk or significantly attenuate the phenotype in carriers of pathogenic GJB2 or AP1B1 variants, although variable expressivity suggests that genetic background and environmental conditions can modulate severity.[2][3][7][19] For example, the same G45E GJB2 mutation causes recessive non‑syndromic hearing loss without skin or ocular disease in some Japanese families but dominant syndromic KID in an Austrian patient, suggesting that differences in other connexins, gap junction regulators, or immune genes might confer relative protection against ectodermal manifestations in some backgrounds.[7] However, specific protective alleles have not been identified.

Environmental protective factors are more intuitive. Rigorous UV protection, avoidance of chronic chemical or mechanical irritation, and proactive management of infections likely reduce SCC risk and prevent rapid progression of skin lesions, though quantitative data are lacking.[6][8][9][15] Similarly, early fitting of hearing aids or cochlear implants and structured educational support can mitigate developmental and quality‑of‑life decrements associated with deafness and visual impairment.[2][5][9] From a gene–environment interaction perspective, the most salient interactions involve genetic predisposition to epithelial barrier dysfunction and carcinogenesis (via GJB2 or AP1B1 mutations) combined with environmental triggers such as chronic infection, UV exposure, and mechanical stress, which together promote SCC formation in a subset of KID patients.[6][15] These interactions can be modeled mechanistically as connexin or AP‑1 dysfunction leading to altered keratinocyte proliferation, impaired DNA damage response, and pro‑inflammatory signaling, which are then amplified by environmental insults, culminating in malignant transformation.

In summary, KID syndromes are primarily monogenic disorders, with environmental factors modulating complication risk and severity rather than disease occurrence, and gene–environment interactions are hypothesized but insufficiently quantified to define discrete protective alleles or exposures.

3. Phenotypes

3.1 Core Triad: Keratitis, Ichthyosis/Erythrokeratoderma, and Deafness

The defining phenotypes of KID syndrome are vascularizing keratitis, ichthyosiform or erythrokeratodermic skin changes, and sensorineural hearing loss, each of which can be mapped to specific HPO terms and characterized in terms of onset, severity, progression, and quality‑of‑life impact.[2][5][6][8][9]

Vascularizing keratitis in KID typically manifests as chronic corneal inflammation and neovascularization, leading to photophobia, decreased visual acuity, and eventual corneal scarring.[2][5][8][9][17] Orphanet notes “photophobia and corneal vascularization” as cardinal ocular features, with keratitis usually appearing later in childhood or adolescence, following neonatal skin and hearing manifestations.[2][5] In KIDAR, severe corneal scarring with vision loss has been observed in adulthood, indicating a progressive course.[3][17] HPO terms that capture this phenotype include “Keratitis” (HP:0012114), “Corneal neovascularization” (HP:0011493), “Photophobia” (HP:0000613), and “Visual impairment” (HP:0000505). Severity ranges from mild photophobia to profound bilateral blindness, and progression is generally chronic and insidious, with episodes of acute exacerbation. Quality‑of‑life impact is high, as progressive visual loss, combined with deafness, severely limits communication and autonomy.[2][5][9] In Alsabbagh et al.’s review, ocular manifestations are highlighted as major contributors to morbidity, and management strategies focus on lubricants, topical anti‑inflammatory therapy, and keratoplasty in selected cases.[8][9]

Cutaneous manifestations include generalized erythema and ichthyosiform scaling at birth, progressing to erythrokeratoderma, palmoplantar keratoderma, follicular hyperkeratosis, and often verrucous or hystrix‑like hyperkeratosis.[2][5][6][8][9][11][12][16][17] Orphanet describes “generalized erythema and ichthyosiform scaling” as the typical neonatal presentation, and OMIM lists “hyperkeratosis of the palms and soles, erythrokeratoderma, follicular hyperkeratosis” as characteristic features.[2][5] In KIDAR, neonatal ichthyotic erythroderma is prominent, and palmoplantar keratoderma appears later, often accompanied by alopecia and photophobia.[3][16][17] HPO terms include “Erythrokeratoderma” (HP:0007470), “Ichthyosis” (HP:0008064), “Palmoplantar keratoderma” (HP:0000982), “Follicular hyperkeratosis” (HP:0007393), and “Alopecia” (HP:0001596). Severity is typically moderate to severe, with chronic scaling, fissuring, and pruritus, and progression is generally stable or slowly progressive, with fluctuations in response to climate, infection, and therapy.[6][8][9] Skin disease profoundly affects quality of life due to discomfort, visible disfigurement, and infection risk, and can limit manual function when palmoplantar keratoderma is severe.[6][8][9]

Sensorineural hearing loss in KID is congenital or neonatal in onset, bilateral, and often profound, reflecting inner ear involvement due to connexin or AP‑1 dysfunction.[2][3][5][7][11][12][16][17] OMIM notes “congenital bilateral sensorineural hearing loss” as a defining feature of KIDAD, and KIDAR is characterized by “profound sensorineural deafness” with early developmental delay.[2][3] Boyden et al. describe “progressive hearing loss” in AP1B1‑mutant individuals, while Vornweg et al. and Faghihi et al. confirm early onset deafness as a constant feature of KIDAR.[11][12][16][17] HPO terms include “Sensorineural hearing impairment” (HP:0000407) and “Congenital sensorineural hearing loss” (HP:0007354). Severity is usually severe to profound, and progression may be stable or slowly worsening, depending on genotype.[7][11][19] Quality‑of‑life impact is major, as deafness impairs language acquisition, education, and social integration, especially when co‑occurring with visual impairment.[2][5][9] Early audiologic intervention and sign language support are critical for mitigating these effects.

3.2 Infectious and Neoplastic Complications

Infectious complications are common phenotypes in KID, primarily chronic mucocutaneous candidiasis and bacterial superinfection of skin lesions.[6] Coggshall et al. emphasize that “chronic mucocutaneous candidiasis and/or superinfection of skin lesions commonly occur and warrant aggressive therapeutic intervention,” highlighting the role of altered barrier and immune function in KID.[6] HPO terms include “Recurrent skin infections” (HP:0001021), “Candidiasis” (HP:0002727), and “Recurrent respiratory infections” (HP:0002205) in some cases. Age of onset is typically early childhood, coinciding with severe skin disease, and severity ranges from mild recurrent localized infections to systemic serious infections. Progression is often relapsing‑remitting, with episodes triggered by environmental factors and partially controlled by antifungal and antibiotic therapy.[6][8][9] Quality‑of‑life impact includes pain, pruritus, systemic malaise, and need for frequent medical care.

Neoplastic complications, especially SCC, constitute a critical phenotype in KID syndrome. Benign trichilemmal tumors, often multiple, have been reported and can presage malignant transformation, reflecting a keratinocyte proliferative niche in KID skin.[2][6] Squamous cell carcinoma of mucosa and skin, particularly acral sites such as feet, occurs in approximately 15% of patients, with cases of aggressive invasive disease necessitating amputations.[6][14][15] The first case of invasive SCC in KID was reported in 1986, when a 35‑year‑old man developed bilateral fungating lesions on his feet, leading to a below‑knee amputation after histological confirmation of SCC.[14] Later reports and reviews document similar aggressive SCCs arising from KID skin, often associated with severe infection and D50N GJB2 mutations.[6][15] HPO terms include “Squamous cell carcinoma of the skin” (HP:0001507) and “Neoplasm of the skin” (HP:0012743). Age of onset for SCC is usually adulthood, though cases in adolescence exist, and progression can be rapid and invasive. Quality‑of‑life impact is profound, including pain, disfigurement, potential limb loss, and oncologic mortality risk.

In addition to SCC, KID patients may develop mucosal carcinomas, particularly of the oral cavity and larynx, likely related to chronic mucosal inflammation and abnormal epithelial differentiation.[5][6] Although frequency data are limited, these malignancies further contribute to morbidity and mortality. Disease knowledge bases should therefore encode SCC and related neoplasms as major complications with moderate frequency (~15%), high severity, and strong impact on survival and function.

3.3 Systemic and Developmental Features

Beyond ectodermal manifestations, KIDAR and related disorders exhibit systemic phenotypes, including failure to thrive, developmental delay, thrombocytopenia, hypotonia, and copper metabolism abnormalities, reflecting AP‑1’s broader role in polarized trafficking and ATP7A localization.[3][11][12][16][17] OMIM notes that autosomal recessive keratitis–ichthyosis–deafness syndrome is “characterized by neonatal‑onset ichthyotic erythroderma and profound sensorineural deafness, with failure to thrive and developmental delay in childhood,” and that severe corneal scarring with vision loss appears in adulthood.[3] Boyden et al. describe patients with ichthyosis, failure to thrive, thrombocytopenia, photophobia, and progressive hearing loss but without intellectual impairment, suggesting variability in neurological involvement.[11] Vornweg et al. and later phenotypic spectrum reviews confirm developmental delay, hypotonia, and alopecia in KIDAR patients, along with low plasma copper and ceruloplasmin in some cases, linking the disorder to inborn errors of copper metabolism and MEDNIK‑like features.[12][16][17]

HPO terms relevant to these systemic manifestations include “Failure to thrive” (HP:0001508), “Global developmental delay” (HP:0001263), “Hypotonia” (HP:0001252), “Thrombocytopenia” (HP:0001873), “Low serum copper” (HP:0003075), and “Low serum ceruloplasmin” (HP:0003160). Onset is typically neonatal or early infancy, with persistent course; severity ranges from mild growth delay to significant undernutrition and functional impairment. Quality‑of‑life impact is substantial, as failure to thrive and developmental delay require intensive nutritional and developmental interventions, and thrombocytopenia confers bleeding risk. These systemic features appear more prominent in KIDAR than in KIDAD, reflecting AP‑1’s role in multiple tissues.

ALSabbagh et al. note that KID can be associated with alopecia, palmoplantar keratoderma, nail dystrophy, and other ectodermal signs, further broadening the phenotypic spectrum.[8][9] HPO terms include “Nail dystrophy” (HP:0001597) and “Palmoplantar fissures” (HP:0005090). The overall phenotype is thus multi‑system, with ectodermal, ophthalmologic, auditory, hematologic, and metabolic components.

3.4 Phenotype Frequencies and Impact on Daily Life

Quantitative frequencies of individual phenotypes in KID are difficult to ascertain due to small numbers, but certain features are near‑universal. Vascularizing keratitis, congenital deafness, and generalized ichthyosis/erythrokeratoderma are present in most reported KID and KIDAR cases, and thus can be annotated with high frequency (>80%).[2][3][5][6][8][9][11][12][16][17] Palmoplantar keratoderma, follicular hyperkeratosis, alopecia, and recurrent infections appear in a majority but not all patients, suggesting intermediate frequencies (~50–80%).[2][5][6][8][9][11][12][16][17] SCC and benign trichilemmal tumors occur in approximately 15% or more, and systemic features such as thrombocytopenia and copper abnormalities are largely restricted to KIDAR, with frequencies varying among small case series.[3][11][12][16][17]

Quality‑of‑life impact is best understood qualitatively. Deafness and keratitis severely affect communication, education, and autonomy, often leading to delayed speech, limited schooling, and social isolation.[2][5][9] Skin manifestations cause chronic discomfort, pruritus, and stigmatizing appearance, impairing psychosocial well‑being and everyday function, particularly when palmoplantar keratoderma limits mobility.[6][8][9] Recurrent infections and SCC risk require frequent medical visits, systemic medications, and sometimes major surgery, further impacting work, schooling, and psychological health.[6][14][15] In KIDAR, failure to thrive and developmental delay demand multidisciplinary care and can limit independent living.[3][11][12][16][17] Disease knowledge bases should therefore represent KID as a high‑morbidity condition with severe functional and psychosocial consequences, even though precise EQ‑5D or SF‑36 scores are not available.

4. Genetic and Molecular Information

4.1 Causal Genes and Pathogenic Variants

The principal causal genes for KID syndromes are GJB2, GJB6, and AP1B1, with VPS33B relevant to the overlapping ARKID syndrome.[2][3][5][7][10][11][12][16][17][18] GJB2 encodes connexin 26, a gap junction β‑2 protein that forms hexameric hemichannels in the plasma membrane, which dock with hemichannels on adjacent cells to create intercellular channels allowing passage of ions, second messengers, and small metabolites.[2][5][7][10] Connexin 26 is widely expressed in epidermis, inner ear cochlear supporting cells, and ocular tissues, and its proper function is essential for epidermal barrier integrity, hearing, and corneal homeostasis.[2][5][10] GJB6 encodes connexin 30, another gap junction protein that co‑forms channels with connexin 26, and its mutation in one reported KID patient with atrichia suggests functional redundancy and convergence in disease pathogenesis.[5][10]

AP1B1 encodes the β1 subunit of the adaptor protein (AP)‑1 complex, which orchestrates polarized vesicular transport in epithelial cells.[11][12][16][17] AP‑1 complexes are involved in clathrin‑associated vesicle formation and in selecting protein cargos in the trans‑Golgi network and endosomes for basolateral transport, including copper transporter ATP7A, crucial for systemic and cellular copper homeostasis.[16][17] Mutations in AP1B1 destabilize the AP‑1 complex, disrupt vesicular trafficking, and lead to accumulation of abnormal vesicles, hyperproliferation, abnormal epidermal differentiation, and deranged intercellular junction proteins, thereby explaining skin and hearing phenotypes in KIDAR.[11][12]

VPS33B encodes a Sec1/Munc18 family protein that interacts with Rab11a and Rab25 and regulates trafficking of the collagen‑modifying enzyme LH3.[18] Homozygous or compound heterozygous VPS33B mutations cause ARKID syndrome, with severe palmoplantar keratoderma, ichthyosis, and sensorineural deafness, due to impaired LH3 trafficking and deficient collagen lysine modifications.[18] While ARKID is distinct from KID, its molecular pathway parallels AP‑1‑dependent vesicular trafficking defects in KIDAR and thus enriches mechanistic understanding of vesicular trafficking disorders.

Pathogenic variants in these genes are predominantly missense in GJB2/GJB6 and loss‑of‑function (nonsense, frameshift, splice‑site) in AP1B1 and VPS33B.[2][3][7][11][12][16][17][18] GJB2 variants such as D50N, G12R, A40V, and G45E have been identified in KID patients, with D50N and G45E particularly notable.[7][15][19] D50N is a recurrent mutation strongly associated with SCC risk, while G45E is linked to fatal neonatal‑onset KID and also known in non‑syndromic hearing loss.[7][15] These variants are best classified as pathogenic according to ACMG criteria, with evidence from segregation, functional studies, and recurrence.[2][7][15][19] Their allele frequencies in general populations are extremely low, consistent with the rarity of KID, but they may be more frequent in specific populations where they act as recessive deafness alleles, such as G45E in Japanese populations.[7] In ClinVar and gnomAD, these variants are typically annotated as rare or absent in healthy cohorts, though exact frequencies are not provided in the search results.

AP1B1 variants implicated in KIDAR include compound heterozygous combinations such as c.430T>C (p.Cys144Arg) and c.2335delC (p.Leu779Serfs26), as described by Boyden et al., and c.322C>T (p.Arg108Trp) and c.2254delC (p.Leu752Serfs26), as described by Vornweg et al.[11][12] Additional variants such as NM_001127.4:c.1263C>A (p.Tyr421) and deletions in AP1B1 have been reported in phenotypic spectrum studies, all leading to complete loss of AP1B1 protein in human epidermis and isolated keratinocytes.[12][16][17] These variants are clearly pathogenic loss‑of‑function alleles, with allele frequencies estimated to be extremely low; in one consanguineous family, homozygosity for a novel missense variant was observed.[13][16][17] VPS33B* variants such as p.Gly131Glu and splice site c.240‑1G>C are pathogenic in ARKID, affecting Rab interactions and LH3 trafficking.[18]

All described KID and KIDAR mutations are germline and inherited according to Mendelian patterns (autosomal dominant for GJB2/GJB6, autosomal recessive for AP1B1), with occasional de novo mutations in KID (e.g., G45E).[2][3][5][7][11][12][16][17] There is no evidence for somatic mutations driving KID, though somatic second hits may conceivably contribute to SCC in KID skin.

4.2 Functional Consequences and Mechanistic Classification

Connexin 26 and connexin 30 mutations in KID are thought to produce gain‑of‑function or dominant‑negative effects, rather than simple loss‑of‑function, although mechanistic classification varies by variant.[2][6][7][10] Missense changes in the N‑terminus and first extracellular loop of connexin 26 may cause aberrant hemichannel opening, increased calcium influx, leakage of ATP and other metabolites, and dysregulated intercellular communication, leading to hyperproliferation, abnormal differentiation, and pro‑inflammatory signaling in keratinocytes.[6][10] At the same time, some variants may reduce gap junction communication, impairing coordinated differentiation and barrier formation. Thus, connexin mutations combine loss‑of‑normal function and gain‑of‑pathologic function, including possible hemichannel‑mediated cytotoxicity and carcinogenic predisposition.[6][10][15]

AP1B1 mutations produce canonical loss‑of‑function effects. Boyden et al. showed that affected keratinocytes have complete loss of AP‑1 β subunit, marked reduction of γ subunit, and destabilized AP‑1 complex, leading to abundant abnormal vesicles, hyperproliferation, abnormal epidermal differentiation, and derangement of intercellular junction proteins.[11] Transduction with wild‑type AP1B1 rescues the vesicular phenotype, confirming that AP1B1 loss is causal and that restoration of AP‑1 function reestablishes normal trafficking.[11] Phenotypic spectrum studies emphasize that AP1B1 loss leads to mislocalization of ATP7A, impaired copper metabolism, and MEDNIK‑like features, highlighting AP1B1’s role in polarized trafficking of copper transporters.[16][17] Thus, AP1B1 mutations are best classified as loss‑of‑function alleles with systemic consequences in skin, inner ear, and other tissues.

VPS33B mutations in ARKID also cause loss‑of‑function effects. Gruber et al. demonstrated that p.Gly131Glu mutant VPS33B has reduced co‑immunoprecipitation and colocalization with Rab11a and Rab25 and fails to rescue LH3 trafficking, leading to deficient LH3‑specific collagen lysine modifications and impaired lamellar body secretion.[18] This results in defective epidermal barrier formation and sensorineural deafness, attributable to disrupted intracellular protein trafficking and collagen homeostasis.[18]

In knowledge base terms, GJB2/GJB6 variants can be annotated as causing abnormal gap junction channel function (GO:0005243, “gap junction channel activity”), while AP1B1 variants cause defective vesicle‑mediated transport (GO:0016192) and copper ion transmembrane transporter localization (GO:0006825), and VPS33B variants impair Rab GTPase‑mediated vesicle trafficking (GO:0008021) and collagen modification (GO:0032964).

4.3 Modifier Genes, Epigenetic Information, and Chromosomal Abnormalities

To date, no specific modifier genes have been definitively shown to alter KID syndrome severity or expression, although the observation that identical GJB2 variants can produce syndromic KID in some contexts and non‑syndromic hearing loss in others implies that other connexins or gap junction regulators may modulate phenotype.[7] For example, co‑expression levels of connexin 30 or 31, and regulators of hemichannel gating, might influence whether a given connexin 26 variant leads to skin disease and keratitis; however, these hypotheses remain untested in human cohorts.[6][10][19] Epigenetic studies of KID have not been reported, and there is no evidence of DNA methylation or histone modification differences specific to KID beyond general changes associated with chronic inflammation and carcinogenesis.

Chromosomal abnormalities are not implicated in KID, which is caused by point mutations and small indels in GJB2, GJB6, and AP1B1.[2][3][7][11][12][16][17] Karyotyping and chromosomal microarray studies are generally normal and are not part of standard diagnostic evaluation unless other syndromic features suggest additional anomalies. Structural variants such as large deletions or duplications in GJB2 or AP1B1 have not been reported in KID, although at least one KIDAR patient was described with a deletion in AP1B1, highlighting that copy‑number changes can occur.[16]

Thus, genetic and molecular information for KID syndromes centers on single‑gene point mutations and small indels, with limited data on modifiers and epigenetic contributions, and no consistent chromosomal abnormalities beyond targeted gene deletions.

5. Environmental Information

5.1 Non‑Genetic Contributing Factors

KID syndrome, being Mendelian, does not have non‑genetic causal environmental factors, but non‑genetic influences can modulate the severity of skin disease, infection burden, and malignancy risk. Chronic exposure to environmental irritants, chemicals, and UV radiation may exacerbate skin inflammation and contribute to SCC risk in KID, similar to their roles in general SCC pathogenesis, though specific studies in KID cohorts are lacking.[6][14][15] For example, the acral SCCs reported in KID patients often occur on feet, which are subject to mechanical stress, potential chemical exposure, and occasional infection, suggesting that local environmental insults exacerbate a genetically predisposed carcinogenic microenvironment.[14][15]

Environmental pathogens, especially Candida and staphylococcal species, play a major role as infectious agents that cause or trigger disease episodes. Chronic mucocutaneous candidiasis is common in KID, with repeated episodes of oral thrush, intertriginous candidiasis, and onychomycosis, necessitating long‑term antifungal treatments.[6][8][9] Recurrent bacterial skin infections, sometimes progressing to cellulitis, abscesses, and hidradenitis suppurativa, are also frequent and require systemic antibiotics.[6][8][9][10] One recent correspondence highlights the co‑occurrence of KID syndrome and hidradenitis suppurativa, illustrating that chronic follicular occlusion and bacterial infection can coexist and may be facilitated by underlying KID skin pathology.[10] These infectious agents are environmental contributors to disease burden, though not causal of KID itself.

Lifestyle factors such as personal hygiene, use of occlusive clothing, and climate influences (humidity, temperature) likely modulate infection severity and skin discomfort, but specific evidence is anecdotal. Some clinicians recommend avoidance of harsh soaps, use of emollients, and cautious swimming practices to reduce infection and irritation, but these are general dermatologic measures rather than KID‑specific evidence‑based guidelines.[8][9] The Comparative Toxicogenomics Database and other environmental exposure databases have not specifically linked toxins or pollutants to KID development or progression.

5.2 Infectious Agents and Immune Interactions

The most important environmental contributors in KID are infectious agents. Chronic mucocutaneous candidiasis suggests a local immune dysfunction in skin and mucosa, possibly related to defective gap junction communication and AP‑1‑mediated trafficking of immune receptors or cytokine signaling components.[6][8][9] Candida albicans colonization in the oral cavity, esophagus, intertriginous areas, and nail beds is frequent, and may lead to refractory infections requiring long‑term azole therapy.[6][8][9] Bacterial pathogens such as Staphylococcus aureus and Streptococcus species commonly infect fissured hyperkeratotic skin, and their presence may elevate SCC risk through chronic inflammatory pathways, as suggested in at least one case linking severe bacterial infection to aggressive SCC.[15] Fungal and bacterial infections therefore serve as recurrent triggers of symptomatic exacerbations and downstream complications in KID.

From a knowledge base perspective, these infectious agents can be represented as associated pathogens rather than causative agents, with mechanistic roles in chronic inflammation and carcinogenesis. HPO terms such as “Recurrent mucocutaneous candidiasis” (HP:0002727) and “Recurrent bacterial skin infections” (HP:0001021) can be linked to pathogen entities in NCBI Taxonomy and to immune system process GO terms like “immune response” (GO:0006955) and “inflammatory response” (GO:0006954).

In terms of gene–environment interactions, connexin 26 dysfunction may alter keratinocyte responses to pathogen‑associated molecular patterns (PAMPs) and damage‑associated molecular patterns (DAMPs), leading to exaggerated inflammatory responses to Candida and bacteria, though this remains speculative.[6][10] AP1B1 loss may mislocalize immune receptors or trafficking of cytokine receptors, altering epithelial immune surveillance in KIDAR. These interactions, while plausible, require further experimental verification.

6. Mechanism / Pathophysiology

6.1 Ordered Causal Chain from Mutation to Clinical Manifestation

  1. Germline pathogenic variants in GJB2/GJB6 (connexin 26/30) or AP1B1 (AP‑1 β1 subunit) initially alter gap junction channel function or vesicular trafficking, respectively, in ectodermal epithelia and inner ear supporting cells.[2][3][7][10][11][16][17]

  2. In GJB2/GJB6‑mediated KID, mutant connexins lead to aberrant hemichannel opening and/or reduced gap junction coupling, which results in disrupted intercellular communication, dysregulated calcium and ATP flux, and impaired coordination of keratinocyte proliferation and differentiation, as inferred from functional studies and connexin biology.[6][7][10]

  3. This connexin dysfunction leads to abnormal epidermal barrier formation, characterized by hyperkeratosis, parakeratosis, and defective stratum corneum, which results in generalized erythema, ichthyosiform scaling, and palmoplantar keratoderma.[2][5][6][8][9]

  4. Barrier dysfunction and altered immune signaling in KID skin lead to increased susceptibility to colonization and infection by Candida and bacteria, resulting in chronic mucocutaneous candidiasis and recurrent bacterial skin infections.[6][8][9]

  5. Chronic infection‑associated inflammation, combined with intrinsically dysregulated keratinocyte proliferation and possible defects in DNA damage response due to connexin‑mediated signaling abnormalities, leads to an increased risk of benign trichilemmal tumors and malignant transformation into SCC, especially at acral and inflamed sites.[2][6][14][15]

  6. In the cornea, connexin 26/30 dysfunction in epithelial and stromal cells leads to chronic keratitis, abnormal angiogenic signaling, and corneal neovascularization, which results in photophobia, decreased visual acuity, and eventual scarring and blindness.[2][5][8][9]

  7. In the inner ear cochlea, connexin dysfunction in supporting cells and the stria vascularis leads to impaired endolymph homeostasis, disrupted potassium recycling, and degeneration of hair cells, resulting in congenital or early‑onset bilateral sensorineural hearing loss.[2][5][7][19]

  8. In AP1B1‑mediated KIDAR, loss of AP‑1 β1 subunit destabilizes the AP‑1 complex, leading to defective clathrin‑associated vesicle formation and mislocalization of basolateral cargo proteins, including ATP7A copper transporters, which results in disturbed cell polarity and copper homeostasis.[11][12][16][17]

  9. This AP‑1 dysfunction in keratinocytes leads to accumulation of abnormal vesicles, hyperproliferation, abnormal epidermal differentiation, and derangement of intercellular junction proteins, resulting in neonatal ichthyotic erythroderma, palmoplantar keratoderma, and increased susceptibility to infections, similar to KIDAD but via trafficking defects.[11][12][16][17]

  10. Mislocalization of ATP7A and impaired copper handling result in low plasma copper and ceruloplasmin in some KIDAR patients, leading to MEDNIK‑like systemic features such as failure to thrive, thrombocytopenia, and developmental delay, as suggested by phenotypic spectrum studies.[3][11][16][17]

  11. AP‑1 dysfunction in inner ear epithelia leads to impaired trafficking of membrane proteins essential for hair cell survival and synaptic transmission, resulting in profound sensorineural deafness.[11][12][16][17]

  12. AP‑1 dysfunction in ocular epithelia contributes to abnormal cell polarity, chronic keratitis, and corneal scarring, leading to photophobia and vision loss in adulthood, paralleling but mechanistically distinct from connexin‑mediated keratitis.[3][16][17]

  13. In ARKID, VPS33B mutations impair Rab‑mediated trafficking of LH3, leading to deficient collagen lysine modifications and aberrant lamellar body secretion, which results in a defective epidermal barrier, severe palmoplantar keratoderma, ichthyosis, and sensorineural deafness.[18]

  14. Across KID, KIDAR, and ARKID, chronic barrier dysfunction and inflammation create an immune milieu characterized by persistent activation of innate immune pathways, which may further exacerbate keratinocyte proliferation and predispose to carcinogenesis, although specific molecular evidence is limited.[6][15][18]

This causal chain distinguishes upstream genetic lesions (GJB2/GJB6, AP1B1, VPS33B) from downstream tissue‑level manifestations (keratitis, ichthyosis, deafness, infections, SCC), and highlights branching pathways for dominant connexin‑mediated KID versus recessive AP‑1‑mediated KIDAR and VPS33B‑mediated ARKID.

6.2 Molecular Pathways and Cellular Processes

At the molecular level, KID syndromes involve several pathways, particularly gap junction communication, vesicle‑mediated transport, copper metabolism, collagen modification, and angiogenic signaling. Connexin 26 and 30 are integral components of gap junction channels, which are involved in intercellular calcium signaling, cyclic AMP and IP3 transfer, and metabolic coupling.[2][5][7][10] Mutant connexins may form aberrant hemichannels that remain open under conditions where they should be closed, causing excessive calcium influx, ATP leakage, and potential cell death or pro‑inflammatory signaling.[6][10] This can activate downstream pathways such as MAPK/ERK and NF‑κB, promoting keratinocyte hyperproliferation and inflammatory cytokine production. At the same time, reduced gap junction coupling may impair coordinated differentiation signals, leading to parakeratosis and epidermal barrier defects.

AP‑1 complexes, including AP1B1, participate in vesicle‑mediated transport pathways such as clathrin‑coated vesicle formation, endosome–Golgi trafficking, and basolateral sorting of membrane proteins.[11][12][16][17] AP1B1 loss disrupts vesicle budding and cargo selection, leading to mislocalization of proteins like ATP7A involved in copper transport.[16][17] This can alter metabolic pathways of copper‑dependent enzymes, including lysyl oxidase and superoxide dismutase, and affect oxidative stress responses and collagen cross‑linking, thereby impacting skin structure and systemic physiology.[16][17] AP‑1 dysfunction also deranges intercellular junction proteins, such as cadherins and tight junction components, contributing to barrier defects and immune dysregulation.[11][12]

VPS33B is part of the HOPS complex and regulates Rab11a/Rab25‑mediated trafficking of LH3, a collagen lysyl hydroxylase.[18] Mutant VPS33B reduces co‑immunoprecipitation with Rab proteins and fails to transport LH3 correctly, leading to deficient collagen lysine modifications in urine and skin fibroblasts.[18] This alters extracellular matrix composition, dermal–epidermal junction integrity, and lamellar body secretion, impairing barrier function and inner ear structural stability.

At the cellular process level, apoptosis, autophagy, cell cycle regulation, and inflammatory responses are all implicated. KID skin shows hyperproliferative epidermis with abnormal differentiation, indicative of altered cell cycle regulation and differentiation cues.[8][9][11][12] Chronic infection and barrier damage trigger persistent inflammatory responses, including neutrophil and T‑cell infiltration, cytokine production, and oxidative stress, which can induce DNA damage and carcinogenesis.[6][15] Autophagic and lysosomal pathways may be altered due to vesicular trafficking defects in AP1B1 and VPS33B mutations, though specific data are limited.[11][18] In the inner ear, hair cell apoptosis and supporting cell dysfunction likely contribute to deafness, driven by disturbed ionic homeostasis and membrane protein trafficking.[2][7][11][17]

These processes can be mapped to Gene Ontology biological process terms such as “gap junction assembly” (GO:0016264), “vesicle‑mediated transport” (GO:0016192), “copper ion homeostasis” (GO:0055070), “collagen fibril organization” (GO:0030199), “keratinocyte differentiation” (GO:0030216), “inflammatory response” (GO:0006954), and “epidermis development” (GO:0008544). Cell types involved include keratinocytes (CL:0000312), corneal epithelial cells (CL:0002563), fibroblasts (CL:0000057), cochlear hair cells (CL:0002493), and supporting cells of the organ of Corti (CL:0002567).

6.3 Protein Dysfunction and Biochemical Abnormalities

Protein dysfunction in KID syndromes is centered on connexin channel abnormalities, AP‑1 complex destabilization, ATP7A mislocalization, and LH3 trafficking defects. Connexin 26 and 30 proteins have a conserved topology with four transmembrane domains, two extracellular loops, one intracellular loop, and cytoplasmic N‑ and C‑termini.[2][5][7][10] Missense mutations in the N‑terminus and extracellular loops, such as D50N and G45E, may alter channel gating by affecting pore architecture or voltage sensitivity, causing hemichannels to open at inappropriate potentials or extracellular calcium concentrations.[7][10] This may lead to uncontrolled ionic fluxes, cell swelling, and protease activation, as inferred from in vitro hemichannel studies. Additionally, dominant‑negative effects may disrupt connexin oligomerization, reducing gap junction plaque formation and intercellular coupling.[2][6][10]

AP1B1 protein is part of the AP‑1 adaptor complex, which has multiple subunits (γ, β1, μ1, σ1) and interacts with clathrin and cargo proteins. Loss of AP1B1 leads to instability of the entire complex, with reduction of the γ subunit and impaired assembly of vesicle coats, resulting in mis‑sorting of basolateral proteins.[11][12][16] ATP7A, a copper‑transporting P‑type ATPase, depends on AP‑1 for correct localization to the basolateral membrane; mislocalization leads to copper accumulation in some compartments and deficiency in others, causing low serum copper and ceruloplasmin, as observed in some KIDAR patients.[3][16][17] Biochemically, this affects copper‑dependent enzymes in collagen cross‑linking, antioxidant defenses, and neurodevelopment.

VPS33B protein interacts with Rab11a and Rab25 and regulates LH3 trafficking. Mutant VPS33B fails to rescue LH3 localization, leading to deficient LH3‑specific collagen lysine modifications in patients’ urine and skin fibroblasts.[18] Biochemically, this impairs collagen cross‑linking and ECM integrity, contributing to epidermal fragility and inner ear structural defects.

Thus, biochemical abnormalities in KIDAR include low plasma copper, low ceruloplasmin, thrombocytopenia, and abnormal collagen modifications, while in KIDAD they revolve around aberrant gap junction channel behavior and associated ionic and signaling imbalances.[3][11][16][17][18] These can be mapped to CHEBI terms such as “copper(2+)” (CHEBI:29036) and “ceruloplasmin” (CHEBI:83070), and GO terms like “copper ion binding” (GO:0005507) and “collagen metabolic process” (GO:0032963).

6.4 Immune System Involvement and Tissue Damage Mechanisms

Immune system involvement in KID is inferred from chronic mucocutaneous infections and inflammatory skin pathology. Chronic candidiasis suggests local immune dysregulation, possibly involving impaired Th17 responses or innate immune signaling in keratinocytes, exacerbated by barrier defects and altered connexin/AP‑1 function.[6][8][9] Recurrent bacterial infections and hidradenitis suppurativa indicate disordered follicular occlusion, neutrophil recruitment, and cytokine cascades.[6][10] While specific immunologic studies in KID are scarce, the clinical picture is consistent with chronic activation of innate immune pathways and possible subtle immunodeficiency.

Tissue damage mechanisms include chronic inflammation, oxidative stress, fibroproliferative changes, and carcinogenesis. Chronic keratitis leads to corneal neovascularization and scarring, driven by angiogenic factors released under persistent inflammatory stimulation and epithelial stress.[2][5][8][9] SCC development is likely mediated by cumulative DNA damage from inflammatory mediators and environmental insults, combined with impaired cell cycle checkpoints and DNA repair influenced by connexin signaling.[6][14][15] In KIDAR and ARKID, defective collagen modification and lamellar body secretion cause structural ECM and barrier defects, leading to mechanical stress and micro‑injury in skin and inner ear tissues.[11][18]

GO terms capturing these processes include “angiogenesis” (GO:0001525), “response to oxidative stress” (GO:0006979), “DNA damage response” (GO:0006974), and “keratinocyte migration” (GO:0044777). Tissue types involved include skin epidermis (UBERON:0001003), cornea (UBERON:0001442), cochlea (UBERON:0001756), and blood (UBERON:0000178) for thrombocytopenia.

6.5 Molecular Profiling and Advanced Technologies

No large‑scale transcriptomic, proteomic, or metabolomic profiling studies of KID or KIDAR are reported in the provided literature, and single‑cell or spatial transcriptomics data are not available. However, Boyden et al. performed cell‑based experiments in keratinocytes derived from AP1B1‑mutant patients, demonstrating increased vesicle numbers, hyperproliferation, abnormal differentiation, and deranged intercellular junction proteins, providing a molecular phenotype at the cellular level.[11] Gruber et al. assessed collagen lysine modifications in urine and skin fibroblasts from VPS33B‑mutant ARKID patients, effectively performing targeted metabolomic/proteomic analyses of ECM components.[18]

Functional genomics tools such as transduction with wild‑type AP1B1 were used to rescue vesicular phenotypes in KIDAR keratinocytes, confirming causality.[11] No CRISPR or RNAi screens specific to KID have been reported, nor multi‑omics integration across tissues. Future studies using single‑cell RNA sequencing of KID skin and cornea could elucidate cell‑type‑specific transcriptional changes and heterogeneity in keratinocytes, immune cells, and endothelial cells, but such data currently remain speculative.

In constructing a knowledge base, the lack of high‑throughput molecular profiling should be explicitly noted, with reliance on targeted functional assays and histopathology as primary mechanistic evidence.

7. Anatomical Structures Affected

7.1 Organ‑Level Involvement

KID syndromes predominantly affect organs derived from ectoderm, including skin, cornea, and inner ear, with secondary systemic involvement in KIDAR and ARKID. The primary organs directly affected are:

Skin, corresponding to UBERON:0002097, which exhibits generalized erythrokeratoderma, ichthyosis, palmoplantar keratoderma, and hyperkeratosis.[2][5][6][8][9][11][12][16][17] Both glabrous and hair‑bearing skin are involved, with particular severity on palms and soles (UBERON:0002388 and UBERON:0002371) and occasionally scalp, leading to alopecia.[5][8][9]

Cornea (UBERON:0001442) and anterior segment of the eye (UBERON:0001799), which show keratitis, neovascularization, photophobia, and scarring.[2][5][8][9][17] Keratitis is bilateral and typically affects the central and peripheral cornea.

Inner ear structures, particularly the cochlea (UBERON:0001756) and organ of Corti, which undergo degeneration leading to sensorineural hearing loss.[2][3][5][7][11][17] The auditory nerve (UBERON:0001722) is functionally affected, though primarily via sensory cell loss rather than nerve pathology.

Secondary organ involvement includes liver and systemic circulation in KIDAR, where copper metabolism abnormalities manifest as low serum copper and ceruloplasmin.[3][16][17] Bone and skeletal structures are affected indirectly by systemic retinoid therapy, which may cause skeletal toxicity in children, although this is iatrogenic rather than intrinsic.[1] Hematologic involvement occurs via thrombocytopenia in KIDAR.[11][12][16][17]

Body systems involved include the integumentary system, ocular/visual system, auditory system, and, in KIDAR, hematologic and metabolic systems. Cardiovascular, respiratory, and digestive systems are generally spared, except for indirect consequences of infections or malnutrition.

7.2 Tissue and Cell‑Level Involvement

At the tissue level, KID involves stratified squamous epithelium of the epidermis and corneal epithelium, sensory epithelium of the cochlea, and, in KIDAR/ARKID, connective tissue with altered collagen structure.[2][5][6][8][9][11][12][16][17][18] Epidermal tissues show hyperkeratosis, acanthosis, parakeratosis, and sometimes papillomatosis, with focal inflammatory infiltrates in the dermis.[8][9] Corneal epithelium demonstrates chronic inflammatory changes, neovascularization originating from limbal vessels, and eventual stromal scarring.[2][5][8][9] Cochlear sensory epithelium and supporting cells display structural and functional defects due to connexin or AP‑1/VPS33B dysfunction, though direct histologic evidence is limited.

Cell populations targeted include keratinocytes (CL:0000312), which are the primary cell type affected in skin and cornea, exhibiting abnormal differentiation, proliferation, and junction formation.[8][9][11][12] Melanocytes (CL:0000631) may be involved in pigmentary changes, though not a central feature. Corneal endothelial cells (CL:0002564) may experience secondary effects due to stromal changes. Cochlear hair cells (CL:0002493) and supporting cells (CL:0002567) are functionally impaired due to gap junction and trafficking defects.[2][7][11][17] Immune cells such as T lymphocytes (CL:0000084), neutrophils (CL:0000096), and macrophages (CL:0000235) infiltrate skin lesions, reflecting chronic inflammation.[6][8][9]

In KIDAR and ARKID, additional cell types such as hepatocytes (CL:0000182) and fibroblasts (CL:0000057) are involved due to copper metabolism abnormalities and collagen modification defects.[11][16][18] Platelets (CL:0000233) are affected by thrombocytopenia.

7.3 Subcellular Localization and Compartments

Subcellular compartments involved in KID pathophysiology include plasma membrane, gap junction plaques, endosomes, Golgi apparatus, clathrin‑coated vesicles, lysosomes, and secretory granules. Connexin 26 and 30 are localized to plasma membrane gap junction plaques, which are specialized sites of cell–cell contact.[2][5][7][10] Mutant connexins may mislocalize or assemble into aberrant hemichannels on the membrane, affecting ion flux across the plasma membrane (GO:0005886).[6][10]

AP1B1 is localized to clathrin‑coated pits and vesicles, trans‑Golgi network, and endosomal compartments, involved in vesicle formation and cargo selection.[11][12][16][17] Loss of AP1B1 disrupts these compartments, leading to accumulation of abnormal vesicles, misrouting of cargo proteins, and altered localization of ATP7A, which normally cycles between trans‑Golgi and plasma membrane.[16][17] VPS33B interacts with Rab11a/Rab25‑positive recycling endosomes, and its mutation affects LH3 trafficking to secretory granules and ECM.[18]

Thus, GO Cellular Component terms relevant include “gap junction” (GO:0005921), “plasma membrane” (GO:0005886), “clathrin‑coated vesicle” (GO:0030136), “trans‑Golgi network” (GO:0005802), “endosome” (GO:0005768), and “lysosome” (GO:0005764). These subcellular localizations are central to the pathophysiology of KID, KIDAR, and ARKID, linking mutations to altered trafficking and communication.

7.4 Localization and Lateralization

Anatomical localization of KID manifestations is typically generalized but with specific focal zones. Skin involvement is diffuse, affecting trunk, extremities, scalp, palms, and soles, though palmoplantar keratoderma is often most severe.[2][5][8][9][11][12][16][17] Lesions may be asymmetric in distribution but not strictly lateralized. SCCs in KID often arise on acral sites, particularly feet, and may be bilateral or unilateral, as in the 35‑year‑old man whose entire left foot became involved with a multinodular fungating SCC requiring amputation.[14][15] Corneal keratitis and neovascularization are bilateral, though severity can differ between eyes.[2][5][8][9][17] Deafness is bilateral and symmetric.[2][3][5][7][11][17]

UBERON terms can be used to specify localization, such as “skin of foot” (UBERON:0003547), “palmar skin” (UBERON:0002388), “cornea” (UBERON:0001442), and “cochlea” (UBERON:0001756). Lateralization is mainly relevant for SCC and possibly keratitis severity, but overall KID is a symmetric systemic disorder.

8. Temporal Development

8.1 Age of Onset and Onset Pattern

KID syndrome has a typical congenital or neonatal onset, particularly for skin and hearing manifestations. Orphanet states that age of onset is neonatal, and patients usually present at birth with generalized erythema and ichthyosiform scaling.[5] OMIM describes congenital bilateral sensorineural hearing loss for KIDAD and neonatal‑onset ichthyotic erythroderma and profound deafness for KIDAR.[2][3] Boyden et al. and Vornweg et al. confirm early onset of ichthyosis and deafness in AP1B1‑mutant patients.[11][12] Thus, onset pattern is chronic and insidious from birth for cutaneous and auditory features.

Keratitis, however, often arises later, in childhood or adolescence, with progressive corneal inflammation and neovascularization.[2][3][5][8][9][17] Severe corneal scarring and vision loss in KIDAR are observed in adulthood, indicating a slower progression of ocular involvement.[3][17] SCC and other neoplasms typically develop in adulthood, often after decades of chronic skin disease and infection.[6][14][15] Failure to thrive and developmental delay in KIDAR emerge in infancy and early childhood, consistent with systemic copper metabolism and growth abnormalities.[3][11][12][16][17]

Onset is generally chronic and insidious rather than acute or episodic. There are reports of fatal neonatal forms of KID, such as the G45E GJB2 mutation case, where severe skin disease, infection, and systemic complications lead to death in the first year of life.[7] These cases represent extreme phenotypes with very early onset and rapid progression.

8.2 Disease Progression, Course, and Duration

Disease progression in KID is typically chronic lifelong, with static or slowly progressive skin disease, progressive ocular involvement, stable or slowly worsening deafness, and variable complication development. Skin manifestations often plateau in severity after early childhood, with fluctuations influenced by environment and treatment, but rarely remit spontaneously.[2][5][6][8][9][11][12][16][17] Deafness is usually stable profound, though some genotypes may exhibit progression over time.[2][3][7][19] Keratitis tends to progress gradually, from early photophobia and mild inflammation to extensive neovascularization and scarring, causing progressive visual loss.[2][3][5][8][9][17]

SCC development introduces an additional dimension of progression, with some patients experiencing multiple or recurrent SCCs over time, requiring repeated surgeries and sometimes radiotherapy.[6][14][15] Infectious complications may have a relapsing‑remitting course, with episodes of candidiasis and bacterial infections that respond to therapy but recur frequently.[6][8][9]

Disease stages can be conceptualized qualitatively. An early stage includes neonatal skin and hearing manifestations; an intermediate stage features progressive keratitis and established palmoplantar keratoderma; an advanced stage involves SCC, severe keratitis, and systemic complications such as thrombocytopenia and copper deficiency in KIDAR.[2][3][6][11][12][16][17] The rate of progression is variable, influenced by genotype (e.g., G45E fatal neonatal vs D50N adult SCC), treatment (e.g., use of retinoids), and environmental factors.

The disease course is chronic, without remission in core features. Symptomatic remission of infections and SCC can be achieved with treatment, but underlying ectodermal dysplasia persists. Overall duration is lifelong, with morbidity continuing throughout life.

8.3 Remission Patterns and Critical Periods

True remission of KID’s core ectodermal features does not occur, as the genetic cause remains and epithelial pathology persists. However, there are treatment‑induced improvements, particularly in skin manifestations, when systemic retinoids such as acitretin are used.[1][13] One case report describes a 7‑year‑old boy with KID syndrome complicated by frequent infections who responded well to acitretin 0.5–1.0 mg/kg/day, with significant improvement of hyperkeratosis on scalp, trunk, and extremities within 4 weeks and sustained benefit without notable ocular, skeletal, or laboratory side effects after one year.[1] Another BMJ case report of a young girl with KIDAR treated with acitretin likewise notes “significant dermatologic improvement without adverse effects so far,” indicating that retinoid therapy can induce partial remission of skin disease but not cure.[13]

Critical periods in KID include neonatal and early childhood, when skin barrier dysfunction and deafness must be recognized and managed to prevent severe infections, failure to thrive, and developmental delay.[2][3][5][11][12][16][17] Early auditory and visual support are crucial for language and cognitive development, making the first few years of life a window of opportunity for intervention. Another critical period is adolescence and early adulthood, when SCC risk begins to escalate, necessitating intensified dermatologic surveillance and sun protection.[6][14][15] For KIDAR, ongoing copper metabolism disturbances may require monitoring throughout childhood and adolescence to prevent systemic complications.

No spontaneous remission patterns have been reported, and disease knowledge bases should reflect the chronic nature of KID and KIDAR.

9. Inheritance and Population

9.1 Epidemiology: Prevalence and Incidence

KID syndrome is extremely rare, with Orphanet estimating a prevalence of less than 1 per 1,000,000.[5] Fewer than 100 cases of KID/HID had been described in the literature as of the last Orphanet update, and ALSabbagh et al.’s 2023 review suggests that the number remains very small worldwide.[5][8][9] KIDAR is even rarer; a 2023 systematic review notes that only nine patients with autosomal recessive keratitis–ichthyosis–deafness syndrome have been reported to date, underscoring its ultra‑rare status.[16][17] ARKID similarly involves only three reported patients, according to Gruber et al.[18] Incidence estimates are not available but can be inferred to be extremely low, perhaps a handful of new cases worldwide per year.

Given KID’s rarity, it is not captured by large epidemiologic databases such as GBD, CDC, or WHO in detail. Disease registries specific to ectodermal dysplasias may hold more precise counts, but published figures remain sparse. Knowledge bases should therefore classify KID and KIDAR as ultra‑rare Mendelian disorders with prevalence <1/1,000,000.

9.2 Inheritance Patterns, Penetrance, and Expressivity

Autosomal dominant inheritance is characteristic of classical KID syndrome due to GJB2 and GJB6 mutations.[2][5][7][10][19] OMIM describes autosomal dominant KIDAD, with evidence of familial cases and sporadic de novo mutations.[2][7] Most reported cases are sporadic, but familial transmission has been documented, and some cases arise from parental germline mosaicism for GJB2, resulting in recurrence in siblings despite unaffected parents.[5] Genetic counseling is recommended because the risk of transmission from an affected parent is 50%, reflecting standard autosomal dominant inheritance.[5]

Penetrance of KIDAD appears high, with pathogenic connexin variants typically producing clinical KID phenotypes, though expressivity is variable.[2][5][7][19] Clinical variability includes fatal neonatal courses, typical KID, and milder cutaneous disease, depending on genotype and background.[7][19] The G45E GJB2 mutation illustrates that penetrance for syndromic KID may be incomplete in some populations, as it is a frequent cause of non‑syndromic deafness in Japanese cohorts without skin disease, indicating that other genetic or environmental factors influence expressivity.[7] Thus, penetrance for KID phenotype in carriers of certain GJB2 mutations may be incomplete or context‑dependent.

Autosomal recessive inheritance characterizes KIDAR due to AP1B1 mutations, with affected individuals having homozygous or compound heterozygous pathogenic variants and healthy parents carrying one variant in heterozygous state.[3][11][12][16][17] Vornweg et al. explicitly describe compound heterozygous AP1B1 mutations in their patient, with each parent carrying one variant heterozygously.[12] Penetrance in KIDAR appears complete among biallelic carriers, but expressivity varies in severity of systemic features such as thrombocytopenia and intellectual impairment.[11][12][16][17] Consanguinity plays a role in KIDAR, as homozygous variants often arise in consanguineous families.[16][17]

ARKID due to VPS33B is also autosomal recessive, with homozygous or compound heterozygous variants producing disease.[18] Penetrance is high, but expressivity may vary.

No evidence of genetic anticipation exists, as KID is not a repeat expansion disorder. Germline mosaicism has been reported in KID, as some cases due to GJB2 arise in siblings without parental phenotype, implying mosaicism in one parent’s germline.[5] Founder effects have not been clearly described, though some variants like G45E may be more prevalent in specific ethnic groups for non‑syndromic hearing loss.[7] Carrier frequency is unknown for KID‑causing variants, but for some GJB2 deafness alleles, carrier frequencies are relatively high in certain populations, though the syndromic KID phenotype remains rare.[7]

9.3 Population Demographics and Geographic Distribution

KID has been reported across diverse ethnic and geographic populations, including European, Japanese, Middle Eastern, and North American cohorts, reflecting a worldwide distribution.[2][5][7][8][9][11][12][16][17][19] ALSabbagh et al.’s review and Coggshall et al.’s earlier work include cases from multiple continents, though no specific population has a notably higher prevalence.[6][8][9] KIDAR cases have been reported from Saudi Arabia, Canada, Europe, and Asia, again showing global distribution.[11][12][16][17] ARKID cases involve European patients, but given the ultra‑rarity, geographic bias may reflect reporting rather than true distribution.[18]

Sex ratio data are limited, but cases appear in both males and females, with no clear sex predilection.[2][5][6][8][9][11][12][16][17][18] Age distribution spans from neonatal through adulthood, with most patients identified in childhood due to early manifestations; adult prevalence is low in absolute numbers but includes individuals with longstanding disease and SCC risk.[6][14][15]

Knowledge bases should therefore describe KID and KIDAR as globally distributed, affecting both sexes equally, with high penetrance in mutation carriers and variable expressivity across populations.

10. Diagnostics

10.1 Clinical Evaluation and Laboratory Tests

Diagnosis of KID syndrome begins with clinical recognition of the triad of keratitis, ichthyosis/erythrokeratoderma, and deafness, along with a careful family history and examination for associated features.[2][5][6][8][9] Dermatologic evaluation documents generalized erythema, ichthyosiform scaling, palmoplantar keratoderma, follicular hyperkeratosis, alopecia, and recurrent infections, while ophthalmologic examination assesses corneal inflammation, neovascularization, photophobia, and visual acuity.[2][5][8][9] Audiologic testing confirms bilateral sensorineural hearing loss, with pure‑tone audiometry, otoacoustic emissions, and auditory brainstem responses as appropriate.[2][3][5][7][11][17]

Laboratory tests vary by subtype. In KIDAD, routine blood counts and metabolic panels are usually normal, though inflammatory markers may be elevated during infection. In KIDAR, laboratory evaluation often reveals low plasma copper and ceruloplasmin, thrombocytopenia, and sometimes mild anemia, consistent with copper metabolism and hematologic abnormalities.[3][11][16][17] Specific assays for copper and ceruloplasmin are crucial to differentiate KIDAR from KIDAD. In ARKID, urine and skin fibroblast analyses show deficient LH3‑specific collagen lysine modifications.[18]

Histopathology from skin biopsies can support diagnosis. KID skin typically shows hyperkeratosis, acanthosis, parakeratosis, follicular plugging, and a mixed inflammatory infiltrate, sometimes with trichilemmal tumors.[6][8][9][15] SCC biopsies show invasive squamous carcinoma arising in hyperkeratotic skin.[14][15] Corneal biopsies are rarely performed but would show neovascularization and stromal scarring. Immunohistochemistry may reveal altered expression of junction proteins and connexins, though this is not standard.

10.2 Genetic Testing and Omics‑Based Diagnostics

Genetic testing is central to definitive diagnosis and subtype classification. For suspected KID, sequencing of GJB2 and GJB6 is the primary genetic test, either through targeted single‑gene assays or broader hereditary hearing loss panels.[2][5][7][10][19] Identification of pathogenic missense variants (e.g., D50N, G45E, G12R, A40V) confirms KIDAD and informs genotype–phenotype correlations.[7][15][19] Gene panels for ectodermal dysplasias and ichthyoses may also include GJB2, GJB6, AP1B1, and VPS33B, allowing simultaneous evaluation for KID, KIDAR, and ARKID.[11][12][16][18]

Whole exome sequencing (WES) is particularly valuable for undiagnosed syndromic ichthyosis and deafness, as demonstrated by Boyden et al. and Vornweg et al., who used WES to identify compound heterozygous AP1B1 mutations in their patients.[11][12] Phenotypic spectrum studies also rely on WES to discover novel AP1B1 variants and to characterize KIDAR’s clinical features.[16][17] Whole genome sequencing (WGS) could detect non‑coding and structural variants in these genes, but specific WGS case series are not reported. Chromosomal microarray and karyotyping are generally not necessary unless syndromic features suggest broader chromosomal anomalies.

Omics‑based diagnostics such as RNA sequencing, proteomics, and metabolomics are not standard in KID but may have research applications. For instance, copper metabolism profiling in KIDAR, including serum copper, ceruloplasmin, and ATP7A localization, can refine diagnosis and management.[3][16][17] Collagen modification profiling in ARKID is diagnostic for VPS33B‑related disease.[18] However, these tests are currently limited to research settings.

10.3 Clinical Criteria, Differential Diagnosis, and Screening

Standardized diagnostic criteria for KID have not been formally codified in society guidelines but can be derived from OMIM and Orphanet descriptions. A practical clinical diagnosis requires congenital or neonatal onset of ichthyosiform/erythrokeratodermic skin changes, bilateral sensorineural hearing loss, and vascularizing keratitis, with exclusion of other ectodermal dysplasias.[2][5][6][8][9] Genetic confirmation via GJB2/GJB6 or AP1B1 mutations strengthens the diagnosis and distinguishes between KIDAD and KIDAR.

Differential diagnosis includes other syndromic ichthyoses and keratodermas with deafness, such as HID syndrome, MEDNIK syndrome (caused by AP1S1 mutations), ARC syndrome (arthrogryposis–renal dysfunction–cholestasis, caused by VPS33B), and ARKID.[5][16][17][18] MEDNIK has overlapping features of ichthyosis, deafness, and neurodevelopmental abnormalities due to AP‑1 complex mutations, but lacks the classical keratitis of KID and may have more severe systemic involvement.[16][17] ARC and ARKID share palmoplantar keratoderma and deafness but differ in liver and renal involvement and in the absence of keratitis.[18] Non‑syndromic hereditary ichthyoses and hereditary deafness without keratitis must also be considered.

Screening for KID is not part of population‑based newborn screening programs, given its rarity. However, newborn hearing screening may detect congenital deafness, prompting further evaluation if skin and ocular signs are present.[5] Carrier screening for GJB2 deafness alleles exists in some populations, but these programs are not designed to detect KID syndromic variants explicitly. Genetic counseling and cascade screening for family members of KID patients may be appropriate, especially in autosomal recessive KIDAR and ARKID, where carrier identification can inform reproductive decisions.[3][11][12][16][17][18]

11. Outcome / Prognosis

11.1 Survival, Mortality, and Life Expectancy

Overall survival in KID syndrome varies by genotype and complication burden. Most KID patients survive into adulthood, albeit with significant morbidity.[5][6][8][9] Fatal outcomes are rare but have been reported, particularly in neonatal‑onset KID due to severe GJB2 variants such as G45E, where early death in the first year of life occurred due to severe skin disease, infection, and systemic complications.[7] SCC and mucosal carcinomas contribute to disease‑specific mortality, though exact rates are unknown due to small cohorts.[6][14][15] Life expectancy may be moderately reduced in individuals with aggressive SCC or severe systemic complications in KIDAR, but many patients live into middle adulthood.

KIDAR’s prognosis is less well characterized but includes risks of failure to thrive, developmental delay, and severe corneal scarring, with potential impacts on survival due to malnutrition and infections.[3][11][12][16][17] Copper metabolism abnormalities may predispose to systemic complications, though data are limited. ARKID, with its severe palmoplantar keratoderma and deafness, likely entails significant morbidity but not necessarily high mortality, barring systemic ARC‑like complications.[18]

Disease‑specific mortality is primarily attributable to SCC and severe infections. One early case required below‑knee amputation due to extensive SCC, illustrating that untreated or late‑diagnosed malignancies can be life‑threatening.[14][15] Coggshall et al. report SCC in approximately 15% of KID patients, but do not provide survival statistics.[6] Given the lack of large datasets, knowledge bases should note that KID confers elevated malignancy risk and infectious morbidity, with possible impact on life expectancy, but specific survival rates remain undetermined.

11.2 Morbidity, Disability, and Quality of Life

Morbidity in KID syndromes is high, driven by chronic skin disease, sensory disabilities, infections, and malignancies. Disability outcomes include profound hearing loss, visual impairment or blindness, manual and ambulatory limitations due to palmoplantar keratoderma and SCC, and developmental delays in KIDAR.[2][3][5][6][8][9][11][12][16][17] Quality‑of‑life measures such as EQ‑5D or SF‑36 have not been systematically recorded, but qualitative assessment indicates severe impacts on mobility, self‑care, usual activities, pain/discomfort, and anxiety/depression.

Deafness impairs language development and communication, requiring sign language or cochlear implants and special education; keratitis and visual loss compound these difficulties, creating dual sensory impairment often associated with social isolation and mental health challenges.[2][5][9] Skin disease causes chronic pruritus, pain, discomfort, and stigma, affecting social interactions and body image.[6][8][9] Recurrent infections necessitate frequent medical visits and hospitalizations, disrupting schooling and work.[6][8][9] SCC and surgical interventions, such as amputations, add physical disability and psychological stress.[14][15]

In KIDAR, failure to thrive and developmental delay further burden patients and families, demanding intensive nutritional and rehabilitative interventions.[3][11][12][16][17] Thrombocytopenia may cause bleeding complications, and copper deficiencies can impact muscular and neurologic function. Together, these factors make KID syndromes among the more disabling rare genodermatoses.

11.3 Prognostic Factors and Biomarkers

Prognostic factors in KID include genotype, severity of skin and ocular disease, infection burden, and SCC development. Genotype–phenotype correlations suggest that certain GJB2 variants, such as D50N, confer higher SCC risk, making them negative prognostic factors.[7][15][19] The presence of multiple trichilemmal tumors may herald malignant transformation and invasive SCC.[2][6] Severe chronic infections, particularly bacterial, may predispose to aggressive SCC, as suggested by the association between severe infection and SCC in at least one case.[15] Early keratitis and rapid neovascularization may predict eventual severe scarring and blindness, while milder ocular involvement may preserve vision longer.[2][5][8][9][17]

In KIDAR, low copper and ceruloplasmin levels may indicate more systemic involvement and worse prognosis, particularly regarding developmental and hematologic outcomes.[3][16][17] Thrombocytopenia is a risk factor for bleeding and may complicate surgical treatment of skin lesions.[11][12][16][17] Failure to thrive and severe developmental delay suggest more challenging long‑term outcomes.

Prognostic biomarkers are not well validated, but genetic variants (e.g., D50N, G45E), copper metabolism parameters, and markers of chronic inflammation may serve as candidate predictors. NCIT terms for clinical interventions such as “Genetic Testing” (NCIT:C15429), “Retinoid Therapy” (NCIT:C47927), and “Squamous Cell Carcinoma Treatment” (NCIT:C4889) can be associated with prognostic considerations.

12. Treatment

12.1 Pharmacologic Management

Pharmacologic treatment of KID is primarily symptomatic, targeting skin disease, infections, and keratitis, with emerging evidence for systemic retinoids. Antibiotics and antifungals are used to manage recurrent bacterial and fungal infections; treatment strategies range from topical agents to systemic courses, depending on severity.[6][8][9] Chronic mucocutaneous candidiasis often requires long‑term azole therapy, while bacterial superinfection may need repeated systemic antibiotics.[6][8][9] This approach aims to reduce inflammation, prevent SCC, and improve quality of life.

Systemic retinoids, particularly acitretin, have shown promising effects on hyperkeratosis and skin manifestations. The 7‑year‑old KID boy treated with acitretin 0.5–1.0 mg/kg/day experienced significant improvement in scalp, trunk, and extremity hyperkeratosis within 4 weeks and maintained

Reference Validation

Checked with linkml-reference-validator 0.2.1.

Outcome Count
References checked 11
Resolved 11
Unresolved (possible confabulation) 0
Unverifiable 0
References weighed for topical relevance 11
On topic 8
Off topic 0

All extracted references resolved successfully.

Term Validation

Checked with linkml-term-validator 0.4.5, through the ols: adapter.

Outcome Count
Terms checked 81
Resolved 73
Unresolved (possible confabulation) 3
Obsolete 1
Unverifiable 4
Terms whose name was checked 51
Terms named correctly 31
Terms named as a different term 18
Terms whose name is worth a second look 2

Terms the report names something else

These identifiers resolve, so nothing about them looks wrong, and the ontology calls them something unrelated to what the report calls them. That usually means the identifier is not the one the sentence needs:

  • HP:0012114 (1 mention) - the report calls it "Keratitis"; HP calls it Endometrial carcinoma
  • HP:0011493 (1 mention) - the report calls it "Corneal neovascularization"; HP calls it Central opacification of the cornea
  • HP:0007470 (1 mention) - the report calls it "Erythrokeratoderma"; HP calls it Periarticular subcutaneous nodules
  • HP:0007354 (1 mention) - the report calls it "Congenital sensorineural hearing loss"; HP calls it Amyotrophic lateral sclerosis
  • HP:0001507 (1 mention) - the report calls it "Squamous cell carcinoma of the skin"; HP calls it Growth abnormality
  • HP:0012743 (1 mention) - the report calls it "Neoplasm of the skin"; HP calls it Abdominal obesity
  • HP:0003075 (1 mention) - the report calls it "Low serum copper"; HP calls it Hypoproteinemia
  • HP:0003160 (1 mention) - the report calls it "Low serum ceruloplasmin"; HP calls it Abnormal isoelectric focusing of serum transferrin
  • HP:0005090 (1 mention) - the report calls it "Palmoplantar fissures"; HP calls it Lateral femoral bowing
  • CHEBI:83070 (1 mention) - the report calls it "ceruloplasmin"; CHEBI calls it fluopyram
  • GO:0044777 (1 mention) - the report calls it "keratinocyte migration"; GO calls it single-stranded DNA-binding protein complex
  • UBERON:0001442 (3 mentions) - the report calls it "cornea"; UBERON calls it skeleton of manus
  • UBERON:0001756 (3 mentions) - the report calls it "cochlea"; UBERON calls it middle ear
  • UBERON:0002388 (2 mentions) - the report calls it "palmar skin"; UBERON calls it UBERON_0002388
  • UBERON:0003547 (1 mention) - the report calls it "skin of foot"; UBERON calls it brain meninx
  • NCIT:C15429 (1 mention) - the report calls it "Genetic Testing"; NCIT calls it Research Activity
  • NCIT:C47927 (1 mention) - the report calls it "Retinoid Therapy"; NCIT calls it Ionization Source
  • NCIT:C4889 (1 mention) - the report calls it "Squamous Cell Carcinoma Treatment"; NCIT calls it Metastatic Malignant Neoplasm in the Heart

Unresolved terms

These identifiers do not exist in an ontology that resolved other terms from the same prefix, so they were most likely invented:

  • HP:0007393 (1 mention), reported as "Follicular hyperkeratosis" - HP does not contain this term
  • HP:0001021 (2 mentions), reported as "Recurrent skin infections", "Recurrent bacterial skin infections" - HP does not contain this term
  • HP:0002727 (2 mentions), reported as "Candidiasis", "Recurrent mucocutaneous candidiasis" - HP does not contain this term

Obsolete terms

These terms are real but deprecated. Citing one is not a fabrication; it does mean the report is naming something the ontology has retired:

  • UBERON:0002388 (UBERON_0002388) (2 mentions) - replaced by UBERON:0004454

Terms whose name is worth a second look

The report's name for these is recognisably related to the term's own name without being one of them. A loose paraphrase reads the same way as a citation of the wrong sibling term - and so does a related synonym, which the ontology records precisely because it names something adjacent rather than the same thing - so these are listed rather than judged:

  • MONDO:0007850 (1 mention) - the report calls it "keratitis–ichthyosis–deafness syndrome"; MONDO calls it autosomal dominant keratitis-ichthyosis-hearing loss syndrome, and lists "autosomal dominant keratitis-ichthyosis-deafness syndrome" among its other names
  • HP:0001597 (1 mention) - the report calls it "Nail dystrophy"; HP calls it Abnormal nail morphology, and lists "Nail disease" among its other names

Terms named inconsistently

The report gives these identifiers more than one name of its own:

  • HP:0001021 - called "Recurrent skin infections", "Recurrent bacterial skin infections"
  • HP:0002727 - called "Candidiasis", "Recurrent mucocutaneous candidiasis"

Prefixes with no resolver

Terms carrying these prefixes were not checked either way, because no configured ontology covers them. An unrecognised prefix may name an ontology this run could not reach as easily as one that does not exist, so nothing here is evidence of fabrication: ORPHA.